European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Open accessAbstract
nine societies and by invited experts)
Verified 2026-10-05 · 15 references not checked yet
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 655 cited sources checked · 0 supported · 0 flagged
- Findingown data
When evaluated with the AGREE instrument, only seven of the identified publications achieved a level considered considerable rigour.
“When these were evaluated using the Appraisal of Guidelines Research and Evaluation (AGREE) instrument, only seven achieved the level considered 'considerable rigour'.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Ferket, 2010, Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?, Arch Intern Med source
Not checked in the free run.
- Findingreasoning
In many MONICA centres there were substantial changes, up or down, in CVD events within periods as short as 10 years.
“In many MONICA centres there were quite substantial changes, up or down, in CVD events within time periods as small as 10 years.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
- Findingcitation
The relationship between changes in risk factor scores and changes in event rates was substantial.
“The relationship between changes in risk factor scores and changes in event rates was substantial.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
- Findingcitation
There was a significant association between treatment change and case fatality.
“Moreover, there was a significant association between treatment change and case fatality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
- Findingcitation
Lipid control has improved significantly.
“On the other hand, lipid control has improved significantly. 5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
- Findingcitation
The EUROASPIRE III hospital arm (2006-2007) in 8966 patients with established CHD from 22 European countries showed that large proportions do not achieve the lifestyles, risk factor levels, and therapeutic targets set in 2003.
“the results from the hospital arm of EUROASPIRE III 33 (2006-2007) in 8966 patients with established CHD from 22 European countries show that large proportions of patients still do not achieve the lifestyles, risk factor levels, and therapeutic targets set in 2003 by the third JTF.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Kotseva, 2009, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Findingcitation
A 5% SCORE risk of CVD death corresponds to a 10-25% Framingham risk of total CVD, depending on the Framingham function chosen.
“An examination of the Framingham estimates of risk of total CVD events results in similar conclusions: a 5% SCORE risk of CVD death equates to a 10 -25% Framingham risk of total CVD, depending upon which of the several Framingham functions is chosen.”
Quote in the paperNot a substantial claim - Findingown data
A person with a cholesterol concentration of 8 mmol/L can be at 10 times lower risk than someone with a cholesterol concentration of 5 mmol/L if the latter is a male hypertensive smoker.
“Table 5 shows that a person with a cholesterol concentration of 8 mmol/L (310 mg/dL) can be at 10 times lower risk than someone with a cholesterol concentration of 5 mmol/L (190 mg/dL) if the latter is a male hypertensive smoker.”
Quote in the paperSubstantial claim - Findingcitation
The EURO-ACTION project demonstrated that recommended lifestyle changes and targeted management of cardiovascular risk factors are achievable and sustainable in daily clinical practice in both primary and secondary care.
“The efficacy and safety of such programmes have been demonstrated in the EURO-ACTION project-an ESC demonstration project showing that the recommended lifestyle changes and the targeted management of cardiovascular risk factors are achievable and sustainable in daily clinical practice, in both primary and secondary care.35”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Wood, 2008, Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial, Lancet source
Not checked in the free run.
- Findingnone given
In some age categories, especially men, estimated cardiovascular death risks exceed 5-10% based on age and gender alone even when other risk factor levels are relatively low.
“In some age categories the majority, especially of men, will have estimated cardiovascular death risks exceeding the 5 -10% level, based on age (and gender) only, even when other cardiovascular risk factor levels are relatively low.”
Quote in the paperSubstantial claim - Findingreasoning
The multiplier from fatal to total CVD is smaller in older persons, in whom a first event is more likely to be fatal.
“This three-fold multiplier is somewhat smaller in older persons in whom a first event is more likely to be fatal.”
- Also stated in: § 3.1.3 Risk estimation · plain
“Again the lower end of the range applies to older persons.”
Quote in the paperNot a substantial claim - Also stated in: § 3.1.3 Risk estimation · plain
- Findingown data
At the 5% level of risk management advice, total CVD event risk calculated from FINRISK is 15%.
“Calculating total event rates from FINRISK suggests that, at the level (5%) at which risk management advice is likely to be intensified, total event risk is 15%.”
Quote in the paperSubstantial claim - Findingcitation
Fewer than half of patients tend to reach the targets for different recommendations and risk factor management.
“ideally, 100% of patients should reach the goals, but in practice fewer than half tend to reach the targets.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Kotseva, 2009, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Findingcitation
HDL cholesterol modifies risk at all levels of risk estimated from the SCORE cholesterol charts.
“For example, HDL cholesterol modifies risk at all levels of risk as estimated from the SCORE cholesterol charts.50”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Cooney, 2009, How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Findingcitation
In EUROASPIRE III, asymptomatic high-risk subjects in the primary prevention arm had even worse adherence to recommended lifestyles and proportions at goal for blood pressure, lipids, and blood glucose.
“In EUROASPIRE III, asymptomatic high-risk subjects have been included in the primary prevention arm; the adherence to the recommended lifestyles and the proportions at goal for blood pressure, lipids, and blood glucose are even worse.34”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Kotseva, 2010, EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Findingcitation
In post-myocardial infarction and heart failure patients, beta-blockade in carefully titrated doses is associated with improved outcomes.
“In those post-myocardial infarction and in heart failure patients, use of beta-blockade in carefully titrated doses is associated with improved outcomes.62,63”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
The clinical benefits of commercial genetic testing have not yet been demonstrated.
“The clinical benefits of commercial testing have not yet been demonstrated.74”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Botkin, 2010, Outcomes of interest in evidence-based evaluations of genetic tests, Genet Med source
Not checked in the free run.
- Findingcitation
Increased resting heart rate over time is associated with increased risk of cardiac events.
“Two large observational studies have demonstrated increased risk of cardiac events in individuals whose resting heart rate increased over time.58,59”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [58] Jouven, 2009, Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men, Am J Cardiol source
Not checked in the free run.
- cites [59] Nauman, 2011, Temporal changes in resting heart rate and deaths from ischemic heart disease, JAMA source
Not checked in the free run.
- Findingnone given
A person in the top right-hand box of the relative risk chart has a risk 12 times higher than a person in the bottom left.
“Thus a person in the top right-hand box has a risk that is 12 times higher than a person in the bottom left.”
Quote in the paperNot a substantial claim - Findingcitation
After adjustment for HDL cholesterol, there is no significant association between triglycerides and CVD.
“After adjustment for HDL cholesterol, there is no significant association between triglycerides and CVD.52”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Di Angelantonio, 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA source
Not checked in the free run.
- Findingcitation
Between one-third and one-half of age differences in CHD risk in Finnish people is explained by smoking, HDL:total cholesterol ratio, SBP, BMI, and diabetes.
“However, exposure to common risk factors also increases with age, and between one-third and one-half of the age differences (between 25 -49 vs. 50 -59 and 60 -64 years) in CHD risk in Finnish people is explained by smoking, HDL:total cholesterol ratio, SBP, body mass index (BMI), and diabetes.76”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Jousilahti, 1999, Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland, Circulation source
Not checked in the free run.
- Findingnone given
At any given age, risk estimates are lower for women than for men.
“At any given age, risk estimates are lower for women than for men.”
Quote in the paperNot a substantial claim - Findingcitation
Elevated heart rate is associated with increased risk of further cardiac events in those with established CVD.
“Elevated heart rate has been shown to be associated with increased risk of further cardiac events in those with established CVD.60,61”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [60] Fox, 2008, Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial, Lancet source
Not checked in the free run.
- cites [61] Diaz, 2005, Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease, Eur Heart J source
Not checked in the free run.
- Findingcitation
Decreased heart rate over time is associated with lower CVD risk in one study.
“However, the reverse has only been demonstrated in one of these studies; that individuals whose heart rate decreased over time had a lower risk of CVD.58”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Jouven, 2009, Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men, Am J Cardiol source
Not checked in the free run.
- Findingcitation
The HDL cholesterol effect is seen in both sexes and in all age groups, including older women.
“Furthermore, this effect is seen in both sexes and in all age groups, including older women.51”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Cooney, 2009, HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk, Atherosclerosis source
Not checked in the free run.
- Findingnone given
Some European countries have CVD mortality more than double the 220/100000 in men used to define low-risk countries.
“Some European countries have levels of risk that are more than double the CVD mortality of 220/100 000 in men used to define low-risk countries.”
Quote in the paperNot a substantial claim - Findingcitation
Sudden cardiac death is particularly associated with elevated resting heart rate.
“Sudden cardiac death was particularly associated with elevated resting heart rate.57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Shaper, 1993, Heart rate ischaemic heart disease sudden cardiac death in middle-aged British men, Br Heart J source
Not checked in the free run.
- Findingcitation
DNA-based tests for common genetic polymorphisms do not presently add significantly to diagnosis, risk prediction, or patient management.
“DNA-based tests for common genetic polymorphisms do not presently add significantly to diagnosis, risk prediction, or patient management and cannot be recommended.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Botkin, 2010, Informed consent for genetic research, Curr Protoc Hum Genet
Not checked in the free run.
- Findingcitation
Risk age is independent of the cardiovascular endpoint used.
“Risk age has been shown to be independent of the cardiovascular endpoint used, 67 which bypasses the dilemma of whether to use a risk estimation system based on CVD mortality or on the more attractive but less reliable endpoint of total CVD events.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Ehrenthal, 2012, Cardiovascular risk age: Concepts and practicalities Heart
Not checked in the free run.
- Findingcitation
In patients with resting heart rates at least 70 b.p.m. and reduced left ventricular function, trials of pure heart rate reduction have shown benefit.
“More recently, in patients with resting heart rates ≥70 b.p.m. and reduced left ventricular function (either coronary artery disease or heart failure), trials of pure heart rate reduction have shown benefit.64,65”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Fox, 2008, Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial, Lancet source
Not checked in the free run.
- cites [65] Swedberg, 2010, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Lancet source
Not checked in the free run.
- Findingcitation
Studies involving women were too few to draw firm conclusions about work stress.
“Studies involving women were too few to draw firm conclusions.94”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [94] Eller, 2009, Work-related psychosocial factors and the development of ischemic heart disease: a systematic review, Cardiol Rev source
Not checked in the free run.
- Findingcitation
Type D personality predicts poor prognosis in CVD patients (OR 3.7), even after adjustment for depressive symptoms, stress, and anger.
“The type D personality has been shown to predict poor prognosis in patients with CVD (OR 3.7), even after adjustment for depressive symptoms, stress, and anger.115”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [115] Denollet, 2010, A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile, Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- Findingcitation
Generalized, phobic anxiety, and panic attacks may worsen the course of established CVD (OR 1.01 and 2.0).
“and generalized, phobic anxiety, and panic attacks may worsen the course of established CVD (OR 1.01 and 2.0, respectively).107 -109”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [107] Frasure-Smith, 2008, Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease, Arch Gen Psychiatry source
Not checked in the free run.
- cites [108] Shibeshi, 2007, Anxiety worsens prognosis in patients with coronary artery disease, J Am Coll Cardiol source
Not checked in the free run.
- cites [109] Szekely, 2007, Anxiety predicts mortality and morbidity after coronary artery and valve surgery—a 4-year follow-up study, Psychosom Med source
Not checked in the free run.
- Findingcitation
Both women and men of lower socio-economic status and/or with chronic stress are more likely to be depressed, hostile, and socially isolated.
“For example, both women and men of lower socio-economic status and/or with chronic stress are more likely to be depressed, hostile, and socially isolated.116,117”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [116] Wamala, 1999, Potential explanations for the educational gradient in coronary heart disease: a population-based case–control study of Swedish women, Am J Public Health source
Not checked in the free run.
- cites [117] Chandola, 2008, Work stress and coronary heart disease: what are the mechanisms?, Eur Heart J source
Not checked in the free run.
- Findingcitation
There was an 18% difference in major CVD events in favour of ideal lifestyle versus no-risk factor groups: 2.2% and 2.6% per 10 years.
“There was a 18% difference in major CVD events in favour of the ideal lifestyle vs. the no-risk factor groups: 2.2% and 2.6% per 10 years, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Hsia, 2010, Evaluation of the American Heart Association cardiovascular disease prevention guideline for women, Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- Findingcitation
Lack of social support leads to decreased survival and poorer prognosis among people with clinical CVD (RR 1.5-3.0).
“Similarly lack of social support leads to decreased survival and poorer prognosis among people with clinical manifestations of CVD (RR 1.5-3.0).92,93”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Mookadam, 2004, Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview, Arch Intern Med source
Not checked in the free run.
- cites [93] Lett, 2005, Social support and coronary heart disease: epidemiologic evidence and implications for treatment, Psychosom Med source
Not checked in the free run.
- Findingcitation
Low socio-economic status is associated with increased all-cause and CVD mortality risk (RR 1.3-2.0).
“Multiple prospective studies have shown that men and women with low socio-economic status, defined as low educational level, low income, holding a low-status job, or living in a poor residential area, have an increased all-cause as well as CVD mortality risk [relative risk (RR) 1.3 -2.0].87 -91”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [87] Woodward, 2007, Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC), Heart source
Not checked in the free run.
- cites [88] Stringhini, 2010, Association of socioeconomic position with health behaviors and mortality, JAMA source
Not checked in the free run.
- cites [89] Tonne, 2005, Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods, Circulation source
Not checked in the free run.
- cites [90] Albert, 2006, Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events, Circulation source
Not checked in the free run.
- cites [91] Rahimi, 2007, Financial barriers to health care and outcomes after acute myocardial infarction, JAMA source
Not checked in the free run.
- Findingcitation
Social isolation is associated with increased risk of premature CVD death.
“Recent systematic reviews confirm that people who are isolated or disconnected from others are at increased risk of dying prematurely from CVD.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Mookadam, 2004, Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview, Arch Intern Med source
Not checked in the free run.
- cites [93] Lett, 2005, Social support and coronary heart disease: epidemiologic evidence and implications for treatment, Psychosom Med source
Not checked in the free run.
- Findingcitation
CVD patients who suppress their anger have increased risk of adverse cardiac events (OR 2.9).
“Failure to express anger might be of particular importance, as patients with CVD who suppress their anger have an increased risk of adverse cardiac events (OR 2.9).114”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [114] Denollet, 2010, Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease, Am J Cardiol source
Not checked in the free run.
- Findingcitation
Anger and hostility are associated with increased risk for cardiovascular events in healthy and CVD populations (HR 1.2).
“A recent meta-analysis has confirmed that anger and hostility are associated with an increased risk for cardiovascular events in both healthy and CVD populations (HR 1.2).113”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Chida, 2009, The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence, J Am Coll Cardiol source
Not checked in the free run.
- Findingcitation
Higher mortality in anxious patients was observed only in post-myocardial infarction patients with reduced systolic left ventricular function (HR 1.3).
“A higher mortality could only be observed in post-myocardial infarction patients with reduced systolic left ventricular function (HR 1.3), suggesting antipodal effects of anxiety in different subgroups of CVD patients.110”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Meyer, 2010, Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality, Psychosom Med source
Not checked in the free run.
- Findingcitation
Panic attacks increase risk of incident cardiovascular events (HR 1.7 and 4.2).
“Large epidemiological studies indicate that panic attacks increase the risk of incident cardiovascular events (HR 1.7 and 4.2, respectively), 105,106”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [105] Smoller, 2007, Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study, Arch Gen Psychiatry source
Not checked in the free run.
- cites [106] Chen, 2009, Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study, Psychosom Med source
Not checked in the free run.
- Findingcitation
A recent post-hoc analysis found lower all-cause mortality in anxious CVD patients (HR 0.7).
“In contrast to these findings, a recent post-hoc analysis of a large prospective cohort study found a lower all-cause mortality in anxious CVD patients (HR 0.7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Meyer, 2010, Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality, Psychosom Med source
Not checked in the free run.
- Findingcitation
A 45-year-old man who smokes, has SBP 180 mmHg, and cholesterol 8 mmol/L has a 10-year fatal CVD risk of 4% by SCORE charts.
“For example, a man of 45 who smokes, has a SBP of 180 mmHg, and a blood cholesterol of 8 mmol/L has a risk of fatal CVD of only 4% over 10 years (SCORE charts), suggesting no need for drug treatment.”
Quote in the paperSubstantial claim - Findingown data
The relative risk chart indicates that this man's risk is already 12-fold higher than that of a man with no risk factors.
“However, the relative risk chart (Figure 5) indicates that his risk is already 12-fold higher than that of a man with no risk factors.”
Quote in the paperNot a substantial claim - Findingcitation
Intervention studies using B vitamins to reduce plasma homocysteine have proven inefficient in reducing risk of CVD.
“In addition, intervention studies using B vitamins to reduce plasma homocysteine have proven inefficient in reducing risk of CVD.128”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Clarke, 2010, Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals, Arch Intern Med source
Not checked in the free run.
- Findingcitation
Homocysteine has shown precision as an independent risk factor for CVD.
“Homocysteine has shown precision as an independent risk factor for CVD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Clarke, 2010, Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals, Arch Intern Med source
Not checked in the free run.
- Findingnone given
There is lack of dose-effect or causality relationship between changes in hsCRP level and risk of CVD.
“Lack of dose-effect or causality relationship between changes in hsCRP level and risk of CVD.”
Quote in the paperSubstantial claim - Findingnone given
hsCRP has lack of precision: a narrow diagnostic window for hsCRP level and risk of CVD.
“Lack of precision: narrow diagnostic window for hsCRP level and risk of CVD.”
Quote in the paperSubstantial claim - Findingnone given
There is lack of specific therapeutic strategies or agents targeting circulating CRP and showing reduction in CVD incidence.
“Lack of specific therapeutic strategies or agents targeting circulating CRP and showing reduction in CVD incidence.”
Quote in the paperSubstantial claim - Findingnone given
hsCRP has multiplicity of confounders, depending on other classical major risk factors.
“Multiplicity of confounders: dependence on other classical major risk factors.”
Quote in the paperSubstantial claim - Findingnone given
hsCRP test has higher cost compared with classical biological risk factors.
“Higher cost of test compared with classical biological risk factors (e.g.blood glucose and lipids).”
Quote in the paperNot a substantial claim - Findingcitation
High-sensitivity CRP has shown consistency across large prospective studies as a risk factor integrating multiple metabolic and low-grade inflammatory factors underlying unstable atherosclerotic plaques, with magnitude matching classical major risk factors.
“High-sensitivity CRP has shown consistency across large prospective studies as a risk factor integrating multiple metabolic and lowgrade inflammatory factors underlying the development of unstable atherosclerotic plaques, with a magnitude of effect matching that of classical major risk factors.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [125] Berger, 2010, Screening for cardiovascular risk in asymptomatic patients, J Am Coll Cardiol source
Not checked in the free run.
- cites [126] Kaptoge, 2010, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet source
Not checked in the free run.
- Findingcitation
Financial barriers to healthcare predict negative outcomes after myocardial infarction.
“Financial barriers to healthcare have also been shown to predict negative outcomes after myocardial infarction.91”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Rahimi, 2007, Financial barriers to health care and outcomes after acute myocardial infarction, JAMA source
Not checked in the free run.
- Findingcitation
Routine screening for depression does not contribute to better cardiac prognosis in the absence of changes in current models of cardiovascular care.
“Routine screening for depression does not contribute to better cardiac prognosis in the absence of changes in current models of cardiovascular care.124”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [124] Thombs, 2008, Depression screening and patient outcomes in cardiovascular care: a systematic review, JAMA source
Not checked in the free run.
- Findingnone given
hsCRP has lack of specificity: similar level of risk for other noncardiovascular causes of morbidity and mortality.
“Lack of specificity: similar level of risk for other noncardiovascular causes of morbidity and mortality (e.g.other lowgrade inflammatory diseases).”
Quote in the paperSubstantial claim - Findingnone given
Thiazides have often been administered together with beta-blockers in trials showing a relative excess of new-onset diabetes, making the contributions of the two agents difficult to distinguish.
“Thiazides have often been administered together with beta-blockers in trials showing a relative excess of new-onset diabetes, thus making a distinction between the contributions of the two agents difficult to dissociate.”
Quote in the paperNot a substantial claim - Findingnone given
ACE inhibitors and angiotensin receptor antagonists are particularly effective in reducing left ventricular hypertrophy, including the fibrotic component.
“ACE inhibitors and angiotensin receptor antagonists are particularly effective in reducing LVH, including the fibrotic component”
Quote in the paperNot a substantial claim - Findingnone given
In subjects with high normal blood pressure uncomplicated by diabetes or previous cardiovascular events, no trial evidence shows treatment benefits except for delayed onset of hypertension.
“In subjects with high normal BP (SBP 130 -139 or DBP 85-89 mmHg) uncomplicated by diabetes or previous cardiovascular events, no trial evidence is available of treatment benefits, except for a delayed onset of hypertension.”
Quote in the paperSubstantial claim - Findingcitation
In a large observational study, the incidence of cardiovascular outcomes was not higher on atenolol-based treatment than on other antihypertensive agents.
“the incidence of cardiovascular outcomes was not higher on atenololbased treatment vs. other antihypertensive agents.405”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [405] Blackburn, 2007, Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents, J Hypertens source
Not checked in the free run.
- Findingcitation
The extra blood pressure reduction from combining drugs from two different classes is approximately five times greater than doubling the dose of one drug.
“The extra BP reduction from combining drugs from two different classes is approximately five times greater than doubling the dose of one drug.428”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [428] Wald, 2009, Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials, Am J Med source
Not checked in the free run.
- Findingcitation
The latest meta-analysis of 147 randomized trials reports that beta-blockers are slightly inferior to other agents in preventing stroke, with a 17% reduction rather than 29%.
“The latest meta-analysis of 147 randomized trials 394 reports only a slight inferiority of beta-blockers in preventing stroke (17% reduction rather than 29% reduction with other agents)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [394] Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ source
Not checked in the free run.
- Findingnone given
Effective 24-hour blood pressure control is prognostically important in addition to office blood pressure control.
“while effective 24-h BP control is prognostically important in addition to 'office' BP control.”
Quote in the paperSubstantial claim - Findingnone given
Initiation of antihypertensive drug therapy in patients with diabetes and high normal blood pressure is presently unsupported by prospective trial evidence.
“Initiation of antihypertensive drug therapy in patients with diabetes with high normal BP is presently unsupported by prospective trial evidence.”
Quote in the paperSubstantial claim - Findingnone given
Aliskiren's effect on cardiovascular morbidity and mortality has not yet been proven.
“However, its effect on cardiovascular morbidity and mortality has not yet been proven, but a number of studies are under way.”
Quote in the paperNot a substantial claim - Findingcitation
Beta-blockers have a similar effect to other agents in preventing coronary events and heart failure.
“but a similar effect to other agents in preventing coronary events and heart failure”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [394] Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ source
Not checked in the free run.
- Findingnone given
Thiazide diuretics have dyslipidaemic and diabetogenic effects, particularly when used at high doses.
“This also applies to thiazide diuretics, which have dyslipidaemic and diabetogenic effects, particularly when used at high doses.”
Quote in the paperSubstantial claim - Findingcitation
Beta-blockers have higher efficacy than other drugs in patients with a recent coronary event.
“and higher efficacy than other drugs in patients with a recent coronary event”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [394] Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ source
Not checked in the free run.
- Findingnone given
Combination treatment is needed to control blood pressure in most patients.
“Combination treatment is needed to control BP in most patients.”
Quote in the paperSubstantial claim - Findingnone given
There are no data documenting that alpha 1-blockers, centrally acting agents, and antialdosterone drugs reduce cardiovascular morbidity and mortality in hypertension.
“However, there are no data documenting the ability of these drugs to reduce cardiovascular morbidity and mortality in hypertension.”
Quote in the paperSubstantial claim - Findingreasoning
The main benefits of antihypertensive treatment are due to lowering blood pressure per se and are largely independent of the drugs employed.
“the main benefits of antihypertensive treatment are due to lowering of BP per se, and are largely independent of the drugs employed”
Quote in the paperSubstantial claim - Findingnone given
Until recently there has been little evidence that specifically targeting glycaemic control can reduce the frequency of cardiovascular endpoints.
“until recently there has been little evidence that specifically targeting glycaemic control can reduce the frequency of cardiovascular endpoints.”
Quote in the paperNot a substantial claim - Findingcitation
The UKPDS demonstrated a 16% risk reduction for myocardial infarction that was not statistically significant (P=0.052) associated with a 0.9% difference in HbA1c between intensive and conventional treatment groups.
“The study demonstrated a 16% risk reduction for myocardial infarction that was not statistically significantly (P ¼ 0.052) associated with the 0.9% difference in HbA 1c that was obtained between the intensive and conventional treatment groups.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [434] UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet source
Not checked in the free run.
- cites [439] UK Prospective Diabetes Study Group, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet source
Not checked in the free run.
- Findingcitation
Large meta-analyses confirm that antihypertensive treatment is highly beneficial in elderly hypertensive patients.
“Large meta-analyses confirm that treatment is highly beneficial in the elderly hypertensive patient.”
Quote in the paperSubstantial claim - Findingcitation
The proportional benefit of antihypertensive treatment in patients aged over 65 years is no less than that of younger patients.
“The proportional benefit in patients aged .65 years is no less than that of younger patients.”
Quote in the paperSubstantial claim - Findingnone given
Evidence is missing in elderly hypertensive patients for the benefit of lowering systolic blood pressure below 140 mmHg in randomized trials.
“Evidence is only missing in the elderly hypertensive patient, in whom the benefit of lowering SBP ,140 mmHg has not been tested in randomized trials.”
Quote in the paperSubstantial claim - Findingcitation
Similar legacy effects of early intensive glycaemic control were seen in patients with type 1 diabetes in the DCCT/EDIC trial.
“Similar legacy effects of early, intensive glycaemic control were seen in patients with type 1 diabetes in the DCCT/ EDIC trial.445”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [445] Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med source
Not checked in the free run.
- Findingcitation
A renin-angiotensin system blocker has superior protective effect against initiation or progression of nephropathy in diabetes.
“A renin -angiotensin system blocker (ACE inhibitor/angiotensin receptor blocker) should always be included because of the evidence of its superior protective effect against initiation or progression of nephropathy.”
- Also stated in: § 4.8.6 Blood pressure · plain
“An ACE inhibitor or angiotensin receptor antagonist should always be included because of the evidence of superior protective effects against initiation or progression of nephropathy.”
Quote in the paperSubstantial claim - Also stated in: § 4.8.6 Blood pressure · plain
- Findingcitation
The combination of an ACE inhibitor and an angiotensin receptor blocker is associated with a consistent increase in serious side effects.
“The combination of an ACE inhibitor and an angiotensin receptor blocker is associated with a consistent increase in serious side effects.431”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [431] Yusuf, 2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med source
Not checked in the free run.
- Findingcitation
Evidence is available from an outcome trial that antihypertensive treatment has benefits in patients aged 80 years or older.
“Evidence is now available from an outcome trial that antihypertensive treatment also has benefits in patients aged ≥80 years.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites HYVET
Not checked in the free run.
- Findingnone given
Existing data indicate a relationship between increased levels of glycaemia and cardiovascular events.
“While existing data indicate a relationship between increased levels of glycaemia and cardiovascular events”
Quote in the paperSubstantial claim - Findingnone given
The systolic blood pressure goal traditionally recommended in diabetes (below 130 mmHg) is based on epidemiological evidence, not on evidence from randomized trials.
“The SBP goal traditionally recommended in diabetes (i.e.,130 mmHg) is based on epidemiological evidence, and not on evidence from randomized trials.”
Quote in the paperSubstantial claim - Findingcitation
Another systematic review of the same data found a similar result.
“A similar result was also found in another systematic review of the same data.450”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [450] Kelly, 2009, Systematic review: glucose control and cardiovascular disease in type 2 diabetes, Ann Intern Med source
Not checked in the free run.
- Findingnone given
Improving glycaemic control significantly reduces the risk of developing diabetic microvascular complications (retinopathy, nephropathy, and neuropathy).
“there is conclusive evidence that improving glycaemic control significantly reduces the risk of developing diabetic microvascular complications (retinopathy, nephropathy, and neuropathy).”
Quote in the paperNot a substantial claim - Findingcitation
Trial evidence of outcome reduction has been obtained particularly for the combination of a diuretic with an ACE inhibitor, an angiotensin receptor antagonist, or a calcium antagonist.
“Trial evidence of outcome reduction has been obtained particularly for the combination of a diuretic with an ACE inhibitor or an angiotensin receptor antagonist or calcium antagonist.429,430”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [429] Dahlof, 2005, Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial, Lancet source
Not checked in the free run.
- cites [430] Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, N Engl J Med source
Not checked in the free run.
- Findingnone given
The claim that antihypertensive drug classes differ significantly in their ability to lower blood pressure and exert cardiovascular protection in younger and elderly patients has not been proven.
“The claim that antihypertensive drug classes differ significantly in their ability to lower BP and to exert cardiovascular protection, both in younger and in elderly patients, has not been proven.”
Quote in the paperSubstantial claim - Findingnone given
Intensive treatment of blood pressure in diabetes reduces the risk of macrovascular and microvascular outcomes.
“Intensive treatment of BP in diabetes reduces the risk of macrovascular and microvascular outcomes.”
Quote in the paperNot a substantial claim - Findingnone given
Antihypertensive treatment is beneficial in patients aged 80 years or older.
“Antihypertensive treatment is beneficial in patients aged ≥80 years.”
Quote in the paperNot a substantial claim - Findingcitation
In the SHEP and Syst-Eur studies, treatment effects were generally bigger in diabetic groups than in non-diabetic groups.
“For example, in the Systolic Hypertension in the Elderly Program (SHEP) and Systolic Hypertension in Europe (Syst-Eur) studies, treatment effects were generally bigger in diabetic groups than in non-diabetic groups.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites SHEP
Not checked in the free run.
- cites Syst-Eur
Not checked in the free run.
- Findingnone given
Multiple antihypertensive drugs are usually required to reach the blood pressure target in diabetes.
“Multiple antihypertensive drugs are usually required to reach the target.”
Quote in the paperNot a substantial claim - Findingnone given
Subclinical organ damage in hypertension predicts cardiovascular death independently of SCORE.
“Subclinical organ damage in hypertension predicts cardiovascular death independently of SCORE”
Quote in the paperNot a substantial claim - Findingnone given
The beta-blocker/diuretic combination favours the development of diabetes.
“the betablocker/diuretic combination favours the development of diabetes”
Quote in the paperSubstantial claim - Findingnone given
Initiation of antihypertensive treatment in patients with diabetes and high-normal blood pressure is not sufficiently supported by outcome evidence from trials.
“Initiation of treatment in the high-normal BP range is at present not sufficiently supported by outcome evidence from trials.”
Quote in the paperSubstantial claim - Findingreasoning
The previous guidelines' recommendation to aim at a lower systolic blood pressure goal below 130 mmHg in patients with diabetes and those at very high cardiovascular risk is not consistently supported by trial evidence.
“The recommendation of previous guidelines 401 to aim at a lower SBP goal (,130 mmHg) in patients with diabetes and those at very high cardiovascular risk (previous cardiovascular events) is not consistently supported by trial evidence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [401] Mancia, 2007, 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension, J Hypertens source
Not checked in the free run.
- Findingnone given
Cessation of antihypertensive therapy in hypertensive patients is mostly followed by return of blood pressure to pre-treatment levels.
“Cessation of therapy in hypertensive patients is mostly followed by the return of BP to pre-treatment levels.”
Quote in the paperNot a substantial claim - Findingcitation
A legacy effect also occurred in the metformin arm, in which patients treated with metformin maintained a reduction in cardiovascular events compared with those on conventional therapy.
“This so-called 'legacy' effect also occurred in the metformin arm, in which patients treated with metformin maintained a reduction in cardiovascular events compared with those on conventional therapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [444] Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med source
Not checked in the free run.
- Findingcitation
The HOT study showed benefit from more aggressive blood pressure treatment (diastolic blood pressure goal 80 mmHg), resulting in a reduction in risk of cardiovascular events in diabetic versus nondiabetic individuals.
“The Hypertension Optimal Study (HOT), which compared different DBP goals, showed the benefit from more aggressive treatment of BP (DBP goal: 80 mmHg), resulting in a reduction in risk of cardiovascular events in diabetic vs. nondiabetic individuals.440”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [440] Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet source
Not checked in the free run.
- Findingcitation
In the ADVANCE BP study, lowering blood pressure to a mean of 135/75 mmHg further reduced the risk of cardiovascular events and total mortality.
“In the ADVANCE BP study, lowering BP to a mean of 135/75 mmHg further reduced the risk of cardiovascular events and total mortality.397”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [397] Patel, 2007, Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial, Lancet source
Not checked in the free run.
- Findingnone given
In 15-20% of hypertensive patients, a combination of three drugs is needed to achieve blood pressure control.
“In 15 -20% of hypertensive patients, a combination of three drugs is needed to achieve BP control”
Quote in the paperNot a substantial claim - Findingcitation
In overweight patients treated with metformin, a significant reduction in risk of myocardial infarction was seen (P<0.01).
“In overweight patients treated with metformin, a significant reduction in risk of myocardial infarctions was seen (P , 0.01).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [434] UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet source
Not checked in the free run.
- cites [439] UK Prospective Diabetes Study Group, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet source
Not checked in the free run.
- Findingnone given
Combination treatment is commonly needed to lower blood pressure effectively in diabetes.
“Combination treatment is commonly needed to lower BP effectively in diabetes.”
- Also stated in: § 4.8.6 Blood pressure · plain
“Combination treatment is commonly needed to lower BP effectively in diabetes.”
Quote in the paperSubstantial claim - Also stated in: § 4.8.6 Blood pressure · plain
- Findingcitation
Lowering LDL cholesterol to 1.8 mmol/L or less is associated with the lowest risk of recurrent CVD events in secondary prevention populations.
“More recently trials have confirmed that lowering LDL cholesterol to ≤1.8 mmol/L ( 70 mg/dL) is associated with the lowest risk of recurrent CVD events in secondary prevention populations.459”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [459] Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet source
Not checked in the free run.
- Findingcitation
Evidence that reducing plasma LDL cholesterol reduces CVD risk is unequivocal.
“The evidence that reducing plasma LDL cholesterol reduces CVD risk is unequivocal”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J source
Not checked in the free run.
- Findingcitation
Evidence relating to harm from aspirin was inconsistent.
“Evidence relating to harm was inconsistent.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [443] De Berardis, 2009, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials, BMJ source
Not checked in the free run.
- Findingnone given
There appears to be less laboratory error in the determination of apoB than LDL cholesterol, particularly in patients with hypertriglyceridaemia.
“Also, there appears to be less laboratory error in the determination of apoB than LDL cholesterol, particularly in patients with hypertriglyceridaemia”
Quote in the paperSubstantial claim - Findingcitation
A recent meta-analysis of six RCTs found no statistically significant reduction in the risk of major cardiovascular events or all-cause mortality when aspirin was compared with placebo or no aspirin in people with diabetes and no pre-existing CVD.
“A recent meta-analysis of six RCTs found no statistically significant reduction in the risk of major cardiovascular events or all-cause mortality when aspirin was compared with placebo or no aspirin in people with diabetes and no pre-existing CVD.443”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [443] De Berardis, 2009, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials, BMJ source
Not checked in the free run.
- Findingcitation
The association between LDL cholesterol and CVD risk applies to individuals without CVD as well as to patients with established disease.
“This association applies to individuals (women as well as men) without CVD as well as to patients with established disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [457] Neaton, 1992, Serum cholesterol level mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group, Arch Intern Med source
Not checked in the free run.
- Findingcitation
The role of aspirin in primary prevention remains unproven.
“The role of aspirin in primary prevention remains unproven.”
Quote in the paperSubstantial claim - Findingcitation
Meta-analyses of many trials show a clear dose-dependent relative reduction in CVD with LDL cholesterol lowering.
“Meta-analyses of many trials show a clear dose-dependent relative reduction in CVD with LDL cholesterol lowering.”
Quote in the paperSubstantial claim - Findingcitation
Meta-analysis has confirmed the benefits of lipid lowering with statins compared with placebo in people with diabetes.
“Meta-analysis has confirmed the benefits of lipid lowering with statins compared with placebo in people with diabetes.452”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [452] Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet source
Not checked in the free run.
- Findingnone given
Patients with type 1 or type 2 diabetes have an increased tendency to develop thrombotic phenomena.
“Patients with type 1 or type 2 diabetes have an increased tendency to develop thrombotic phenomena.”
Quote in the paperNot a substantial claim - Findingnone given
Increased plasma cholesterol and LDL cholesterol are among the main risk factors for CVD.
“Increased plasma cholesterol and LDL cholesterol are among the main risk factors for CVD.”
Quote in the paperSubstantial claim - Findingnone given
Genetic and pathological studies, as well as observational and interventional studies, have established the crucial role of dyslipidaemia, especially hypercholesterolaemia, in the development of CVD.
“Genetic and pathological studies, as well as observational and interventional studies, have established the crucial role of dyslipidaemia, especially hypercholesterolaemia, in the development of CVD.”
Quote in the paperSubstantial claim - Findingcitation
Over a wide range of cholesterol concentrations, there is a strong and graded positive association between total and LDL cholesterol and risk of CVD.
“over a wide range of cholesterol concentrations, there is a strong and graded positive association between total as well as”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [457] Neaton, 1992, Serum cholesterol level mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group, Arch Intern Med source
Not checked in the free run.
- Findingcitation
Every 1.0 mmol/L reduction in LDL cholesterol is associated with a corresponding 20-25% reduction in CVD mortality and non-fatal myocardial infarction.
“Every 1.0 mmol/L reduction in LDL cholesterol is associated with a corresponding 20 -25% reduction in CVD mortality and non-fatal myocardial infarction.”
Quote in the paperSubstantial claim - Findingcitation
Treatment with antiplatelet drugs (mainly aspirin) resulted in a 25% significant reduction in risk of cardiovascular events in diabetic patients.
“They analysed data from 4500 diabetic patients in the trials and concluded that treatment with antiplatelet drugs (mainly aspirin) resulted in a 25% significant reduction in risk of cardiovascular events.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [453] Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, 1994, Antiplatelet Trialists' Collaboration, BMJ
Not checked in the free run.
- Findingnone given
Studies examining possible benefits of lipid lowering with fibrates in diabetes have given inconsistent results.
“Studies examining possible benefits of lipid lowering with fibrates in diabetes have given inconsistent results.”
Quote in the paperNot a substantial claim - Findingcitation
CARDS showed that cholesterol lowering with atorvastatin 10 mg reduced the risk of CHD and stroke events in type 2 diabetic patients without clinically manifest CVD.
“The Collaborative AtoRvastatin Diabetes Study (CARDS), a specifically designed RCT in type 2 diabetic patients without clinically manifest CVD, also showed that cholesterol lowering with atorvastatin 10 mg reduced the risk of CHD and stroke events.166”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet source
Not checked in the free run.
- Findingcitation
The Antiplatelet Trialists' Collaboration meta-analysis demonstrated benefits of antithrombotic therapy in diabetic patients with clinically established CHD, cerebrovascular disease, or other forms of atherothrombotic disease.
“The Antiplatelet Trialists' Collaboration meta-analysis demonstrated benefits of antithrombotic therapy in diabetic patients with clinically established CHD, cerebrovascular disease, or other forms of atherothrombotic disease.453”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [453] Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, 1994, Antiplatelet Trialists' Collaboration, BMJ
Not checked in the free run.
- Findingnone given
Statin therapy has a beneficial effect on atherosclerotic CVD outcomes.
“Statin therapy has a beneficial effect on atherosclerotic CVD outcomes.”
Quote in the paperNot a substantial claim - Findingcitation
A subgroup analysis of 1501 diabetic patients in the TNT study showed a reduction in risk of primary events, cerebrovascular events, and all cardiovascular events in the intensive statin therapy group.
“A subgroup analysis of 1501 diabetic patients included in the Treating to New Targets (TNT) study, which compared intensive statin therapy (atorvastatin 80 mg) with standard statin therapy (atorvastatin 10 mg), showed a reduction in risk of primary events, cerebrovascular events, and all cardiovascular events in patients in the intensive statin therapy group.442”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [442] Shepherd, 2006, Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study, Diabetes Care source
Not checked in the free run.
- Findingcitation
After a further 5 years of observational follow-up, the intensive multifactorial intervention was associated with a significant reduction in cardiovascular mortality.
“After a further 5 years of observational follow-up this was associated with a significant reduction in cardiovascular mortality.456”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [456] Gaede, 2008, Effect of a multifactorial intervention on mortality in type 2 diabetes, N Engl J Med source
Not checked in the free run.
- Findingcitation
The Antithrombotic Trialists' Collaboration demonstrated a non-significant 7% reduction in risk of vascular events in patients who were at high risk because of diabetes.
“A further analysis by the Antithrombotic Trialists' Collaboration demonstrated a non-significant 7% reduction in risk of vascular events in patients who were at high risk because of the presence of diabetes.454”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [454] Antithrombotic Trialists' Collaboration, 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ source
Not checked in the free run.
- Findingcitation
The Heart Protection Study demonstrated that treatment with simvastatin 40 mg reduced the risk of CHD and stroke in diabetic and non-diabetic individuals without prior myocardial infarction or angina pectoris.
“The Heart Protection Study (HPS) demonstrated that treatment with simvastatin 40 mg reduced the risk of CHD and stroke in diabetic and non-diabetic individuals without prior myocardial infarction or angina pectoris.436”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [436] Collins, 2003, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial, Lancet source
Not checked in the free run.
- Study design and conductcitation
A literature search of clinical guidelines for cardiovascular risk assessment identified more than 1900 publications.
“A literature search of clinical guidelines aimed at cardiovascular risk assessment in clinical practice identified .1900publications.4”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Ferket, 2010, Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?, Arch Intern Med source
Not checked in the free run.
- Premisecitation
CVD is strongly connected to lifestyle factors, especially tobacco use, unhealthy diet, physical inactivity, and psychosocial stress.
“CVD is strongly connected to lifestyle, especially the use of tobacco, unhealthy diet habits, physical inactivity, and psychosocial stress.2”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] World Health Organization, 2002, Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases
Not checked in the free run.
- Study design and conductcitation
The JTF used both the ESC-recommended evaluation method and the GRADE rating system to provide congruent guidance.
“An important novelty in reviewing quality of evidence and making recommendations is the use of both the ESC-recommended method of evaluation and the GRADE rating system.9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
- Premisecitation
GRADE can upgrade observational data from cohort or case-control studies from moderate or low to high if bias is unlikely and findings are consistent and precise.
“Similarly, observational data from cohort or case-control studies may be upgraded from moderate or low (as is typical in the old levels-of-evidence approach) to high if bias is unlikely, and findings are consistent and precise.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
- Premisecitation
The gap between state-of-the-art knowledge and its implementation in clinical practice remains wide, as shown by surveys such as EUROASPIRE III.
“The gap between state-of-the-art knowledge and its implementation in clinical practice remains wide, as shown in recent surveys such as EUROASPIRE III. 5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
- Premisecitation
The GRADE approach can be applied to diagnostic strategies with minor changes to the quality criteria used.
“The GRADE approach can be applied to diagnostic strategies in the same way with a few minor changes to the quality criteria used, 9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
- Premisecitation
GRADE can downgrade biased, inconsistent, or imprecise systematic review or RCT evidence from high to moderate or low quality.
“The value of this new approach is that systematic review or randomized control trial (RCT) evidence that is biased, inconsistent, or imprecise may be downgraded from high-to moderate-or lowquality evidence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
- Interpretationcitation
Limited attention on CVD prevention in the elderly has proven unjustified.
“Also, the limited attention on CVD prevention in the elderly has proven unjustified.”
Quote in the paperSubstantial claim - Premisecitation
The MONICA project showed that only part of the variation in time trends of coronary event rates could be predicted by trends in risk factors.
“The MONICA project, performed during the 1980s and 1990s, showed that only part of the variation in the time trends of coronary event rates could be predicted by trends in risk factors.16”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
- Interpretationreasoning
The CVD epidemic is dynamic and influenced by changes in cardiovascular risk factors and increased opportunities for targeted interventions.
“On the contrary, the epidemic has been and still is extremely dynamic and is influenced by both changes in cardiovascular risk factors and in increased opportunities for targeted interventions to prevent and treat CVD.”
Quote in the paperNot a substantial claim - Premisecitation
In different parts of the world, the dynamics of the CVD epidemic vary greatly in pattern, magnitude, and timing.
“In different parts of the world, the dynamics of the epidemic vary greatly in pattern, magnitude, and timing.13”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Mirzaei, 2009, Coronary heart disease epidemics: not all the same, Heart source
Not checked in the free run.
- Interpretationreasoning
The impact of the population strategy on total cardiovascular events may be large because all subjects are targeted and most events occur in the substantial group at only modest risk.
“The impact of such an approach on the total number of cardiovascular events in the population may be large, because all subjects are targeted and a majority of events occur in the substantial group of people at only modest risk.”
Quote in the paperSubstantial claim - Premisecitation
Evidence has accumulated that increased cardiovascular risk starts developing at a very young age.
“Importantly, evidence that increased cardiovascular risk starts developing at a (very) young age has accumulated over past decades.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because of an ageing population and reduced case fatality of acute coronary events, the total number of people living with CHD increases.
“One should also realize that because of an ageing population and a reduced case fatality of acute coronary events, the total number of people living with CHD increases.”
Quote in the paperNot a substantial claim - Premisecitation
There is still substantial room for improvement in risk factor control, even in individuals at very high risk.
“There is still substantial room for improvement in risk factor control, even in individuals at very high risk.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
- cites [33] Kotseva, 2009, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Premisecitation
Studies have shown that preventive measures such as blood pressure lowering and smoking cessation are beneficial up to advanced age.
“Studies have shown that preventive measures (i.e.BP lowering and smoking cessation) are beneficial up to advanced age.24,25”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Bejan-Angoulvant, 2010, Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials, J Hypertens source
Not checked in the free run.
- cites [25] Doolan, 2008, Smoking cessation interventions and older adults, Prog Cardiovasc Nurs source
Not checked in the free run.
- Premisereasoning
There is consensus that the largest preventive effect is achieved when population and high-risk strategies are combined.
“There is consensus that the largest preventive effect is achieved when these are combined.”
Quote in the paperSubstantial claim - Premisecitation
Clinical trials and natural experiments show that a decline in CHD mortality can happen rapidly after individual or population-wide changes in diet or smoking.
“Results from clinical trials and natural experiments also show that a decline in CHD mortality can happen rapidly after individual or population-wide changes in diet or smoking.30”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Capewell, 2011, Rapid mortality falls after risk-factor changes in populations, Lancet source
Not checked in the free run.
- Premisecitation
The IMPACT mortality model estimates the expected influence on CHD mortality by age and gender based on changes in coronary risk factors and treatment.
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Ford, 2007, deaths from coronary disease, 1980–2000, N Engl J Med source
Not checked in the free run.
- Premisecitation
In several eastern European countries, CVD and CHD mortality remains high.
“In several eastern European countries, however, CVD and CHD mortality remains high.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Levi, 2009, Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Premisecitation
Exposure to risk factors before birth may influence the lifetime risk of CVD, as illustrated by studies of offspring of women who were pregnant during the Dutch famine in the Second World War.
“Even exposure to risk factors before birth may influence the lifetime risk of CVD, 21 as has been illustrated from studies in the offspring of women who were pregnant during the Dutch famine in the Second World War.22”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] Forsen, 1999, Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study, BMJ source
Not checked in the free run.
- cites [22] Painter, 2006, Early onset of coronary artery disease after prenatal exposure to the Dutch famine, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
A decline in age-standardized CHD and CVD mortality has been observed in many European countries between the 1970s and 1990s, with the earliest and most prominent decrease in more affluent countries.
“However, a decline in age-standardized CHD and CVD mortality has been observed in many European countries between the 1970s and 1990s, with the earliest and most prominent decrease in the more affluent countries”
Quote in the paperNot a substantial claim - Interpretationreasoning
Using fatal CVD as the endpoint allows accurate re-calibration to other countries and cultures to adjust for time trends in mortality and risk factor prevalence.
“The use of fatal CVD as the endpoint allows accurate re-calibration to other countries and cultures to adjust for time trends in mortality and in risk factor prevalence, an important consideration given the cultural diversity within Europe.”
Quote in the paperSubstantial claim - Premisenone given
In apparently healthy persons, CVD risk is most frequently the result of multiple interacting risk factors.
“In apparently healthy persons, CVD risk is most frequently the result of multiple interacting risk factors.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Auditing and studying the most effective preventive measures is challenging.
“Auditing and studying the most effective preventive measures is therefore challenging.”
Quote in the paperSubstantial claim - Premisenone given
Nonfatal event rates are critically dependent upon definitions and methods used in their ascertainment.
“Nonfatal event rates are critically dependent upon definitions and the methods used in their ascertainment.”
Quote in the paperSubstantial claim - Premisecitation
The SCORE risk function has been externally validated.
“The SCORE risk function has been externally validated.46”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Aktas, 2004, Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program, JAMA source
Not checked in the free run.
- Premisenone given
All ICD codes that could reasonably be assumed to be atherosclerotic are included in SCORE.
“All ICD (International Classification of Diseases) codes that could reasonably be assumed to be atherosclerotic are included.”
Quote in the paperNot a substantial claim - Premisenone given
The mechanisms whereby changes in behaviour translate into changes in disease patterns are incompletely understood.
“The mechanisms whereby such changes in behaviour translate into changes in disease patterns are also incompletely understood.”
Quote in the paperSubstantial claim - Premisereasoning
Data quality does not permit re-calibration for non-fatal events.
“Data quality does not permit this for non-fatal events.”
Quote in the paperSubstantial claim - Premisenone given
RCTs of single risk factors do not give sufficient data to address these issues fully.
“RCTs of single risk factors do not give sufficient data to address these issues fully.”
Quote in the paperSubstantial claim - Premisecitation
Audits such as EUROASPIRE suggest inadequate risk factor management in very-high-risk subjects.
“While audits such as EUROASPIRE 5,38,39 suggest inadequate risk factor management in very-high-risk subjects”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
- cites [38] Pyorala, 1994, Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension, Eur Heart J
Not checked in the free run.
- cites [39] EUROASPIRE II Study Group, 2001, Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Heart Survey Programme, Eur Heart J source
Not checked in the free run.
- Interpretationreasoning
In low-risk subjects who have not had a vascular event, there is potential for substantial overuse of drugs by inappropriate extrapolation of trial results mostly in high-risk men to low-risk individuals.
“it is also likely that, in the context of low-risk subjects who have not had a vascular event, there is the potential for substantial overuse of drugs by inappropriate extrapolation of the results of trials conducted mostly in high-risk men to low-risk individuals.”
Quote in the paperSubstantial claim - Premisecitation
There were several problems with this chart, outlined in the fourth JTF guidelines, which led to the presently recommended SCORE system.
“There were several problems with this chart, outlined in the fourth JTF guidelines on prevention, 37 which led to the presently recommended risk estimation system, SCORE.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Graham, 2007, European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts), Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Interpretationreasoning
In young people with high risk factor levels, a low absolute risk may conceal a high relative risk requiring intensive lifestyle advice.
“A particular problem relates to young people with high levels of risk factors: a low absolute risk may conceal a high relative risk requiring advice for intensive lifestyle measures.”
Quote in the paperSubstantial claim - Premisecitation
The chart used in the 1994 and 1998 guidelines used age, sex, smoking status, total cholesterol, and systolic blood pressure to estimate the 10-year risk of a first fatal or non-fatal CHD event.
“This chart, developed from a concept pioneered by Anderson et al., 41 used age, sex, smoking status, total cholesterol, and systolic blood pressure (SBP) to estimate the 10-year risk of a first fatal or non-fatal CHD event.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Anderson, 1991, Cardiovascular disease risk profiles, Am Heart J source
Not checked in the free run.
- Premisecitation
The majority of deaths in a community come from those at lower levels of risk, simply because they are more numerous.
“However, as noted elsewhere, the majority of deaths in a community come from those at lower levels of risk, simply because they are more numerous.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Rose, 1985, Sick individuals and sick populations, Int J Epidemiol source
Not checked in the free run.
- Premisereasoning
Re-calibration to allow for secular changes can be undertaken if good quality, up-to-date mortality and risk factor prevalence data are available.
“Re-calibration to allow for secular changes can be undertaken if good quality, up-to-date mortality and risk factor prevalence data are available.”
Quote in the paperSubstantial claim - Interpretationnone given
A high risk of CVD death automatically indicates a higher risk of total events.
“A high risk of CVD death automatically indicates a higher risk of total events.”
Quote in the paperNot a substantial claim - Premisecitation
HDL cholesterol can contribute substantially to risk estimation if entered as an independent variable.
“This work has shown that HDL cholesterol can contribute substantially to risk estimation if entered as an independent variable.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Cooney, 2009, How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [49] Cooney, 2009, HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk, Atherosclerosis source
Not checked in the free run.
- Premisereasoning
The use of mortality permits re-calibration to allow for time trends in CVD mortality.
“Critically, the use of mortality permits re-calibration to allow for time trends in CVD mortality.”
Quote in the paperSubstantial claim - Premisenone given
There are no recent RCTs of a total risk approach to risk assessment or risk management.
“There are no recent RCTs of a total risk approach to: (i) risk assessment; or (ii) risk management.”
Quote in the paperSubstantial claim - Interpretationcitation
Many risk factors other than those in available risk functions have been identified, but their contribution to absolute cardiovascular risk estimation in individual patients is generally modest.
“It should be stressed, however, that although many risk factors other than the few included in the available risk functions have been identified [such as C-reactive protein (CRP) and homocysteine levels], their contribution to absolute cardiovascular risk estimations of individual patients (in addition to traditional risk factors) is generally modest.66”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Wilson, 2008, C-reactive protein reclassification of cardiovascular risk in the Framingham Heart Study, Circulation Cardiovasc Qual Outcomes source
Not checked in the free run.
- Premisenone given
A number of genetic polymorphisms appear associated with statistically significant effects on risk at the population level.
“A number of genetic polymorphisms (sequence variants that occur at a frequency .1%)appear to be associated with statistically significant effects on risk at the population level.”
Quote in the paperNot a substantial claim - Interpretationnone given
Risk may be higher than indicated in charts in those with moderate to severe chronic kidney disease with GFR below 60 mL/min/1.73 m2.
“Those with moderate to severe chronic kidney disease [glomerular filtration rate (GFR) ,60 mL/min/1.73m 2 ].”
Quote in the paperSubstantial claim - Premisecitation
Heart rate is an independent risk factor for CVD in the general population.
“Heart rate has been shown to be an independent risk factor for CVD in the general population.56,57”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [56] Cooney, 2010, Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women, Am Heart J
Not checked in the free run.
- cites [57] Shaper, 1993, Heart rate ischaemic heart disease sudden cardiac death in middle-aged British men, Br Heart J source
Not checked in the free run.
- Premisenone given
No trial of heart rate lowering for CVD prevention in a healthy population has been conducted to date.
“No trial of heart rate lowering for CVD prevention in a healthy population has been conducted to date; therefore, pharmacological lowering of heart rate in primary prevention cannot be recommended.”
Quote in the paperSubstantial claim - Premisecitation
Non-fasting triglycerides may be more strongly related to risk independently of HDL cholesterol.
“More recently, attention has focused on non-fasting triglycerides, which may be more strongly related to risk independently of the effects of HDL cholesterol.53 -55”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [53] Ridker, 2008, Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?, Clin Chem source
Not checked in the free run.
- cites [54] Abdel-Maksoud, 2002, The complex role of triglycerides in cardiovascular disease, Semin Vasc Med source
Not checked in the free run.
- cites [55] Sarwar, 2007, Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies, Circulation source
Not checked in the free run.
- Interpretationnone given
Risk may be higher than indicated in charts in socially deprived individuals and ethnic minorities.
“Socially deprived individuals and those from ethnic minorities.”
Quote in the paperNot a substantial claim - Interpretationnone given
Risk may be higher than indicated in charts in asymptomatic individuals with preclinical atherosclerosis, such as carotid plaque.
“Asymptomatic individuals with preclinical evidence of atherosclerosis, for example plaque on carotid ultrasonography.”
Quote in the paperSubstantial claim - Interpretationown data
Risk is merely deferred in women, with a 60-year-old woman resembling a 50-year-old man in terms of risk.
“Inspection of the charts indicates that risk is merely deferred in women, with a 60-year-old woman resembling a 50-year-old man in terms of risk.”
Quote in the paperNot a substantial claim - Interpretationnone given
Risk may be higher than indicated in charts in those with a positive family history of premature CVD.
“Positive family history of premature CVD.”
Quote in the paperNot a substantial claim - Premisenone given
There is evidence of strong heritability of many cardiovascular risk factors.
“There is evidence of strong heritability of many cardiovascular risk factors.”
Quote in the paperNot a substantial claim - Interpretationnone given
There is not enough evidence to recommend a target heart rate.
“There is not enough evidence, at present, to recommend a target heart rate.”
Quote in the paperSubstantial claim - Interpretationnone given
The importance of familial prevalence of early-onset CVD is not yet sufficiently understood in clinical practice.
“The importance of the familial prevalence of early-onset CVD is not yet sufficiently understood in clinical practice.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because of polygenic and polyfactorial determinants, the impact of any single polymorphism remains modest.
“Because of the polygenic and polyfactorial determinants of the most common CVDs, the impact of any single polymorphism remains rather modest.”
Quote in the paperSubstantial claim - Premisereasoning
Genetic testing can identify variants associated with increased risk to individual CVD risk factors, CHD, or stroke.
“Genetic testing can identify variants associated with increased risk to individual CVD risk factors, CHD, or stroke.”
Quote in the paperSubstantial claim - Premisecitation
In some conditions, genetic counselling can be optimized and extended with cascade screening, as for familial hypercholesterolaemia.
“In some conditions the process of genetic counselling can be optimized and extended with cascade screening, which identifies patients at risk and enables timely treatment of affected relatives, as is the case for familial hypercholesterolaemia.72,75”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [72] Paynter, 2010, Association between a literature-based genetic risk score and cardiovascular events in women, JAMA source
Not checked in the free run.
- cites [75] Huijgen, 2010, Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal, PLoS One source
Not checked in the free run.
- Interpretationcitation
Many subjects just below the 5% threshold will qualify for intensive advice if their HDL cholesterol is low.
“Many of these subjects will qualify for intensive advice if their HDL cholesterol is low.50”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Cooney, 2009, How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Interpretationreasoning
Other risk factors such as physical inactivity and low socio-economic status are also likely to contribute to age differences in risk.
“Other risk factors such as physical inactivity and low socio-economic status are also likely to contribute to age differences in risk.”
Quote in the paperNot a substantial claim - Premisereasoning
Relatively young people are at low absolute risk of a CVD event in the ensuing 10 years despite having a full complement of risk factors.
“Relatively young people are at low absolute risk of a CVD event in the ensuing 10 years despite having a full complement of risk factors.”
Quote in the paperSubstantial claim - Premisenone given
Age is a good marker of duration of exposure to known and unknown CHD risk factors.
“Age is a good marker of duration of exposure to known and unknown CHD risk factors.”
Quote in the paperSubstantial claim - Premisenone given
Low socio-economic status, lack of social support, stress at work and in family life, depression, anxiety, hostility, and type D personality contribute both to risk of developing CVD and worsening clinical course and prognosis.
“Low socio-economic status, lack of social support, stress at work and in family life, depression, anxiety, hostility, and the type D personality contribute both to the risk of developing CVD and the worsening of clinical course and prognosis of CVD.”
Quote in the paperSubstantial claim - Interpretationcitation
Sex differences in dietary fat intake, rather than excess smoking in men, may be responsible for the difference.
“Sex differences in dietary fat intake (rather than excess smoking in men) may be responsible.81”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Lawlor, 2001, Sex matters: secular, geographical trends in sex differences in coronary heart disease mortality, BMJ source
Not checked in the free run.
- Premisecitation
Psychosocial risk factors cluster in the same individuals and groups.
“In most situations, psychosocial risk factors cluster in the same individuals and groups.”
Quote in the paperNot a substantial claim - Premisenone given
Distinct psychobiological mechanisms are directly involved in the pathogenesis of CVD.
“In addition, distinct psychobiological mechanisms have been identified, which are directly involved in the pathogenesis of CVD.”
Quote in the paperNot a substantial claim - Premisenone given
These psychosocial factors act as barriers to treatment adherence and lifestyle improvement.
“These factors act as barriers to treatment adherence and efforts to improve lifestyle, as well as to promoting health and wellbeing in patients and populations.”
Quote in the paperSubstantial claim - Interpretationcitation
Enhanced risk in patients with depression may be due in part to adverse effects of tricyclic antidepressants.
“Enhanced risk in patients with depression may also be due in part to adverse effects of tricyclic antidepressants.121,122”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [121] Cohen, 2000, Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents, Am J Med source
Not checked in the free run.
- cites [122] Hippisley-Cox, 2001, Antidepressants as risk factor for ischaemic heart disease: case–control study in primary care, BMJ source
Not checked in the free run.
- Premisecitation
Population-based studies show a correlation between the severity of atherosclerosis in one arterial territory and the involvement of other arteries.
“Population-based studies have shown a correlation between the severity of atherosclerosis in one arterial territory and the involvement of other arteries.130”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] O'Leary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group, N Engl J Med source
Not checked in the free run.
- Interpretationreasoning
Measurements of subclinical disease may be useful for improving CVD risk prediction.
“Thus measurements of subclinical disease may be useful for improving CVD risk prediction.”
Quote in the paperSubstantial claim - Interpretationcitation
Calcium scanning is especially suited for patients at moderate risk.
“Although calcium scanning is widely applied today, it is especially suited for patients at moderate risk.137”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] van Werkhoven, 2009, Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood, Heart source
Not checked in the free run.
- Premisecitation
Three-dimensional black blood vessel wall imaging permits in vivo distinction of normal and diseased vessel walls.
“The current fast technical improvement has led to three-dimensional black blood vessel wall imaging, which permits in vivo distinction of 'normal' and diseased vessel walls.145”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] Kim, 2002, Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease, Circulation source
Not checked in the free run.
- Premisecitation
Recent studies show that multislice CT coronary angiography with decreased radiation levels is highly effective in re-stratifying patients into either a low or high post-test risk group.
“Recent studies have also shown that multislice computed tomography coronary angiography with decreased radiation levels is highly effective in re-stratifying patients into either a low or high post-test risk group.160”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Perrone-Filardi, 2011, Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology, Eur Heart J
Not checked in the free run.
- Premisecitation
Many prospective studies have shown the prognostic relevance of the amount of coronary calcium.
“Many prospective studies have shown the prognostic relevance of the amount of coronary calcium.156”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [156] Arad, 2000, Prediction of coronary events with electron beam computed tomography, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Coronary calcium scanning shows a very high negative predictive value: Agatston score 0 has NPV nearly 100% for ruling out significant coronary narrowing.
“In contrast, coronary calcium scanning shows a very high negative predictive value: the Agatston score of 0 has a negative predictive value of nearly 100% for ruling out a significant coronary narrowing.154”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [154] Haberl, 2001, Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients, J Am Coll Cardiol source
Not checked in the free run.
- Interpretationreasoning
Emerging validated biomarkers may add value in specialized practice to assess CVD risk more precisely in specific subgroups at moderate, unusual, or undefined risk.
“Overall, emerging validated biomarkers may add value in a context of specialized practice, to assess CVD risk more precisely in specific subgroups of patients at moderate, unusual, or undefined levels of risk”
Quote in the paperSubstantial claim - Interpretationnone given
The number of potential novel risk markers scales down to close to unity once candidates have passed through grading of clinical evidence.
“Although the number of potential novel risk markers is ever expanding yearly, this number scales down to a level close to unity once the possible candidates have passed through the grading of clinical evidence.”
Quote in the paperSubstantial claim - Premisecitation
Coronary wall MRI detected positive remodelling in asymptomatic patients with subclinical atherosclerosis.
“Recently, coronary wall MRI detected positive remodelling in asymptomatic patients with subclinical atherosclerosis, opening up a new research field in the prevention of CVD.143”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [143] Miao, 2009, Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol source
Not checked in the free run.
- Premisereasoning
At every level of risk factor exposure, there is substantial variation in the amount of atherosclerosis.
“At every level of risk factor exposure, there is substantial variation in the amount of atherosclerosis.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Together with the cost of the test, homocysteine remains a second-line marker for CVD risk estimation.
“Together with the cost of the test, homocysteine remains a 'second-line' marker for CVD risk estimation.”
Quote in the paperNot a substantial claim - Premisecitation
Persons and patients with depression and/or chronic stress show alterations in autonomic function, hypothalamic-pituitary axis, and other endocrine markers, affecting haemostatic and inflammatory processes, endothelial function, and myocardial perfusion.
“In addition, persons and patients with depression and/or chronic stress show alterations in autonomic function (including reduced heart rate variability) in the hypothalamic-pituitary axis and in other endocrine markers, which affect haemostatic and inflammatory processes, endothelial function, and myocardial perfusion.117,118,120”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [117] Chandola, 2008, Work stress and coronary heart disease: what are the mechanisms?, Eur Heart J source
Not checked in the free run.
- cites [118] Rozanski, 2005, The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology, J Am Coll Cardiol source
Not checked in the free run.
- cites [120] Steptoe, 2002, The role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk, Eur Heart J source
Not checked in the free run.
- Premisecitation
Coronary calcification is an indicator neither of stability nor of instability of an atherosclerotic plaque.
“Coronary calcification is an indicator neither of stability nor of instability of an atherosclerotic plaque.148”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Burke, 2002, Morphological predictors of arterial remodeling in coronary atherosclerosis, Circulation source
Not checked in the free run.
- Premisecitation
MRI sensitivity, specificity, and robustness are not sufficiently high to screen for coronary stenoses in asymptomatic people.
“Currently, the sensitivity, specificity, and robustness of this technique are not sufficiently high to perform screening for coronary stenoses in asymptomatic people.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [141] Achenbach, 2001, Noninvasive coronary angiography—an acceptable alternative?, N Engl J Med source
Not checked in the free run.
- cites [142] van Geuns, 2002, Comparison of coronary imaging between magnetic resonance imaging and electron beam computed tomography, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Coronary calcifications indicate atherosclerosis of coronary arteries.
“Coronary calcifications indicate atherosclerosis of coronary arteries.147”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [147] Tinana, 2002, Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments, Am J Cardiol source
Not checked in the free run.
- Premisecitation
The Rotterdam calcification study showed that the upper percentile range reflects a 12-fold increased risk of myocardial infarction independent of classical risk factors even in elderly people.
“The Rotterdam calcification study showed that the upper percentile range reflects a 12-fold increased risk of myocardial infarction-independent of the classical risk factors-even in elderly people.159”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [159] Vliegenthart, 2002, Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study, Eur Heart J source
Not checked in the free run.
- Premisecitation
The extent of coronary calcification correlates with the extent of total coronary plaque burden.
“The extent of the calcification correlates with the extent of the total coronary plaque burden.147”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [147] Tinana, 2002, Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments, Am J Cardiol source
Not checked in the free run.
- Interpretationreasoning
Novel biomarkers have only limited additional value when added to CVD risk assessment with the SCORE algorithm.
“Novel biomarkers have only limited additional value when added to CVD risk assessment with the SCORE algorithm.”
Quote in the paperSubstantial claim - Interpretationcitation
LpPLA2 remains a second-line marker for CVD risk estimation.
“Together with the cost of the test, LpPLA2 remains a 'second-line' marker for CVD risk estimation.129”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129] Garza, 2007, Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review, Mayo Clin Proc source
Not checked in the free run.
- Premisecitation
In patients with ACS, the extent of coronary calcification is more pronounced than in control groups without known CHD.
“In patients with an ACS, the extent of coronary calcification is more pronounced than in control groups without known CHD. 149”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [149] Schmermund, 2001, Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital, Atherosclerosis source
Not checked in the free run.
- Interpretationreasoning
Imaging methods can be relevant in CVD risk assessment in individuals at moderate risk.
“Imaging methods can be relevant in CVD risk assessment in individuals at moderate risk.”
Quote in the paperSubstantial claim - Premisecitation
In vitro, MRI can differentiate plaque components of carotid, aortic, and coronary artery specimens obtained at autopsy.
“In vitro, MRI can differentiate the plaque components of carotid, aortic, and coronary artery specimens obtained at autopsy.144”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [144] Shinnar, 1999, The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization, Arterioscler Thromb Vasc Biol source
Not checked in the free run.
- Premisereasoning
Psoriasis appears to be an independent risk factor for myocardial infarction.
“Psoriasis appears to be an independent risk factor for myocardial infarction.”
Quote in the paperSubstantial claim - Premisenone given
Several diseases in which infection or non-infectious inflammatory processes determine the clinical picture are associated with an increased cardiovascular event rate.
“Several diseases in which infection or non-infectious inflammatory processes determine the clinical picture are associated with an increased cardiovascular event rate.”
Quote in the paperSubstantial claim - Premisenone given
Hypertension, dyslipidaemia, and diabetes mellitus are common among patients with CKD.
“Hypertension, dyslipidaemia, and diabetes mellitus are common among patients with CKD.”
Quote in the paperNot a substantial claim - Premisecitation
ABI is inversely related to CVD risk.
“ABI is inversely related to CVD risk.163”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Fowkes, 2010, Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial, JAMA source
Not checked in the free run.
- Premisecitation
When IMT is used to predict incidence of subsequent stroke, the risk is graded but non-linear, with hazards increasing more rapidly at lower IMTs than at higher IMTs.
“When IMT is used to predict the incidence of subsequent stroke, the risk is graded but non-linear, with hazards increasing more rapidly at lower IMTs than at higher IMTs.130”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [130] O'Leary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group, N Engl J Med source
Not checked in the free run.
- Premisecitation
Lifestyle modification and pharmacotherapy for risk factors are effective in improving sexual function in men with ED.
“Lifestyle modification and pharmacotherapy for risk factors are effective in improving sexual function in men with ED. 169”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [169] Gupta, 2011, The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis, Arch Intern Med source
Not checked in the free run.
- Premisenone given
An ABI <0.9 indicates ≥50% stenosis between the aorta and the distal leg arteries.
“An ABI ,0.9 indicates ≥50% stenosis between the aorta and the distal leg arteries.”
Quote in the paperSubstantial claim - Premisecitation
There is a quantitative association between decreased GFR and cardiovascular risk: patients with stage 3 CKD have a two- to four-fold increased risk compared with persons free of CKD.
“function (stage 3, GFR 30-59 mL/min/1.73m 2 ) have a two-to four-fold increased risk in comparison with persons free of CKD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Schiffrin, 2007, Chronic kidney disease: effects on the cardiovascular system, Circulation source
Not checked in the free run.
- Premisecitation
OSA has been associated with a 70% relative increased risk of cardiovascular morbidity and mortality.
“OSA has been associated with a 70% relative increased risk of cardiovascular morbidity and mortality.177”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [177] Mooe, 2001, Sleep-disordered breathing and coronary artery disease: long-term prognosis, Am J Respir Crit Care Med source
Not checked in the free run.
- Premisenone given
In asymptomatic individuals over 55 years of age, an ABI <0.9 may be found in 12-27%.
“In asymptomatic individuals over 55 years of age, an ABI ,0.9 may be found in 12 -27%.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Carotid ultrasound can add information beyond assessment of traditional risk factors that may help to make decisions about the necessity to institute medical treatment for primary prevention.
“Consequently, carotid ultrasound can add information beyond assessment of traditional risk factors that may help to make decisions about the necessity to institute medical treatment for primary prevention.”
Quote in the paperSubstantial claim - Premisecitation
The incidence of ischaemic heart disease and stroke is increased many years after radiation exposure for treatment of lymphomas and for breast cancer, as well as for head and neck cancer.
“The incidence of ischaemic heart disease and stroke is increased many years after radiation exposure for treatment of lymphomas and for breast cancer, as well as for head and neck cancer.191,192”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [191] Darby, 2003, Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women, BMJ source
Not checked in the free run.
- cites [192] Smith, 2008, Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy, J Clin Oncol source
Not checked in the free run.
- Premisenone given
Echolucent plaques imply an increased risk of cerebrovascular events as compared with calcified plaques.
“Echolucent plaques imply an increased risk of cerebrovascular events as compared with calcified plaques.”
Quote in the paperNot a substantial claim - Premisecitation
Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.
“Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.187,188”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [187] Westlake, 2010, The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review, Rheumatology (Oxford) source
Not checked in the free run.
- cites [188] Prodanovich, 2005, Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis, J Am Acad Dermatol source
Not checked in the free run.
- Premisenone given
Microalbuminuria increases cardiovascular risk two- to four-fold.
“Microalbuminuria increases cardiovascular risk two-to four-fold.”
Quote in the paperNot a substantial claim - Premisecitation
Because of its acceptable sensitivity (79%) and specificity, an ABI <0.90 is considered to be a reliable marker of PAD.
“Because of its acceptable sensitivity (79%) and specificity, an ABI ,0.90 is considered to be a reliable marker of PAD.133”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Hiatt, 2001, Medical treatment of peripheral arterial disease and claudication, N Engl J Med source
Not checked in the free run.
- Premisecitation
The ABI also predicts further development of angina, myocardial infarction, congestive heart failure, CABG surgery, stroke, or carotid surgery.
“The ABI also predicts further development of angina, myocardial infarction, congestive heart failure, CABG surgery, stroke, or carotid surgery.135”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Vogt, 1993, Decreased ankle/arm blood pressure index and mortality in elderly women, JAMA source
Not checked in the free run.
- Premisecitation
Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Nichol, 2003, Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly, N Engl J Med source
Not checked in the free run.
- Premisecitation
Arterial stiffness has been shown to provide added value in stratification of patients.
“Arterial stiffness has been shown to provide added value in stratification of patients.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [161] Safar, 2011, Arterial stiffness, pulse pressure, and cardiovascular disease—is it possible to break the vicious circle?, Atherosclerosis source
Not checked in the free run.
- cites [162] Mitchell, 2010, Arterial stiffness and cardiovascular events: the Framingham Heart Study, Circulation source
Not checked in the free run.
- Premisenone given
Influenza epidemics are associated with an increased rate of cardiovascular events.
“Influenza epidemics are associated with an increased rate of cardiovascular events.”
Quote in the paperSubstantial claim - Premisecitation
Plaque characteristics as assessed by carotid ultrasound were found to be predictive of subsequent cerebral ischaemic events.
“Plaque characteristics as assessed by carotid ultrasound were found to be predictive of subsequent cerebral ischaemic events.131”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131] Chambless, 1997, Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993, Am J Epidemiol source
Not checked in the free run.
- Premisecitation
Screening for and treating OSA in patients with chronic coronary artery disease and hypertension may result in decreased cardiac events and cardiac death.
“Screening for and treating OSA in patients with chronic coronary artery disease 178 and hypertension may result in decreased cardiac events and cardiac death.168”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [168] Cassar, 2007, Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention, J Am Coll Cardiol source
Not checked in the free run.
- Premisenone given
Patients with rheumatoid arthritis are twice as likely as the general population to suffer a myocardial infarction.
“Patients with rheumatoid arthritis are twice as likely as the general population to suffer a myocardial infarction.”
Quote in the paperNot a substantial claim - Premisecitation
CKD patients tend to be less intensely treated than patients with normal renal function.
“yet these patients tend to be less intensely treated than patients with normal renal function.165”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165] Fox, 2010, Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry, Circulation source
Not checked in the free run.
- Premisenone given
A decreasing GFR is an indicator of increased risk for CVD and all-cause mortality.
“A decreasing GFR is an indicator of increased risk for CVD and all-cause mortality.”
Quote in the paperSubstantial claim - Premisenone given
ABI is an easy-to-perform and reproducible test to detect asymptomatic atherosclerotic disease.
“The ankle-brachial BP index (ABI) is an easy-to-perform and reproducible test to detect asymptomatic atherosclerotic disease.”
Quote in the paperSubstantial claim - Premisecitation
Persons without known CVD with increased IMT are at increased risk for cardiac events and stroke.
“Persons without known CVD with increased IMT are at increased risk for cardiac events and stroke.”
Quote in the paperSubstantial claim - Premisecitation
Smoking is deleterious regardless of how it is smoked, including by waterpipe.
“Smoking is deleterious regardless of how it is smoked, including by waterpipe.221,222”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [221] WHO Study Group on Tobacco Product Regulation TobReg, 2005
Not checked in the free run.
- cites [222] Akl, 2010, The effects of waterpipe tobacco smoking on health outcomes: a systematic review, Int J Epidemiol source
Not checked in the free run.
- Premisecitation
The 'Ten strategic steps' have been shown to enhance counselling on behavioural change effectively.
“The following 'Ten strategic steps' have been shown to enhance counselling on behavioural change effectively (Table 8).203”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] US Preventive Services Task Force, 1996
Not checked in the free run.
- Premisecitation
There is evidence that more extensive/longer interventions may lead to better long-term results with respect to behaviour change and somatic outcome.
“There is evidence that more extensive/longer interventions may lead to better long-term results with respect to behaviour change and somatic outcome.195,202”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [195] Dusseldorp, 1999, A meta-analysis of psychoeduational programs for coronary heart disease patients, Health Psychol source
Not checked in the free run.
- cites [202] Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
- Premisecitation
A non-smoker living with a smoking spouse has an estimated 30% higher risk of CVD.
“A non-smoker living with a smoking spouse has an estimated 30% higher risk of CVD, 224”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [224] Law, 1997, Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence, BMJ source
Not checked in the free run.
- Premisecitation
Combining the knowledge and skills of clinicians into multimodal, behavioural interventions can help to optimize the preventive efforts.
“Combining the knowledge and skills of clinicians (such as physicians, nurses, psychologists, and experts in nutrition, cardiac rehabilitation, and sports medicine) into multimodal, behavioural interventions can help to optimize the preventive efforts.35,202,204,205”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [35] Wood, 2008, Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial, Lancet source
Not checked in the free run.
- cites [202] Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
- cites [204] Balady, 2007, Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation, Circulation source
Not checked in the free run.
- Premisecitation
Smokeless tobacco is associated with a small but statistically significant increased risk of myocardial infarction and stroke.
“Also smokeless tobacco is associated with a small but statistically significant increased risk of myocardial infarction and stroke.223”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [223] Boffetta, 2009, Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis, BMJ source
Not checked in the free run.
- Premisenone given
Evidence has confirmed cognitive-behavioural strategies to be essential components of interventions targeting lifestyle change.
“Evidence has confirmed cognitive-behavioural strategies to be essential components of interventions targeting lifestyle change.”
Quote in the paperSubstantial claim - Premisecitation
From descriptive studies, the lesions after radiation exposure exhibit typical features of atherosclerosis, including lipid accumulation, inflammation, and thrombosis.
“From descriptive studies, the lesions exhibit typical features of atherosclerosis, including lipid accumulation, inflammation, and thrombosis.193”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [193] Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med
Not checked in the free run.
- Premisecitation
Behavioural interventions such as motivational interviewing increase motivation and self-efficacy.
“Behavioural interventions such as 'motivational interviewing' 201 increase motivation and self-efficacy.196”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [201] Rollnick, 2010, Motivational interviewing, BMJ source
Not checked in the free run.
- cites [196] Rubak, 2005, Motivational interviewing: a systematic review and meta-analysis, Br J Gen Pract
Not checked in the free run.
- Premisenone given
Cardiac allograft vasculopathy is the leading cause of late morbidity and mortality in heart transplant patients.
“Cardiac allograft vasculopathy is the leading cause of late morbidity and mortality in heart transplant patients.”
Quote in the paperNot a substantial claim - Premisecitation
Recently imposed public smoking bans in different geographical locations have led to a significant decrease in the incidence of myocardial infarction.
“Indeed, recently imposed public smoking bans in different geographical locations have led to a significant decrease in the incidence of myocardial infarction.210”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [210] Lightwood, 2009, Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke, Circulation source
Not checked in the free run.
- Premisecitation
Risk associated with smoking is proportionately higher in women than in men.
“Risk associated with smoking is proportionately higher in women than in men.215,218”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [215] Prescott, 1998, Smoking and risk of myocardial infarction in women and men: longitudinal population study, BMJ source
Not checked in the free run.
- cites [218] Mucha, 2006, Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking, Gend Med source
Not checked in the free run.
- Premisecitation
Accumulated evidence shows that passive smoking increases the risk of CHD, with a higher relative risk than might be expected.
“Accumulated evidence shows that passive smoking increases the risk of CHD, with a higher relative risk than might be expected.209,224,225”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [209] He, 1999, Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies, N Engl J Med source
Not checked in the free run.
- cites [224] Law, 1997, Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence, BMJ source
Not checked in the free run.
- cites [225] Raupach, 2006, Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm, Eur Heart J source
Not checked in the free run.
- Premisecitation
Evidence from epidemiological, clinical, and mechanistic studies consistently shows CHD risk reduced by 2-3% when 1% of energy from saturated fatty acids is replaced with polyunsaturated fatty acids.
“The evidence from epidemiological, clinical, and mechanistic studies is consistent in finding that the risk of CHD is reduced by 2 -3% when 1% of energy intake from saturated fatty acids is replaced with polyunsaturated fatty acids.270”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [270] Astrup, 2011, The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
A meta-analysis of 36 trials found bupropion versus control relative success rate 1.69 (95% CI 1.53-1.85) for long-term cessation.
“A meta-analysis of 36 trials comparing long-term cessation rates using bupropion vs. control yielded a relative success rate of 1.69 (95% CI 1.53-1.85)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [258] Hughes, 2007, Antidepressants for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
Nicotine patches have been tested successfully without adverse effects in patients with CHD.
“The use of nicotine patches has been successfully tested, without adverse effects, in patients who have CHD.257”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [257] Ludvig, 2005, Smoking cessation in patients with coronary artery disease, Am Heart J source
Not checked in the free run.
- Premisecitation
Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [283] Mozaffarian, 2009, Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils, Eur J Clin Nutr source
Not checked in the free run.
- Interpretationreasoning
A biphasic response to smoking cessation of CVD risk is compatible with the dual effects of smoking-acute and reversible effects on haemostasis and plaque stability and a more prolonged effect on plaque formation.
“A biphasic response to smoking cessation of CVD risk is thus compatible with the dual effects of smoking-acute and reversible effects on haemostasis and plaque stability and a more prolonged effect on plaque formation.”
Quote in the paperSubstantial claim - Premisecitation
Acupuncture, acupressure, laser therapy, hypnotherapy, and electrostimulation lack consistent evidence of effectiveness for smoking cessation.
“There is no consistent evidence that acupuncture, acupressure, laser therapy, hypnotherapy, or electrostimulation are effective for smoking cessation.269”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [269] White, 2006, Acupuncture and related interventions for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
Bupropion aids long-term smoking cessation with efficacy similar to NRT.
“The antidepressant bupropion aids long-term smoking cessation with a similar efficacy to NRT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [258] Hughes, 2007, Antidepressants for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
Monounsaturated fatty acids have a favourable effect on HDL cholesterol when they replace saturated fatty acids or carbohydrates.
“Monounsaturated fatty acids have a favourable effect on HDL cholesterol levels when they replace saturated fatty acids or carbohydrates in the diet.281”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [281] Mensink, 1992, Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials, Arterioscler Thromb source
Not checked in the free run.
- Premisecitation
Nicotine replacement has shown no adverse effect on outcomes in patients with cardiac disease.
“and nicotine replacement has shown no adverse effect on outcomes in patients with cardiac disease.246,247”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [246] Joseph, 1996, The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease, N Engl J Med source
Not checked in the free run.
- cites [247] Joseph, 2003, Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease
Not checked in the free run.
- Premisecitation
Evidence for an additional effect of adding bupropion to NRT is insufficient.
“whereas evidence of any additional effect of adding bupropion to NRT was insufficient.258”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [258] Hughes, 2007, Antidepressants for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
In experimental studies, several of these effects are fully or partly reversible within a very short time.
“In experimental studies, several of these effects are fully or partly reversible within a very short time.243,244”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [243] Moreno, 1998, Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation, Am J Physiol
Not checked in the free run.
- cites [244] Morita, 2005, Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Varenicline may be slightly more effective than NRT or bupropion.
“Trials suggested a modest benefit of varenicline over NRT and bupropion.258,261”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Further evidence points towards risk of CVD approaching the risk of never-smokers within 10-15 years, without ever quite reaching the same level.
“Further evidence points towards risk of CVD approaching the risk of never-smokers within 10 -15 years, without ever quite reaching the same level.248”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [248] International Agency for Research on Cancer, 2007
Not checked in the free run.
- Premisecitation
A recent meta-analysis of cohort studies did not show increased relative risk for CHD or CVD with higher saturated fat intake.
“Recently, a meta-analysis of cohort studies did not show an increase in the relative risk for CHD or CVD with higher intake of saturated fat, 279”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [279] Siri-Tarino, 2010, Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
Studies of subjects without established CVD find risk in former smokers to be moderate between that of current and never-smokers.
“Studies of subjects without established CVD find risk in former smokers to be moderate between that of current and never-smokers.248”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [248] International Agency for Research on Cancer, 2007
Not checked in the free run.
- Premisecitation
A meta-analysis of 14 randomized trials (8216 patients) found a small but significant rise in cardiovascular events with varenicline.
“A meta-analysis based on 14 RCTs including 8216 patients has indicated a small but significantly increased risk of cardiovascular events associated with the use of varenicline.262”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [262] Singh, 2011, Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis, CMAJ source
Not checked in the free run.
- Premisecitation
Evidence from randomized trials supports the beneficial effect of smoking cessation.
“Also, evidence from randomized trials supports the beneficial effect of smoking cessation.251,252”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [251] Anthonisen, 2005, The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial, Ann Intern Med source
Not checked in the free run.
- cites [252] Mohiuddin, 2007, Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease, Chest source
Not checked in the free run.
- Premisecitation
Most current evidence suggests that nicotine exposure from smoking has only minor effects on the atherosclerotic process.
“Most current evidence suggests that nicotine exposure from smoking has only minor effects on the atherosclerotic process, 227,245”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [227] Ambrose, 2004, The pathophysiology of cigarette smoking and cardiovascular disease: an update, J Am Coll Cardiol source
Not checked in the free run.
- cites [245] Hanna, 2006, Nicotine effect on cardiovascular system and ion channels, J Cardiovasc Pharmacol source
Not checked in the free run.
- Premisereasoning
The same CHD risk reduction has not been clearly shown when saturated fatty acids are replaced with carbohydrates or monounsaturated fatty acids.
“The same has not been clearly shown for the replacement with carbohydrates and monounsaturated fatty acids.”
Quote in the paperSubstantial claim - Premisecitation
Replacing saturated fat with unsaturated fatty acids lowers serum total cholesterol.
“In 1965, Keys et al. 278 described how replacing saturated fat in the diet by unsaturated fatty acids lowered serum total cholesterol levels.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [278] Keys, 1965, Effects of different dietary fats on plasma-lipid levels, Lancet source
Not checked in the free run.
- Premisecitation
Smoking reduction has not been shown to increase probability of future smoking cessation.
“Smoking reduction has not been shown to increase probability of future smoking cessation, but some advocate nicotine-assisted smoking reduction in smokers unable or unwilling to quit.11,253”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [11] Schunemann, 2008, Grading quality of evidence and strength of recommendations for diagnostic tests and strategies, BMJ source
Not checked in the free run.
- cites [253] National Institute for Health and Clinical Excellence, 2008, NICE Public Health Guidance 10. Smoking Cessation Services in Primary Care, Pharmacies, Local Authorities and Workplaces, Particularly for Manual Working Groups, Pregnant Women and Hard to Reach Communities
Not checked in the free run.
- Premisenone given
There is no age limit to the benefits of smoking cessation.
“There is no age limit to the benefits of smoking cessation.”
Quote in the paperNot a substantial claim - Premisecitation
Firm explicit physician advice to quit smoking completely increases the odds of successful cessation (OR 1.66, 95% CI 1.42-1.94).
“The physician's firm and explicit advice that the person should stop smoking completely is important in starting the smoking-cessation process and increases the odds of success (OR 1.66, 95% CI 1.42-1.94).225,254”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Continuing smoking cessation after hospital discharge increases success.
“Smoking cessation initiated during hospital admission should continue for a prolonged period after discharge to increase success.255”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [255] Rigotti, 2008, Smoking cessation interventions for hospitalized smokers: a systematic review, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Regular physical activity and aerobic exercise training are related to reduced risk of fatal and non-fatal coronary events in healthy individuals, subjects with coronary risk factors, and cardiac patients over a wide age range.
“Regular physical activity and aerobic exercise training are related to a reduced risk of fatal and non-fatal coronary events in healthy individuals, 305 -307,311 subjects with coronary risk factors, 312 and cardiac patients 309 310 over a wide age range.”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [305] Talbot, 2007, Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging, Prev Med source
Not checked in the free run.
- cites [306] Nocon, 2008, Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [307] Lollgen, 2009, Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories, Int J Sports Med source
Not checked in the free run.
- cites [311] US Department of Health and Human Services, 2008, Physical Activity Guidelines Advisory Committee Report
Not checked in the free run.
- cites [312] Richardson, 2004, Physical activity and mortality across cardiovascular disease risk groups, Med Sci Sports Exerc source
Not checked in the free run.
- cites [309] Taylor, 2004, Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials, Am J Med source
Not checked in the free run.
- cites [310] Piepoli, 2004, Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH), BMJ source
Not checked in the free run.
- Premisecitation
Based on a meta-analysis, the optimal level of alcohol intake for all-cause mortality is 20 g/day for men and 10 g/day for women.
“Based on a meta-analysis, 275 the optimal level of intake with respect to all-cause mortality is 20 g/ day for men and 10 g/day (equivalent to approximately one drink) for women.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [275] Corrao, 2004, A meta-analysis of alcohol consumption and the risk of 15 diseases, Prev Med source
Not checked in the free run.
- Interpretationcitation
B-vitamin supplementation to lower homocysteine levels does not lower CVD risk.
“Thus, B-vitamin supplementation to lower homocysteine levels does not lower risk.”
Quote in the paperSubstantial claim - Premisecitation
In healthy subjects, growing levels of physical activity and cardiorespiratory fitness are associated with a significant reduction (20-30%) in risk of all-cause and cardiovascular mortality in a dose-response fashion.
“In healthy subjects, growing levels of both physical activity and cardiorespiratory fitness are associated with a significant reduction ( 20 -30%) in risk of all-cause and cardiovascular mortality, in a dose-response fashion.305 -308,311,328,329”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [305] Talbot, 2007, Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging, Prev Med source
Not checked in the free run.
- cites [306] Nocon, 2008, Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [307] Lollgen, 2009, Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories, Int J Sports Med source
Not checked in the free run.
- cites [308] Schnohr, 2007, Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [311] US Department of Health and Human Services, 2008, Physical Activity Guidelines Advisory Committee Report
Not checked in the free run.
- cites [328] Williams, 2001, Physical fitness and activity as separate heart disease risk factors: a meta-analysis, Med Sci Sports Exerc source
Not checked in the free run.
- cites [329] Tipton, 2006
Not checked in the free run.
- Interpretationcitation
Accumulated new evidence supports the view that homocysteine is not a causal risk factor for CVD.
“Accumulated new evidence supports the view that homocysteine is not a causal risk factor for CVD.”
Quote in the paperSubstantial claim - Interpretationreasoning
The diet consumed in the Mediterranean cohorts of the Seven Countries Study is probably an important factor underlying the large difference in CVD rates between southern and northern Europe.
“The diet consumed in the Mediterranean cohorts of the Seven Countries Study is probably an important factor underlying the large difference in CVD rates between southern and northern Europe.”
Quote in the paperSubstantial claim - Premisecitation
Conclusive evidence that vitamin D supplementation improves cardiovascular prognosis is lacking.
“Conclusive evidence showing that vitamin D supplementation improves cardiovascular prognosis is however lacking, but trials are underway.294”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [294] Abuannadi, 2011, Give me sunshine: vitamin D cardiovascular health, Prim Care Cardiovasc J
Not checked in the free run.
- Premisecitation
The DASH trial showed that increasing fruit and vegetable intake contributed to the observed decrease in BP in the intervention arm.
“The DASH trial has shown that increasing fruit and vegetable intake contributed to the observed decrease in BP in the intervention arm.297”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [297] Appel, 1997, A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group, N Engl J Med source
Not checked in the free run.
- Premisecitation
Pooled risk estimates show eating fish at least once a week results in a 15% reduction in CHD risk (RR 0.85, 95% CI 0.76-0.96).
“Pooled risk estimates show that eating fish at least once a week results in a 15% reduction in risk of CHD (RR 0.85, 95% CI 0.76-0.96).271”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [271] He, 2004, Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies, Circulation source
Not checked in the free run.
- Premisecitation
A meta-analysis estimated that reducing sodium intake by 1 g/day reduces SBP by 3.1 mmHg in hypertensive patients and 1.6 mmHg in normotensive patients.
“A meta-analysis estimated that even a modest reduction in sodium intake of 1 g/day reduces SBP by 3.1 mmHg in hypertensive patients and 1.6 mmHg in normotensive patients.284”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [284] He, 2002, Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health, J Hum Hypertens source
Not checked in the free run.
- Interpretationreasoning
The protective effect of fruits and vegetables seems slightly stronger for stroke prevention than for CHD prevention.
“The protective effect of fruits and vegetables seems to be slightly stronger for the prevention of stroke compared with the prevention of CHD.”
Quote in the paperSubstantial claim - Premisecitation
The relative risk of stroke in the highest quintile of potassium intake (average 110 mmol/day) is almost 40% lower than in the lowest quintile (average 61 mmol/day).
“Risk of stroke varies greatly with potassium intake: the relative risk of stroke in the highest quintile of potassium intake (average of 110 mmol/day) is almost 40% lower than that in the lowest quintile of intake (average intake of 61 mmol/day).287”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [287] He, 2001, Fortnightly review: beneficial effects of potassium, BMJ source
Not checked in the free run.
- Premisecitation
Three large secondary prevention trials concluded that supplementation with folic acid and vitamin B6 and/or B12 offers no protection against CVD.
“All trials [Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), VITAmins TO Prevent Stroke (VITATOPS), and Supplementation with Folate, vitamin B6 and B12 and/or OMega-3 fatty acids (SU.FOL.OM3)] concluded that supplementation with folic acid and vitamin B6 and/or B12 offers no protection against the development of CVD.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [291] Armitage, 2010, Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial, JAMA source
Not checked in the free run.
- cites [292] Galan, 2010, Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial, BMJ source
Not checked in the free run.
- cites [293] 2010, B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial, Lancet Neurol source
Not checked in the free run.
- Premisecitation
A meta-analysis of prospective cohort studies showed that higher trans fatty acid intake of 2% energy increases CHD risk by 23%.
“A meta-analysis of prospective cohort studies has shown that, on average, a higher trans fatty acid intake of 2% of energy increases the risk of CHD by 23%.272”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [272] Mozaffarian, 2006, Trans fatty acids and cardiovascular disease, N Engl J Med source
Not checked in the free run.
- Premisecitation
Another meta-analysis showed eating fish 2-4 times a week reduced stroke risk by 18% (RR 0.82, 95% CI 0.72-0.94) compared with eating fish less than once a month.
“Another meta-analysis showed that eating fish 2-4 times a week reduced the risk of stroke by 18% (RR 0.82, 95% CI 0.72 -0.94) compared with eating fish less than once a month.282”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [282] He, 2004, Fish consumption and incidence of stroke: a meta-analysis of cohort studies, Stroke source
Not checked in the free run.
- Premisecitation
A sedentary lifestyle is one of the major risk factors for CVD.
“A sedentary lifestyle is one of the major risk factors for CVD.313”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [313] Warren, 2010, Sedentary behaviors increase risk of cardiovascular disease mortality in men, Med Sci Sports Exerc source
Not checked in the free run.
- Premisecitation
A meta-analysis of seven large prospective cohort studies reported a 5% reduction in stroke risk for each additional daily serving of fruits and vegetables.
“In a meta-analysis of seven large prospective cohort studies, a 5% reduction in risk of stroke for each additional serving of fruits and vegetables was reported.273”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [273] Dauchet, 2006, Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies, J Nutr source
Not checked in the free run.
- Premisereasoning
Studies controlling for potential confounders still observed an inverse association between physical activity or cardiorespiratory fitness and all-cause and cardiovascular mortality.
“However, studies controlling for these potential confounders still observed an inverse association between physical activity or cardiorespiratory fitness and all-cause and cardiovascular mortality.”
Quote in the paperSubstantial claim - Premisecitation
The DASH trial showed a dose-response relationship between sodium reduction and BP reduction.
“The DASH trial showed a dose-response relationship between sodium reduction and BP reduction.285”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [285] Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH–Sodium Collaborative Research Group, N Engl J Med source
Not checked in the free run.
- Premisecitation
Functional foods containing phytosterols lower LDL cholesterol by on average 10% when consumed at 2 g/day.
“Functional foods containing phytosterols (plant sterols and stanols) are effective in lowering LDL cholesterol levels by on average 10%, when consumed in amounts of 2 g/day.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [302] Law, 2000, Plant sterol and stanol margarines and health, BMJ source
Not checked in the free run.
- Premisereasoning
The relationship between fish intake and cardiovascular risk is not linear.
“The relationship between fish intake and cardiovascular risk is not linear.”
Quote in the paperSubstantial claim - Premisecitation
Dauchet et al. reported a 4% decrease in CHD risk (RR 0.96, 95% CI 0.93-0.99) for each additional daily serving of fruits and vegetables.
“Dauchet et al. reported a decrease in CHD risk of 4% (RR 0.96, 95% CI 0.93-0.99)for each additional serving of fruits and vegetables per day.273”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] Dauchet, 2006, Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies, J Nutr source
Not checked in the free run.
- Premisecitation
Intervention trials designed to confirm causality of vitamin A/E relationships failed to confirm observational results.
“However, intervention trials designed to confirm the causality of these relationships have failed to confirm the results from observational studies.288”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [288] Vivekananthan, 2003, Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials, Lancet source
Not checked in the free run.
- Premisecitation
The cholesterol-lowering effect of phytosterols is additional to that obtained with a low-fat diet or statins.
“The cholesterol-lowering effect is additional to that obtained with a low-fat diet or use of statins.302”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [302] Law, 2000, Plant sterol and stanol margarines and health, BMJ source
Not checked in the free run.
- Premisecitation
Nonrandomized studies indicate SSRIs may improve CVD prognosis in depressed patients with and without previously documented CVD.
“Results from nonrandomized studies indicate that selective serotonin re-uptake inhibitors may also have the potential to improve CVD prognosis in depressed patients with 345 and without 347 previously documented CVD.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [345] Taylor, 2005, Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction, Arch Gen Psychiatry source
Not checked in the free run.
- cites [347] Sauer, 2003, Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction, Circulation source
Not checked in the free run.
- Premisecitation
In patients with prior acute myocardial infarction, CABG, PTCA, or stable angina (mainly middle-aged men), aerobic exercise training programmes lasting at least 3 months reduce total cardiovascular mortality by 30% and CHD mortality by 35%.
“a meta-analysis including mainly middle-aged men, most of whom had a previous acute myocardial infarction and the rest with a previous CABG or percutaneous transluminal coronary angioplasty or affected by stable angina pectoris, showed a 30% reduction in total cardiovascular mortality for aerobic exercise training programmes of at least 3-months' duration; this percentage rose to 35% when only dea”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [333] Heran, 2011, Exercise-based cardiac rehabilitation for coronary heart disease, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
The exercise-related risk of major cardiovascular events in ostensibly healthy people is exceedingly low, ranging from 1 in 500,000 to 1 in 2,600,000 patient-hours of exercise.
“Generally speaking, the exercise-related risk of major cardiovascular events in ostensibly healthy people is exceedingly low, ranging from 1 in 500 000 to 1 in 2 600 000 patient-hours of exercise.330,331”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [330] Franklin, 2005, Cardiovascular events associated with exercise. The risk–protection paradox, J Cardiopulm Rehabil source
Not checked in the free run.
- cites [331] Thompson, 2007, Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology, Circulation source
Not checked in the free run.
- Premisecitation
Psychological interventions have additional impact on prevention of clinical CHD, especially in patients who achieved behavioural goals.
“Two recent meta-analyses and two recent RCTs 86,199,343,348 have also shown their additional impact on the prevention of clinical CHD, especially in patients who achieved their behavioural goals.349”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [86] Katon, 2010, Collaborative care for patients with depression and chronic illnesses, N Engl J Med source
Not checked in the free run.
- cites [199] Linden, 2007, Psychological treatment of cardiac patients: a meta-analysis, Eur Heart J source
Not checked in the free run.
- cites [343] Whalley, 2011, Psychological interventions for coronary heart disease, Cochrane Database Syst Rev source
Not checked in the free run.
- cites [348] Orth-Gomer, 2009, Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD), Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- cites [349] Cossette, 2001, Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program, Psychosom Med source
Not checked in the free run.
- Premisecitation
The rarity of major cardiovascular events during supervised aerobic exercise training also applies to patients with chronic heart failure and reduced left ventricular function, NYHA class II-IV, on optimal guideline-based therapy.
“The same is also true for patients with chronic heart failure and reduced left ventricular function, New York Heart Association class II-IV symptoms, and treated with optimal, guideline-based background heart failure therapy.342”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [342] Rees, 2004, Exercise based rehabilitation for heart failure, Cochrane Database Syst Rev source
Not checked in the free run.
- Premisecitation
Individuals who exercise only occasionally seem to have an increased risk of acute coronary events and sudden cardiac death during or after exercise.
“Individuals who exercise only occasionally seem to have an increased risk of acute coronary events and sudden cardiac death during or after exercise.330,331”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [330] Franklin, 2005, Cardiovascular events associated with exercise. The risk–protection paradox, J Cardiopulm Rehabil source
Not checked in the free run.
- cites [331] Thompson, 2007, Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology, Circulation source
Not checked in the free run.
- Premisecitation
In patients with CVD, available data do not allow a precise weekly aerobic exercise training volume as for healthy subjects.
“In patients with CVD, available data do not allow definition of an aerobic exercise training weekly volume as precise as that indicated for healthy subjects, 309,310”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [309] Taylor, 2004, Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials, Am J Med source
Not checked in the free run.
- cites [310] Piepoli, 2004, Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH), BMJ source
Not checked in the free run.
- Premisecitation
Adherence to prescribed aerobic exercise training intensity is crucial for prognostic gains in chronic heart failure, as shown by HF-ACTION.
“Adherence to prescribed aerobic exercise training intensity emerged as a crucial issue in determining such prognostic gains, as demonstrated by the results of the recent Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) trial.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [337] O'Connor, 2009, Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial, JAMA source
Not checked in the free run.
- Premisecitation
In large populations of male and female cardiovascular patients, cardiovascular fitness (METs) has an inverse dose-response relationship with all-cause mortality, irrespective of beta-blocker use.
“recent data confirm the existence of an inverse dose-response relationship between cardiovascular fitness (evaluated by treadmill stress testing and expressed in METs) and all-cause mortality in large populations of both male and female cardiovascular patients”
- Also stated in: § 4.4.4 Patients with known cardiovascular disease · plain
“The results were the same irrespective of use of beta-blocking agents.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [334] Kavanagh, 2002, Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation, Circulation source
Not checked in the free run.
- cites [335] Kavanagh, 2003, Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation, J Am Coll Cardiol source
Not checked in the free run.
- Also stated in: § 4.4.4 Patients with known cardiovascular disease · plain
- Premisereasoning
Similar mortality benefits are obtainable with 1-1.5 h/week of vigorous-intensity physical activity/aerobic exercise training or an equivalent combination of moderate and vigorous activity.
“Of note, similar results are obtainable by performing 1 -1.5 h/week of vigorous-intensity physical activity/aerobic exercise training or an equivalent combination of moderate-intensity and vigorous-intensity physical activity/aerobic exercise training.”
Quote in the paperSubstantial claim - Premisecitation
Information is available for evidence-based aerobic exercise training prescription in specific subpopulations of cardiac patients.
“Information is available for evidencebased aerobic exercise training prescription in specific subpopulations of cardiac patients.205”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [205] Piepoli, 2010, Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Premisecitation
Psychological interventions likely have additional beneficial effects on physiological risk factors and distress when added to standard rehabilitation.
“Psychological interventions are likely to have additional beneficial effects on physiological risk factors and distress, even when added to standard rehabilitation.199”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [199] Linden, 2007, Psychological treatment of cardiac patients: a meta-analysis, Eur Heart J source
Not checked in the free run.
- Premisecitation
Visceral adipose tissue is a metabolically active endocrine organ that synthesizes and releases peptides and non-peptide compounds that may play a role in cardiovascular homeostasis.
“It is now clear that one of the components of abdominal fat, visceral adipose tissue, is a metabolically active endocrine organ capable of synthesizing and releasing into the bloodstream an important variety of peptides and non-peptide compounds that may play a role in cardiovascular homeostasis.373”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [373] Haslam, 2005, Obesity, Lancet source
Not checked in the free run.
- Premisecitation
A large case-control study found waist:hip ratio more associated with myocardial infarction than BMI in both men and women.
“A large, case -control prevalence study found that the waist:hip ratio was to a greater extent associated with myocardial infarction than BMI in both men and women.377”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [377] Yusuf, 2005, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study, Lancet source
Not checked in the free run.
- Premisecitation
Overweight and obesity are associated with risk of death in CVD.
“Both overweight and obesity are associated with a risk of death in CVD.363 -365”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- cites [364] Berrington de Gonzalez, 2010, Body-mass index and mortality among 1.46 million white adults, N Engl J Med source
Not checked in the free run.
- cites [365] Zheng, 2011, Association between body-mass index and risk of death in more than 1 million Asians, N Engl J Med source
Not checked in the free run.
- Interpretationreasoning
Currently, there is no strong evidence that waist measurements or direct fat mass measurements should replace BMI in routine public health surveillance or clinical practice.
“Currently, there does not appear to be strong evidence that measurements of waist or direct measurement of fat mass should replace BMI in routine public health surveillance or clinical practice.”
Quote in the paperSubstantial claim - Premisecitation
Further weight reduction cannot be considered protective against CVD.
“Further weight reduction cannot be considered protective against CVD.366 -369”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [366] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Not checked in the free run.
- cites [367] Oreopoulos, 2008, Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis, Obesity (Silver Spring) source
Not checked in the free run.
- cites [368] Hastie, 2010, Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention, Eur Heart J source
Not checked in the free run.
- cites [369] Lavie, 2009, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Prospective Studies Collaboration found positive linear associations of BMI from 22.5 to 25.0 with all-cause mortality.
“Recent findings from the Prospective Studies Collaboration, 363 involving .900000 participants, found positive linear associations of BMI from 22.5 to 25.0 with all-cause mortality.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- Premisecitation
In an Asian population (1.1 million persons in 19 cohorts), lowest risk of death was with BMI 22.6-27.5.
“In an Asian population (1.1 million persons recruited in 19 cohorts), 365 the lowest risk of death was seen with a BMI in the range of 22.6-27.5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [365] Zheng, 2011, Association between body-mass index and risk of death in more than 1 million Asians, N Engl J Med source
Not checked in the free run.
- Premisecitation
A group-based stress-reduction programme for women prolongs lives independent of other prognostic factors.
“Recently, a group-based stressreduction programme for women was shown to prolong lives independent of other prognostic factors.348,358”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [348] Orth-Gomer, 2009, Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD), Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- cites [358] Gulliksson, 2011, Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM), Arch Intern Med source
Not checked in the free run.
- Premisecitation
For women, specific behavioural group treatments may reduce distress.
“For women, specific behavioural group treatments may be useful for reducing distress.348,350,361”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [348] Orth-Gomer, 2009, Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD), Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- cites [350] Bjarnason-Wehrens, 2007, Gender-specific issues in cardiac rehabilitation: do women with ischaemic heart disease need specially tailored programmes?, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [361] Claesson, 2005, Women's hearts—stress management for women with ischemic heart disease: explanatory analyses of a randomized controlled trial, J Cardiopulm Rehabil source
Not checked in the free run.
- Premisecitation
In the USA, if obesity trends from 2005 to 2020 continue unchecked, obesity will increasingly offset the positive effects of declining smoking rates.
“in the USA, if obesity trends from 2005 to 2020 continue unchecked, obesity will increasingly offset the positive effects of declining smoking rates.371”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [371] Stewart, 2009, Forecasting the effects of obesity and smoking on U.S. life expectancy, N Engl J Med source
Not checked in the free run.
- Premisecitation
BMI has a positive linear association with all-cause mortality.
“There is a positive linear association of BMI with all-cause mortality.363”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- Interpretationcitation
Calls for direct measurements of fat mass may be problematic in routine clinical and public health practice due to difficulties with accurate and reliable measurements.
“On the other hand, calls for more direct measurements of fat mass, such as by bioelectrical impedance analysis or the use of skinfold thickness, may be problematic in routine clinical and public health practice because of difficulties with accurate and reliable measurements.383 -386”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [383] Nordhamn, 2000, Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables, Int J Obes Relat Metab Disord source
Not checked in the free run.
- cites [384] Kramer, 2009, The double jeopardy of clustered measurement and cluster randomisation, BMJ source
Not checked in the free run.
- cites [385] Ashwell, 1982, Female fat distribution—a simple classification based on two circumference measurements, Int J Obes
Not checked in the free run.
- cites [386] Lohman, 1998
Not checked in the free run.
- Premisecitation
All-cause mortality is lowest with a BMI of 20-25 kg/m2.
“All-cause mortality is lowest with a BMI of 20 -25 kg/m 2 .363 -365”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- cites [364] Berrington de Gonzalez, 2010, Body-mass index and mortality among 1.46 million white adults, N Engl J Med source
Not checked in the free run.
- cites [365] Zheng, 2011, Association between body-mass index and risk of death in more than 1 million Asians, N Engl J Med source
Not checked in the free run.
- Premisecitation
Data are consistent with four cohorts from British Women's Heart and Health Study, Caerphilly Prospective Study, Boyd Orr Study, and Maidstone-Dewsbury Study.
“The data are consistent with the results of four cohorts of adults from the British Women's Heart and Health Study, the Caerphilly Prospective Study, the Boyd Orr Study, and the Maidstone-Dewsbury Study.379”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [379] Taylor, 2010, Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts, Am J Clin Nutr source
Not checked in the free run.
- Interpretationcitation
The same optimal weight range in Asian and European studies argues against race- or ethnicity-specific BMI cut-offs for overweight and obesity.
“The finding that the same optimal weight range is associated with the lowest risk of death both in this study and in previous studies of European origin argues against the use of race-or ethnicity-specific BMI cut-off points to define overweight and obesity.363”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- Premisecitation
Risk of death is elevated with BMI higher or lower than optimal ranges, with a U-shaped association.
“The risk was elevated with BMI levels either higher or lower than these ranges, with a U-shaped association.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [363] Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- cites [364] Berrington de Gonzalez, 2010, Body-mass index and mortality among 1.46 million white adults, N Engl J Med source
Not checked in the free run.
- cites [365] Zheng, 2011, Association between body-mass index and risk of death in more than 1 million Asians, N Engl J Med source
Not checked in the free run.
- Premisecitation
In pooled analysis of 19 prospective studies (1.46 million white adults), all-cause mortality was lowest with BMI 20.0-24.9.
“In a revised pooled analysis of 19 prospective studies (1.46 million white adults), 364 all-cause mortality was lowest with a BMI of 20.0 -24.9.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [364] Berrington de Gonzalez, 2010, Body-mass index and mortality among 1.46 million white adults, N Engl J Med source
Not checked in the free run.
- Interpretationreasoning
Body weight may be critically important because it exerts its effect on risk through adverse effects on many risk factors.
“This should not be interpreted as indicating that body weight is not important; rather, it may be critically important because it exerts its effect on risk by its adverse effects on many risk factors.”
Quote in the paperSubstantial claim- Rests on an assumption: After multivariable adjustment, raised blood cholesterol and reduced HDL cholesterol remain independently associated with risk, while the association between weight and risk tends to lose significance.
- Premisecitation
In patients with grade 2 or 3 hypertension, BP reduction lowers cardiovascular morbidity and mortality independently of total risk.
“a large number of placebo-controlled trials have conclusively demonstrated that in patients with these BP values, BP reduction lowers cardiovascular morbidity and mortality independently of their level of total risk.”
Quote in the paperSubstantial claim - Premisecitation
Orlistat and/or bariatric surgery are the only options for patients with BMI ≥40 kg/m2 or BMI ≥35 kg/m2 with high-risk comorbid conditions.
“Medical therapy with orlistat 388 and/or bariatric surgery 389 for patients with a BMI ≥40 kg/m 2 or a BMI ≥35 kg/m 2 in the presence of high-risk comorbid conditions are the only options.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [388] Drew, 2007, Obesity management: update on orlistat, Vasc Health Risk Manag
Not checked in the free run.
- cites [389] Poirier, 2011, Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
- Premisecitation
Systematic reviews of patients with coronary artery disease or undergoing PCI suggest an obesity paradox whereby obesity appears protective against adverse prognosis.
“Systematic reviews of patients with coronary artery disease or undergoing PCI have suggested an 'obesity paradox' whereby obesity appears protective against an adverse prognosis.366 -369”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [366] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Not checked in the free run.
- cites [367] Oreopoulos, 2008, Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis, Obesity (Silver Spring) source
Not checked in the free run.
- cites [368] Hastie, 2010, Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention, Eur Heart J source
Not checked in the free run.
- cites [369] Lavie, 2009, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Subclinical organ damage predicts cardiovascular death independently of SCORE.
“there is evidence that subclinical organ damage predicts cardiovascular death independently of SCORE”
- Also stated in: § 4.7.7 Risk stratification in hypertension · plain
“In conclusion, there is evidence that subclinical organ damage predicts cardiovascular death independently of SCORE, and the combination may improve risk prediction, especially in subjects at low or moderate risk (SCORE 1-4%).400”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J source
Not checked in the free run.
- cites [400] Sehestedt, 2010, Risk prediction is improved by adding markers of subclinical organ damage to SCORE, Eur Heart J source
Not checked in the free run.
- Also stated in: § 4.7.7 Risk stratification in hypertension · plain
- Premisecitation
All major antihypertensive drug classes (diuretics, ACE inhibitors, calcium antagonists, angiotensin receptor antagonists, beta-blockers) do not differ significantly in BP-lowering efficacy.
“All major antihypertensive drug classes (i.e.diuretics, ACE inhibitors, calcium antagonists, angiotensin receptor antagonists, and beta-blockers) do not differ significantly in their BP-lowering efficacy”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [394] Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ source
Not checked in the free run.
- Premisereasoning
Evidence for benefit of treating grade 1 hypertension is scantier because earlier trials in mild hypertension mostly enrolled high-risk patients.
“The evidence for the benefit of treating patients with grade 1 hypertension is admittedly scantier, because earlier trials in mild hypertension included patients mostly at high risk.”
Quote in the paperSubstantial claim - Premisecitation
Ambulatory and home BP values are closely related to prognosis.
“Both ambulatory and home BP values are closely related to prognosis.416”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [416] Mancia, 2006, Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure, Hypertension source
Not checked in the free run.
- Premisecitation
Carotid ultrasound with measurement of IMT or presence of plaques predicts both stroke and myocardial infarction.
“Carotid ultrasound with measurement of IMT or the presence of plaques predicts both stroke and myocardial infarction.421”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [421] Touboul, 2004, Mannheim intima-media thickness consensus, Cerebrovasc Dis source
Not checked in the free run.
- Premisecitation
ECG left ventricular hypertrophy is an independent predictor of cardiovascular events.
“Electrocardiographic left ventricular hypertrophy (LVH), detected by the Sokolow-Lyons index, Cornell voltage QRS duration product, or the recently developed Novacode estimate, 418 is an independent predictor of cardiovascular events.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [418] Havranek, 2008, Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity, Am J Med source
Not checked in the free run.
- Premisecitation
Observational data involving >1 million individuals indicate death from CHD and stroke increases progressively and linearly from BP levels as low as 115 mmHg systolic and 75 mmHg diastolic upwards.
“Observational data involving .1 million individuals have indicated that death from both CHD and stroke increases progressively and linearly from BP levels as low as 115 mmHg systolic and 75 mmHg diastolic upwards.412”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [412] Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet source
Not checked in the free run.
- Premisecitation
Co-existence of other risk factors (smoking, increased plasma cholesterol, diabetes mellitus, family history of premature CVD) greatly adds to risk associated with mild BP elevation.
“The co-existence of other risk factors (smoking, increased plasma cholesterol, diabetes mellitus, family history of premature CVD) also greatly adds to the risk associated with mild BP elevation.45”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J source
Not checked in the free run.
- Premisecitation
The same meta-analysis confirmed increasing contribution of pulse pressure after age 55 years.
“This meta-analysis also confirmed the increasing contribution of pulse pressure after age 55 years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [412] Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet source
Not checked in the free run.
- Interpretationreasoning
Because risk factors may interact, overall risk of hypertensive patients is increased even with mild or moderate BP elevation.
“Because risk factors may interact, the overall risk of hypertensive patients is increased although the BP elevation is only mild or moderate.”
Quote in the paperSubstantial claim- Rests on an assumption: Individuals with elevated BP more commonly have other CVD risk factors (diabetes, insulin resistance, dyslipidaemia) and target organ damage.
- Premisecitation
In the largest meta-analysis of observational data from 61 studies, pulse pressure was less predictive than both SBP and DBP.
“However, in the largest meta-analysis of observational data from 61 studies (70% of which have been conducted in Europe), 412 pulse pressure was less predictive than both SBP and DBP.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [412] Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet source
Not checked in the free run.
- Interpretationcitation
A J-curve phenomenon for achieved systolic blood pressure below 130 mmHg cannot be excluded.
“A J-curve phenomenon for achieved SBP below 130 mmHg cannot be excluded. 432”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [432] Mancia, 2009, Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, J Hypertens source
Not checked in the free run.
- Interpretationcitation
The extent to which HYVET data can be extrapolated to more fragile octogenarians is uncertain because HYVET patients were generally in good condition.
“Because patients in the Hypertension in the Very Elderly Trial (HYVET) were generally in a good condition, 433 the extent to which HYVET data can be extrapolated to more fragile octogenarians is uncertain.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [433] Beckett, 2008, Treatment of hypertension in patients 80 years of age or older, N Engl J Med source
Not checked in the free run.
- Interpretationreasoning
A J-curve phenomenon is unlikely to occur down to systolic blood pressure 120 mmHg and diastolic blood pressure 75 mmHg except perhaps in patients with advanced atherosclerotic disease.
“A J-curve phenomenon is unlikely to occur down to these values except, perhaps, in patients with advanced atherosclerotic disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
A combination of subclinical organ damage and SCORE may improve risk prediction, particularly in individuals at low and moderate risk (SCORE 1-4%).
“and a combination of both may improve risk prediction, particularly in individuals at low and moderate risk (SCORE 1-4%).”
Quote in the paperSubstantial claim - Interpretationreasoning
Non-HDL cholesterol is a better measure than calculated LDL cholesterol, particularly for patients with high non-fasting triglyceride concentrations.
“Therefore, it is a better measure than calculated LDL cholesterol, particularly for patients with high non-fasting triglyceride concentrations.”
Quote in the paperSubstantial claim - Premisecitation
Low concentrations of HDL cholesterol are independently associated with higher cardiovascular disease risk.
“Low concentrations of HDL cholesterol are independently associated with higher CVD risk, therefore HDL cholesterol is also included in new SCORE charts.478”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [478] Chapman, 2011, Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management, Eur Heart J source
Not checked in the free run.
- Premisecitation
Occlusive arterial disease of the lower limbs and carotid artery disease are coronary heart disease risk-equivalent conditions.
“Occlusive arterial disease of the lower limbs and carotid artery disease are CHD risk-equivalent conditions, and lipid-lowering therapy is recommended in these patients irrespective of their plasma lipid levels.472,486”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [472] Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev
Not checked in the free run.
- cites [486] Tendera, 2011, ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), Eur Heart J source
Not checked in the free run.
- Study design and conductreasoning
The Friedewald formula for calculating LDL cholesterol is valid only when the triglyceride concentration is below 4.5 mmol/L (400 mg/dL).
“The calculation is valid only when the concentration of triglycerides is ,4.5 mmol/L (400 mg/dL) as the triglyceride/cholesterol ratio in triglyceride-carrying lipoproteins (VLDL and chylomicrons) progressively increases as hypertriglyceridaemia increases in severity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [482] Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem source
Not checked in the free run.
- Premisecitation
Non-HDL cholesterol predicts cardiovascular disease risk similarly to or even better than LDL cholesterol.
“Non-HDL cholesterol predicts CVD risk similarly to or even better than LDL cholesterol.483”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [483] Robinson, 2009, Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk, J Am Coll Cardiol source
Not checked in the free run.
- Premisenone given
Abdominal aortic aneurysm is a coronary heart disease risk-equivalent condition.
“Although abdominal aortic aneurysm is also a CHD risk-equivalent condition, there is no conclusive evidence that treatment with statins reduces perioperative CVD morbidity and mortality in these patients.220,487”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [220] Prescott, 2002, Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study, J Epidemiol Community Health source
Not checked in the free run.
- cites [487] Schouten, 2009, Fluvastatin and perioperative events in patients undergoing vascular surgery, N Engl J Med source
Not checked in the free run.
- Premisecitation
No randomized intervention has shown that reducing lipoprotein(a) decreases cardiovascular disease risk.
“High concentrations of Lp(a) are associated with increased risk of CHD and ischaemic stroke, although there is no randomized intervention showing that reducing Lp(a) decreases CVD risk.480”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [480] Nordestgaard, 2010, Lipoprotein(a) as a cardiovascular risk factor: current status, Eur Heart J source
Not checked in the free run.
- Premisecitation
The apoB:apoA1 ratio is one of the strongest risk markers.
“It is beyond doubt that the apoB:apoA1 ratio is one of the strongest risk markers.475,481”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [475] Thompson, 2006, Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies, J Intern Med source
Not checked in the free run.
- cites [481] Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study, Lancet source
Not checked in the free run.
- Premisecitation
High concentrations of lipoprotein(a) are associated with increased risk of coronary heart disease and ischaemic stroke.
“High concentrations of Lp(a) are associated with increased risk of CHD and ischaemic stroke, although there is no randomized intervention showing that reducing Lp(a) decreases CVD risk.480”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [480] Nordestgaard, 2010, Lipoprotein(a) as a cardiovascular risk factor: current status, Eur Heart J source
Not checked in the free run.
- Premisereasoning
Non-HDL cholesterol does not require the triglyceride concentration to be below 4.5 mmol/L, unlike calculated LDL cholesterol.
“Calculated by simply subtracting HDL cholesterol from total cholesterol, non-HDL cholesterol-unlike LDL cholesterol-does not require the triglyceride concentration to be ,4.5 mmol/L ( 400 mg/dL).”
Quote in the paperSubstantial claim - Premisecitation
The benefit of cholesterol-lowering therapy depends on initial risk: the higher the risk, the greater the benefit.
“The benefit of cholesterol-lowering therapy depends on initial levels of risk: the higher the risk, the greater the benefit (Table 16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 16
Not checked in the free run.
- Premisecitation
Low concentrations of HDL cholesterol may rival hypercholesterolaemia as a risk factor for coronary heart disease.
“Low concentrations of HDL cholesterol may even rival hypercholesterolaemia (due to high concentrations of LDL cholesterol) as a risk factor for CHD.479”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [479] Fruchart, 2008, The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia, Am J Cardiol source
Not checked in the free run.
- Premisecitation
In patients with prior non-cardioembolic ischaemic stroke, dual antiplatelet therapy with dipyridamole plus aspirin showed superiority over aspirin.
“In patients with prior non-cardioembolic ischaemic stroke, dual antiplatelet therapy with dipyridamole plus aspirin showed superiority over aspirin.511”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [511] De Schryver, 2007, Dipyridamole for preventing stroke and other vascular events in patients with vascular disease, Cochrane Database Syst Rev
Not checked in the free run.
- Premisecitation
Dual antiplatelet therapy with clopidogrel plus aspirin versus clopidogrel in patients with transient ischaemic attack and ischaemic stroke was associated with an excess of serious bleeds in the MATCH trial.
“Dual antiplatelet therapy with clopidogrel plus aspirin vs. clopidogrel in patients with transient ischaemic attack and ischaemic stroke was associated with an excess of serious bleeds in the Management of Atherothrombosis with Clopidogrel in High-risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH) trial, 510 and is not recommended in cerebral ischaemia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [510] Diener, 2004, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial, Lancet source
Not checked in the free run.
- Premisecitation
In American veterans, adherence to lipid-lowering medication decreased as co-payment increased.
“For example, in American veterans, adherence to lipid-lowering medication decreased as co-payment increased.521”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [521] Doshi, 2009, Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans, Circulation source
Not checked in the free run.
- Premisecitation
Chronic kidney disease stages 2-5 (GFR below 90 mL/min/1.73m2) is acknowledged as a coronary heart disease risk-equivalent.
“CKD (stages 2 -5, i.e.GFR ,90 mL/min/1.73m 2 ) is acknowledged as a CHD risk-equivalent, and the LDL cholesterol target in these patients has been adapted to the degree of renal failure (see page 1653).42”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J source
Not checked in the free run.
- Interpretationcitation
The benefits of statins far outweigh the risks for the vast majority of patients.
“There are reports indicating increased blood sugar and HbA 1c levels, i.e. increased risk of type 2 diabetes, as a possible adverse effect of long-term statin therapy, but the benefits of statins far outweigh the risks for the vast majority of patients.497,498”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [497] Waters, 2011, Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials, J Am Coll Cardiol source
Not checked in the free run.
- cites [498] Culver, 2012, Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Following acute coronary syndrome, dual antiplatelet therapy with clopidogrel and aspirin reduced the risk of myocardial infarction, stroke, and death over 8 months from 6.4% to 4.5% (P=0.03) in NSTEMI (CURE).
“and from 6.4% to 4.5% (P ¼ 0.03) over a period of 8 months in NSTEMI patients [Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE)].505”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [505] Investigators TCT, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med source
Not checked in the free run.
- Premisecitation
Depression doubles the risk for medication non-adherence, even after control for age, ethnicity, education, social support, and measures of cardiac disease severity.
“Depression also doubles the risk for medication non-adherence, even after control for age, ethnicity, education, social support, and measures of cardiac disease severity.522”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [522] Gehi, 2005, Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Statins at doses that effectively reduce LDL cholesterol by 50% also seem to halt progression or even contribute to regression of coronary atherosclerosis.
“Statins at doses that effectively reduce LDL cholesterol by 50% also seem to halt progression or even contribute to regression of coronary atherosclerosis.495”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [495] Nissen, 2006, Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial, JAMA source
Not checked in the free run.
- Premisecitation
There is no conclusive evidence that statin treatment reduces perioperative cardiovascular disease morbidity and mortality in patients with abdominal aortic aneurysm.
“Although abdominal aortic aneurysm is also a CHD risk-equivalent condition, there is no conclusive evidence that treatment with statins reduces perioperative CVD morbidity and mortality in these patients.220,487”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [220] Prescott, 2002, Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study, J Epidemiol Community Health source
Not checked in the free run.
- cites [487] Schouten, 2009, Fluvastatin and perioperative events in patients undergoing vascular surgery, N Engl J Med source
Not checked in the free run.
- Premisecitation
Recently, a randomized phase II trial in middle-aged individuals without cardiovascular disease demonstrated that the 'Polycap' formulation could conveniently reduce multiple risk factors.
“Recently, a randomized phase II trial in middle-aged individuals without CVD demonstrated that the 'Polycap' formulation could conveniently reduce multiple risk factors.527”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [527] Yusuf, 2009, Lancet source
Not checked in the free run.
- Premisecitation
In patients with acute coronary syndrome for whom an early invasive strategy is planned, dual antiplatelet therapy with a P2Y12 inhibitor (ticagrelor or prasugrel) added to aspirin is superior to clopidogrel plus aspirin.
“In patients with ACS for whom an early invasive strategy is planned, dual antiplatelet therapy with a P2Y12 inhibitor (ticagrelor or prasugrel) added to aspirin was superior to clopidogrel and aspirin.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [501] Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med source
Not checked in the free run.
- cites [502] Gurbel, 2009, Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study, Circulation source
Not checked in the free run.
- cites [503] Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med source
Not checked in the free run.
- Premisecitation
Adherence to medication in individuals at high risk and in patients with cardiovascular disease is low.
“Adherence to medication in individuals at high risk and in patients with CVD is still low.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Increased concentrations of triglycerides and low HDL cholesterol are associated with non-haemorrhagic stroke.
“Increased concentrations of triglycerides and low HDL cholesterol are also associated with non-haemorrhagic stroke.490,491”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [490] Tanne, 2001, Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor, Circulation source
Not checked in the free run.
- cites [491] Sacco, 2001, High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study, JAMA source
Not checked in the free run.
- Premisecitation
Major statin trials reported significant reductions in stroke rates in patients with coronary heart disease or at high risk due to a reduction in ischaemic stroke.
“Major statin trials reported significant reductions in stroke rates in patients with CHD or at high risk due to a reduction in the rates of ischaemic stroke.469”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [469] Amarenco, 2009, Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention, Lancet Neurol source
Not checked in the free run.
- Premisecitation
Evidence suggests that reducing dosage demands is the most effective single approach to enhancing medication adherence.
“Evidence suggests that reducing dosage demands is the most effective single approach to enhancing medication adherence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [520] Kripalani, 2007, Interventions to enhance medication adherence in chronic medical conditions: a systematic review, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Physicians might fail to communicate critical elements of medication use, such as possible adverse effects, how long to take the medication, and the frequency or timing of dosing.
“However, physicians might fail to communicate critical elements of medication use (e.g.possible adverse effects, how long to take the medication, and the frequency or timing of dosing).523”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [523] Tarn, 2006, Physician communication when prescribing new medications, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Several types of interventions are effective in improving medication adherence.
“Several types of interventions are effective in improving medication adherence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [520] Kripalani, 2007, Interventions to enhance medication adherence in chronic medical conditions: a systematic review, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Following acute coronary syndrome, dual antiplatelet therapy with clopidogrel and aspirin reduced the risk of myocardial infarction, stroke, and death over 14 days from 10.1% to 9.2% (P=0.002) in STEMI (COMMIT).
“Following an episode of acute coronary ischaemia [unstable angina, NSTEMI, ST-elevation myocardial infarction (STEMI)], dual antiplatelet therapy with clopidogrel and aspirin reduced the risk of myocardial infarction, stroke, and death over 14 days from 10.1% to 9.2% (P ¼ 0.002) in STEMI [Clopidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT)], 504”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [504] Chen, 2005, Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet source
Not checked in the free run.
- Premisecitation
There are reports indicating increased blood sugar and HbA1c levels, i.e., increased risk of type 2 diabetes, as a possible adverse effect of long-term statin therapy.
“There are reports indicating increased blood sugar and HbA 1c levels, i.e. increased risk of type 2 diabetes, as a possible adverse effect of long-term statin therapy, but the benefits of statins far outweigh the risks for the vast majority of patients.497,498”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [497] Waters, 2011, Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials, J Am Coll Cardiol source
Not checked in the free run.
- cites [498] Culver, 2012, Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative, Arch Intern Med source
Not checked in the free run.
- Premisecitation
After 1 year, fewer than 50% of patients report persistent use of statins, beta-blockers, or antihypertensive therapy.
“After 1 year, ,50% of patients report persistent use of statins, beta-blockers, or antihypertensive therapy.518,519”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Chronic kidney disease is characterized by mixed dyslipidaemia (high triglycerides, high LDL cholesterol, and low HDL cholesterol).
“Chronic kidney disease is characterized by mixed dyslipidaemia (high triglycerides, high LDL cholesterol, and low HDL cholesterol).492”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [492] Kwan, 2007, Lipoprotein metabolism and lipid management in chronic kidney disease, J Am Soc Nephrol source
Not checked in the free run.
- Interpretationreasoning
The success of the interventions despite differences in intensity, duration, and components supports the basic concept that more sustained contact is necessary to achieve changes in lifestyle and improvement of compliance.
“The success of the interventions despite these differences support the basic concept that more sustained contact is necessary to achieve changes in lifestyle and improvement of compliance.”
Quote in the paperSubstantial claim - Premisecitation
The length of routine patient consultations is widely recognized as a barrier to conducting risk assessments.
“The length of routine patient consultations, which provides little time for discussion, is widely recognized as a barrier to conducting risk assessments.545,547”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [545] van Steenkiste, 2004, Barriers to implementing cardiovascular risk tables in routine general practice, Scand J Prim Health Care source
Not checked in the free run.
- cites [547] Marshall, 2006, Estimating the value of information in strategies for identifying patients at high risk of cardiovascular disease, Inform Prim Care
Not checked in the free run.
- Premisecitation
Nurse-co-ordinated prevention programmes are effective across a variety of practice settings.
“Nurse-co-ordinated prevention programmes are effective across a variety of practice settings.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [530] Berra, 2006, Cardiovascular disease prevention and disease management: a critical role for nursing, J Cardiopulm Rehabil source
Not checked in the free run.
- cites [531] Berra, 2011, Global cardiovascular disease prevention: a call to action for nursing: the global burden of cardiovascular disease, J Cardiovasc Nurs source
Not checked in the free run.
- Interpretationreasoning
Increasing numbers of patients receiving medications may result in higher healthcare costs.
“Increasing numbers of patients receiving medications may result in higher healthcare costs.”
Quote in the paperNot a substantial claim - Premisecitation
Physicians were less willing to prescribe antihypertensive medications to patients identified as eligible in guidelines.
“Moreover, physicians were less willing to prescribe antihypertensive medications to patients identified as eligible in guidelines.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [542] Persson, 2004, Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy, J Hypertens source
Not checked in the free run.
- cites [543] 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee, 1999, J Hypertens
Not checked in the free run.
- Premisecitation
Preventive treatment tends to be abandoned within 6 months of hospital discharge after myocardial infarction, PCI, or CABG.
“which has a tendency to be abandoned within 6 months of hospital discharge after myocardial infarction, PCI, or CABG.250”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [250] Chow, 2010, Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes, Circulation source
Not checked in the free run.
- Premisecitation
Nurse case management models which were more intensive with more sustained contact have shown the most successful outcomes, including regression of atherosclerosis and decreased cardiac events.
“Nurse case management models which were more intensive with more sustained contact have shown the most successful outcomes, including regression of atherosclerosis and decreased cardiac events.535”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [535] Haskell, 1994, Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP), Circulation source
Not checked in the free run.
- Premisecitation
Integrating a web-based decision-support system (PREDICT-CVD) with primary care electronic medical record software improved CVD risk documentation fourfold in a practice of 3564 patients.
“integration of a web-based decisionsupport system (PREDICT-CVD) with primary care electronic medical record software improved CVD risk documentation fourfold in a primary care practice of 3564 patients.551”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [551] Wells, 2008, Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Premisecitation
A Norwegian study suggests that using the European SCORE assessment would double the number of individuals needing drugs for primary prevention of CVD.
“Results of a Norwegian study suggest that using the European SCORE assessment would double the number of individuals who need drugs for primary prevention of CVD.548”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [548] Hartz, 2005, Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001, Eur Heart J source
Not checked in the free run.
- Interpretationcitation
Resources spent after risk assessment are more likely to reduce future healthcare costs.
“Resource spent after risk assessment is more likely to reduce future healthcare costs.”
Quote in the paperSubstantial claim - Premisecitation
Patients may have limited understanding of risk tables and how risk relates to disease development.
“Patients may have a limited understanding of risk tables and how risk relates to disease development.546”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [546] van Steenkiste, 2004, Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention, Patient Educ Couns source
Not checked in the free run.
- Premisecitation
Among patients receiving lipid-modifying therapy in Europe, 43% do not achieve total cholesterol targets below 4.5 mmol/L (175 mg/dL).
“among patients receiving lipid-modifying therapy, 43% do not achieve total cholesterol targets (,4.5 mmol/L, 175 mg/dL) in Europe, 5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
- Premisecitation
UK modelling strategies reported that prioritizing patients by estimated CVD risk may reduce healthcare costs by £45,000 compared with a diabetes and hypertension first strategy.
“However, modelling strategies to use resources efficiently and to identify 70% of the CVD burden in the UK have reported that prioritizing patients by estimated CVD risk may reduce healthcare costs by £45 000 compared with a diabetes and hypertension first strategy.547”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [547] Marshall, 2006, Estimating the value of information in strategies for identifying patients at high risk of cardiovascular disease, Inform Prim Care
Not checked in the free run.
- Interpretationcitation
The higher the level of care based on guidelines and performance measures, the greater the impact on prevention and recurrent events.
“The higher the level of care based on the guidelines and performance measures, the better the impact on prevention and recurrent events.82,437”
- Also stated in: § Most important new information · plain
“The higher the level of care based on guidelines and performance measures, the greater the impact on prevention and recurrent events.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [82] Mosca, 2011, Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the american heart association, Circulation source
Not checked in the free run.
- cites [437] Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation source
Not checked in the free run.
- Also stated in: § Most important new information · plain
- Premisecitation
In New Zealand, system improvements in primary care practice software increased the CVD risk assessment screening rate from 4.7% to 53.5% over 12 months in 6570 patients.
“For example, in New Zealand, system improvements in primary care practice software were highly successful, increasing the CVD risk assessment screening rate from 4.7% to 53.5% over 12 months (n ¼ 6570); 550”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [550] Sinclair, 2006, The Bold Promise Project: a system change in primary care to support cardiovascular risk screening, N Z Med J
Not checked in the free run.
- Premisecitation
The approach of the cardiologist reviewing discharge recommendations and helping the patient comply has a significant impact on mid-term prognosis.
“This approach has a significant impact on mid-term prognosis.250,437”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [250] Chow, 2010, Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes, Circulation source
Not checked in the free run.
- cites [437] Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation source
Not checked in the free run.
- Premisecitation
A Dutch qualitative study reported that physicians' knowledge of risk tables and their ability to communicate that knowledge influenced implementation.
“A Dutch qualitative study of the use of risk tables as a key component of risk assessments for primary prevention reported that physicians' knowledge of the risk tables and ability to communicate that knowledge to the patient influenced their implementation.545”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [545] van Steenkiste, 2004, Barriers to implementing cardiovascular risk tables in routine general practice, Scand J Prim Health Care source
Not checked in the free run.
- Interpretationreasoning
Nurses can successfully lead or coordinate prevention schemes in a variety of settings.
“However, the need for effective prevention programmes is undeniable, and the evidence shows that nurses can successfully lead or co-ordinate such schemes in a variety of settings.”
Quote in the paperSubstantial claim- Rests on an assumption: Effective prevention programmes are undeniably needed.
- Premisecitation
The EUROACTION trial demonstrated the feasibility of this type of programme in hospitals and in general practice, outside specialist centres, and in eight different healthcare systems across Europe.
“A particular strength of the programme was the demonstration of the feasibility of this type of programme in hospitals and in general practice, outside of specialist centres, and in eight different healthcare systems across Europe.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Wood, 2008, Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial, Lancet source
Not checked in the free run.
- Premisecitation
In the USA, 64% of patients receiving lipid-modifying therapy fail to reach LDL cholesterol targets.
“whereas 64% fail to reach LDL cholesterol targets in the USA. 539”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [539] Ghandehari, 2008, Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004, Am Heart J source
Not checked in the free run.
- Interpretationcitation
The introduction of quality-improvement programmes improves discharge recommendations.
“The introduction of quality-improvement programmes improves discharge recommendations.”
Quote in the paperSubstantial claim - Premisecitation
In EUROASPIRE III, 49% of patients with established coronary heart disease had total cholesterol below 4.5 mmol/L (175 mg/dL).
“| Total cholesterol <4.5 mmol/L (175 mg/dL) | 49 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Interpretationreasoning
Cardiac rehabilitation after cardiac events or interventions in a specialized centre helps maintain long-term adherence to optimal treatment by educating the patient and repeatedly emphasizing prescribed treatments and lifestyle.
“Cardiac rehabilitation after cardiac events or interventions in a specialized centre helps to maintain long-term adherence to the optimal treatment programme by educating the patient and repeatedly emphasizing the importance of maintaining the prescribed treatments and recommended lifestyle.”
Quote in the paperSubstantial claim - Premisecitation
In an observational study of 5353 patients with acute myocardial infarction, only about half were discharged with optimal medical therapy compared with guideline standards.
“However, only about half of all patients were discharged with optimal medical therapy in an observational study of 5353 patients with acute myocardial infarction compared with the standards in these guidelines.555”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [555] Bramlage, 2010, The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction, Heart source
Not checked in the free run.
- Premisecitation
Adherence to behavioural advice on diet, exercise, and smoking cessation after ACS was associated with a substantially lower risk of recurrent cardiovascular events compared with non-adherence.
“Adherence to behavioural advice (diet, exercise, and smoking cessation) after an ACS was associated with a substantially lower risk of recurrent cardiovascular events compared with non-adherence.250”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [250] Chow, 2010, Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes, Circulation source
Not checked in the free run.
- Interpretationreasoning
Cardiac rehabilitation is cost-effective in reducing the risk of cardiovascular events.
“Cardiac rehabilitation is cost-effective in reducing risk of cardiovascular events.”
Quote in the paperNot a substantial claim - Premisecitation
In EUROASPIRE III, 12% of women with established coronary heart disease had a waist circumference below 80 cm.
“| <80 cm (women) | 12 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
The GOSPEL study supported that a long-term intervention was more effective than a short-term course.
“This was supported by the results of the Global Secondary Prevention Strategies to Limit Event Recurrence After MI (GOSPEL) study, where a long-term intervention was more effective than a short-term course.565”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [565] Giannuzzi, 2008, Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network, Arch Intern Med source
Not checked in the free run.
- Interpretationnone given
In usual care, compliance with lifestyle recommendations and treatment regimens starts to decline within 6 months of hospital discharge.
“In the usual care setting, compliance with lifestyle recommendations and treatment regimens starts to decline within 6 months of discharge from hospital.”
Quote in the paperSubstantial claim - Premisecitation
An intensive educational and process-orientated quality-improvement initiative based on the 2001 ACC/AHA secondary prevention guidelines significantly improved compliance rates at discharge for aspirin, ACE inhibitors, lipid-lowering drugs, smoking cessation counselling, and dietary counselling.
“The introduction of an intensive, educational, and process-orientated quality-improvement initiative, based on the 2001 American College of Cardiology/AHA secondary prevention guidelines, 558 resulted in significantly improved compliance rates at discharge for aspirin, ACE inhibitors, lipid-lowering drugs, smoking cessation counselling, and dietary counselling.559”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [558] Smith, 2001, AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology, Circulation source
Not checked in the free run.
- cites [559] Yam, 2006, Interventions to improve guideline compliance following coronary artery bypass grafting, Surgery
Not checked in the free run.
- Premisecitation
In the Seven Countries Study, 25-year coronary heart disease mortality rates varied across cohorts by baseline total cholesterol quartile, after adjustment for age, smoking, and blood pressure.
“Cumulative 25-year coronary heart disease (CHD) mortality rates in different cohorts of the Seven Countries Study, according to baseline quartiles of total cholesterol level, adjusted for age, smoking, and blood pressure.304”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [304] Verschuren, 1995, Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study, JAMA source
Not checked in the free run.
- Interpretationnone given
Cognitive and behavioural methods are effective in helping individuals adopt a healthy lifestyle.
“Cognitive-behavioural methods are effective in supporting persons in adopting a healthy lifestyle.”
Quote in the paperSubstantial claim - Premisecitation
In EUROASPIRE III, among patients with established coronary heart disease and type 2 diabetes, 27% had fasting glycaemia below 7.0 mmol/L (125 mg/dL).
“| Fasting glycaemia <7.0 mmol/L (125 mg/dL) | 27 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, 50% of patients with established coronary heart disease had blood pressure below 140/90 mmHg.
“| Blood pressure <140/90 mmHg | 50 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, 18% of patients with established coronary heart disease had a BMI below 25 kg/m2.
“| BMI <25 kg/m 2 | 18 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
Patients discharged on less than optimal medical therapy have a worse 1-year prognosis.
“patients discharged on less than optimal medical therapy have a worse 1-year prognosis.555”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [555] Bramlage, 2010, The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction, Heart source
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, 25% of men with established coronary heart disease had a waist circumference below 94 cm.
“| <94 cm (men) | 25 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
A large observational study suggested that the number of rehabilitation sessions attended correlated with improved prognosis.
“From a large observational study, it was suggested that the number of rehabilitation sessions attended (i.e.duration and intensity of the intervention and motivation of the participant) correlated with improved prognosis.67”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Ehrenthal, 2012, Cardiovascular risk age: Concepts and practicalities Heart
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, among patients with established coronary heart disease who smoked, 48% achieved smoking cessation.
“| Smoking cessation among smokers | 48 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, 55% of patients with established coronary heart disease had LDL cholesterol below 2.5 mmol/L (100 mg/dL).
“| LDL cholesterol <2.5 mmol/L (100 mg/dL) | 55 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, among patients with established coronary heart disease and type 2 diabetes, 35% had HbA1c below 6.5%.
“| HbA 1c <6.5% | 35 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Premisecitation
Over 2 years there was a continuous increase in guideline adherence by physicians at patient discharge.
“There appears to be a learning curve: over the course of 2 years there was a continuous increase in guideline adherence by the physicians at discharge of the patients.560”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [560] Williams, 2011, Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice, Circulation source
Not checked in the free run.
- Premisecitation
In EUROASPIRE III, 34% of patients with established coronary heart disease achieved regular physical activity.
“| Regular physical activity | 34 |”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EUROASPIRE III
Not checked in the free run.
- Classified as probably not a substantial claim. 100
- May combine two claims. 237
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOf all deaths before age 75 in Europe, 42% in women and 38% in men are due to CVD.
“of all deaths that occur before the age of 75 years in Europe, 42% are due to CVD in women and 38% in men.”
- Also stated in: § 2.1 Scope of the problem · plain
“CVD was responsible for 42% of all deaths below 75 years of age in European women and for 38% of all deaths at ,75 years in men.14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] European Heart Network, 2008
Not checked in the free run.
- Also stated in: § 2.1 Scope of the problem · plain
May combine two claims.
FindingcitationBeneficial reductions in major risk factors, particularly smoking, blood pressure, and cholesterol, accounted for more than half of the decrease in CHD deaths, although counteracted by increases in obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments.
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Ford, 2007, deaths from coronary disease, 1980–2000, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationChanges in risk factors explained almost half the variation in event rates in men but less in women.
“and the changes in risk factors explained almost half the variation in event rates in men but less in women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
May combine two claims.
Findingown dataThe effect of lipid levels on risk is modest in women who are otherwise at low risk, and the risk advantage of being female is lost by the combination of smoking and mild hypertension.
“The figure shows that the effect of the lipid levels on risk is modest in women who are at otherwise low risk, and that the risk advantage of being female is lost by the combination of smoking and mild hypertension.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationBetween EUROASPIRE I (1996) and EUROASPIRE III, the proportion of smokers did not change and blood pressure control did not improve despite increased use of antihypertensive drugs, while central obesity continued to increase.
“Moreover, the changes between EUROASPIRE I (1996) and EUROASPIRE III reveal that the proportion of smokers did not change and BP control has not improved despite increased use of antihypertensive drugs, while the number of patients with (central) obesity continues to increase.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
May combine two claims.
FindingcitationFasting triglycerides relate to risk in univariate analyses, but the effect is attenuated by adjustment for other factors, especially HDL cholesterol.
“Fasting triglycerides relate to risk in univariate analyses, but the effect is attenuated by adjustment for other factors, especially HDL cholesterol.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningCVD mortality has declined in many European countries, so more countries now fall into the low-risk category.
“The fact that CVD mortality has declined in many European countries means that more countries now fall into the low-risk category.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe impact of diabetes on risk appears greater than in Framingham-based risk estimation systems, with relative risks of 5 in women and 3 in men.
“While there is heterogeneity between cohorts, overall, the impact of diabetes on risk appears greater than in risk estimation systems based on the Framingham cohort, with relative risks of 5 in women and 3 in men.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningFive years later, at age 50, his risk increases to 14% over 10 years and he requires treatment.
“Five years later, when he reaches 50 years, his risk increases into the danger zone of 14% over 10 years and he requires treatment.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn the US Women's Health Initiative, only 4% of women had ideal cardiovascular health and 13% had no risk factors but failed to follow a healthy lifestyle.
“In the US Women's Health Initiative, only 4% of women fell into this ideal state and a further 13% had no risk factors but failed to follow a healthy lifestyle.83”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Hsia, 2010, Evaluation of the American Heart Association cardiovascular disease prevention guideline for women, Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
May combine two claims.
FindingcitationConflicts, crises, and long-term stressful conditions in family life increase CHD risk (HR 2.7-4.0), especially in women (RR 2.9-4.0).
“Conflicts, crises, and long-term stressful conditions in family life have also been shown to increase CHD risk [hazard ratio (HR) 2.7 -4.0], especially in women (RR 2.9 -4.0).96,97”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [96] Eaker, 2007, Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study, Psychosom Med source
Not checked in the free run.
- cites [97] Orth-Gomer, 2000, Marital stress worsens prognosis in women with coronary heart disease: the Stockholm Female Coronary Risk Study, JAMA source
Not checked in the free run.
May combine two claims.
FindingcitationPerceived social support counteracts the adverse effect of depression, while lack of support reinforces it.
“Perceived social support seems to counteract the adverse effect of depression, 103 whereas lack of support was found to reinforce its adverse effects.104”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [103] Frasure-Smith, 2000, Social support, depression, mortality during the first year after myocardial infarction, Circulation source
Not checked in the free run.
- cites [104] Horsten, 2000, Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study, Eur Heart J source
Not checked in the free run.
May combine two claims.
FindingcitationClinical depression and depressive symptoms predict incident CHD (RR 1.6 and 1.9) and worsen prognosis (OR 1.6 and 2.4).
“Several systematic reviews and meta-analyses have shown that clinical depression and depressive symptoms predict incident CHD (RR 1.6 and 1.9), 98 -100 and worsen its prognosis (OR 1.6 and 2.4). 100 -102”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [98] Rugulies, 2002, Depression as a predictor for coronary heart disease. a review and meta-analysis, Am J Prev Med source
Not checked in the free run.
- cites [99] Wulsin, 2003, Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review, Psychosom Med source
Not checked in the free run.
- cites [100] Nicholson, 2006, Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies, Eur Heart J source
Not checked in the free run.
- cites [101] Barth, 2004, Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis, Psychosom Med source
Not checked in the free run.
- cites [102] van Melle, 2004, Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis, Psychosom Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationCVD is the major cause of death in women in all European countries; below 75 years, 42% of women die from CVD compared with 38% of men.
“CVD is the major cause of death in women in all European countries; below 75 years, 42% of women die from CVD compared with 38% of men.14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] European Heart Network, 2008
Not checked in the free run.
May combine two claims.
FindingcitationTwo recent meta-analyses confirmed anxiety is an independent risk factor for incident CHD (HR 1.3) and for adverse events following myocardial infarction (OR 1.5 and 1.7).
“However, two recent meta-analyses confirmed that anxiety is an independent risk factor for incident CHD (HR 1.3) 111 and for adverse events following myocardial infarction (OR 1.5 and 1.7, respectively).112”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [111] Roest, 2010, Anxiety and risk of incident coronary heart disease: a meta-analysis, J Am Coll Cardiol source
Not checked in the free run.
- cites [112] Roest, 2010, Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis, Psychosom Med source
Not checked in the free run.
May combine two claims.
Findingnone givenThere is limited evidence that routine screening for psychosocial risk factors contributes to fewer future cardiac events, as screening has not yet translated into improved healthcare models.
“There is limited evidence that routine screening for psychosocial risk factors contributes to fewer future cardiac events, as screening has not yet translated into improved healthcare models.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationRecent meta-analyses have shown that symptoms of anxiety and type D personality increase risk for CVD and contribute to worse clinical outcome.
“Recent meta-analyses have shown that symptoms of anxiety and the type D personality increase risk for CVD and contribute to worse clinical outcome.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe magnitude of homocysteine's effect on risk is modest, and consistency is often lacking, mainly due to nutritional, metabolic, and lifestyle confounders.
“The magnitude of effect on risk is modest, and consistency is often lacking, mainly due to nutritional, metabolic (e.g.renal disease), and lifestyle confounders.128”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Clarke, 2010, Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals, Arch Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationSimilar statements are made for fibrinogen.
“Similar statements are made for fibrinogen.127”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] Kaptoge, 2007, Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration, Am J Epidemiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Findingnone givenSimplification of treatment improves adherence to therapy.
“Simplification of treatment improves adherence to therapy”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenCalcium antagonists are effective in left ventricular hypertrophy and appear particularly beneficial in slowing progression of carotid hypertrophy and atherosclerosis.
“calcium antagonists, besides being effective in LVH, appear particularly beneficial in slowing down progression of carotid hypertrophy and atherosclerosis.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThiazide and thiazide-like diuretics, beta-blockers, calcium antagonists, ACE inhibitors, and angiotensin receptor antagonists can adequately lower blood pressure and significantly reduce cardiovascular morbidity and mortality.
“thiazide and thiazide-like diuretics (chlorthalidone and indapamide), betablockers, calcium antagonists, ACE inhibitors, and angiotensin receptor antagonists can adequately lower BP, and significantly reduce risk of cardiovascular morbidity and mortality”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAliskiren effectively lowers blood pressure in hypertension and has an antiproteinuric effect.
“Aliskiren, which inhibits the effect of renin and pro-renin on their specific receptors, effectively lowers BP in hypertension 427 and has an antiproteinuric effect.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [427] Gradman, 2005, Aliskiren, a novel orally effective renin inhibitor provides dose-dependent antihypertensive efficacy placebo-like tolerability in hypertensive patients, Circulation source
Not checked in the free run.
May combine two claims.
Findingnone givenVasodilating beta-blockers such as carvedilol and nebivolol have less or no dysmetabolic action and a reduced incidence of new-onset diabetes compared with conventional beta-blockers.
“this may not apply to vasodilating beta-blockers such as carvedilol and nebivolol, which have less or no dysmetabolic action, as well as a reduced incidence of new-onset diabetes compared with conventional beta-blockers.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenACE inhibitors and angiotensin receptor antagonists are effective in reducing microalbuminuria and proteinuria and in preserving renal function and delaying end-stage renal disease.
“they are also quite effective in reducing microalbuminuria and proteinuria and in preserving renal function and delaying end-stage renal disease”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationBeta-blockers induce weight gain, have adverse effects on lipid metabolism, and increase the incidence of new-onset diabetes compared with other drugs.
“as beta-blockers induce weight gain, have adverse effects on lipid metabolism, 395 and increase (compared with other drugs) the incidence of new-onset diabetes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [395] Poulter, 2005, Role of blood pressure other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA), Lancet source
Not checked in the free run.
May combine two claims.
Findingnone givenAlpha 1-blockers, centrally acting agents, and antialdosterone drugs effectively lower blood pressure.
“Alpha 1 -blockers, centrally acting agents [alpa 2adrenoreceptor agonists and imidazoline (I 1 ) receptor agonists], and antialdosterone drugs effectively lower BP.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenHypertension is more common in patients with type 2 diabetes compared with the general population.
“Hypertension is more common in patients with type 2 diabetes compared with the general population.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
FindingcitationThe VADT found no significant difference between intensive and standard groups for any individual composite of the primary outcome or for all-cause mortality.
“There was no significant difference between groups for any of the individual composites of the primary outcome or for all-cause mortality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [438] Duckworth, 2009, Glucose control and vascular complications in veterans with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationThe ACCORD trial was stopped prematurely at 3.5 years due to significantly increased total mortality in the intensive treatment group: 257 vs 203 (P=0.04) for deaths from any cause and 135 vs 94 (P=0.02) for cardiovascular deaths.
“The trial was stopped prematurely at 3.5 years due to a significantly increased total mortality in the intensive treatment group: 257 vs. 203 (P ¼ 0.04) for deaths due to any cause and 135 vs. 94 (P ¼ 0.02) for deaths due to cardiovascular causes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [435] Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationPost-trial monitoring of the UKPDS substudy showed no legacy effect, meaning intensive blood pressure control has to be maintained for continued benefit.
“Post-trial monitoring of the UKPDS substudy showed no legacy effect (i.e.intensive BP control has to be maintained for continued benefit).426”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [426] Holman, 2008, Long-term follow-up after tight control of blood pressure in type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationWeight gain and hypoglycaemia were less frequent in ADVANCE than in ACCORD.
“Weight gain and hypoglycaemia were less frequent than in the ACCORD study.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [435] Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationIn ACCORD, there were significantly more cases of hypoglycaemia requiring assistance and significantly more weight gain in the intensive group.
“There were significantly more cases of hypoglycaemia requiring assistance in the intensive group, who also experienced significantly more weight gain.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [435] Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationIn a UKPDS substudy, there was a marked significant 44% risk reduction for stroke and a non-significant 21% risk reduction for myocardial infarction associated with a 10 mmHg reduction in systolic blood pressure and a 5 mmHg reduction in diastolic blood pressure.
“There was a marked and significant 44% risk reduction for stroke and a non-significant 21% risk reduction for myocardial infarction associated with a 10 mmHg reduction in SBP and a 5 mmHg reduction in DBP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [441] UK Prospective Diabetes Study Group, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ source
Not checked in the free run.
May combine two claims.
FindingcitationPost-hoc analyses of ONTARGET, INVEST, and VALUE suggest that in high-risk hypertensive patients there may be no advantage or even harm in lowering systolic blood pressure below 130 mmHg, except perhaps for stroke.
“Post-hoc analyses of large-scale trials (e.g.ONTARGET, INVEST, and VALUE), although suffering from the limitation posed by comparisons of nonrandomized groups, suggest that at least in high-risk hypertensive patients, there may be no advantage or even harm in lowering systolic BP below 130 mmHg, except perhaps for stroke.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites ONTARGET
Not checked in the free run.
- cites INVEST
Not checked in the free run.
- cites VALUE
Not checked in the free run.
May combine two claims.
FindingcitationIn the UKPDS post-trial monitoring, the intensive treatment group had a 17% relative risk reduction in diabetes-related death (P=0.01), a 15% reduction in risk of myocardial infarction (P=0.01), and a 13% reduction in risk of death from any cause (P=0.007).
“The intensive treatment group had a 17% relative risk reduction in diabetes-related death (P ¼ 0.01), a 15% reduction in risk of myocardial infarction (P ¼ 0.01), and a 13% reduction in risk of death from any cause (P ¼ 0.007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [444] Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
Findingnone givenIn the elderly, outcome trials have only addressed patients with an entry systolic blood pressure of at least 160 mmHg, and no trial achieved an average systolic blood pressure below 140 mmHg.
“In the elderly, outcome trials have only addressed patients with an entry SBP ≥160 mmHg, and no trial achieved an average SBP ,140 mmHg.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningIn diabetes, all major antihypertensive drug classes protect against cardiovascular complications, probably because of the protective effect of blood pressure lowering per se.
“Meta-analyses of available trials show that, in diabetes, all major antihypertensive drug classes protect against cardiovascular complications, probably because of the protective effect of BP lowering per se.”
- Also stated in: § 4.8.6 Blood pressure · hedged
“Meta-analyses of available trials show that, in diabetes, all major antihypertensive drug classes protect against cardiovascular complications, probably because of the protective effect of BP lowering per se.”
Quote in the paperSubstantial claim- Also stated in: § 4.8.6 Blood pressure · hedged
May combine two claims.
FindingcitationPost-hoc analyses indicate a progressive reduction in incidence of cardiovascular events with progressive lowering of systolic blood pressure down to 120 mmHg and diastolic blood pressure down to 75 mmHg, although additional benefit at low blood pressure values becomes small.
“post-hoc analyses of trial data indicate a progressive reduction in incidence of cardiovascular events with progressive lowering of SBP down to 120 mmHg and DBP down to 75 mmHg, 412 although the additional benefit at low BP values becomes rather small.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [412] Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet source
Not checked in the free run.
May combine two claims.
FindingcitationIn ADVANCE, intensive control significantly reduced the total number of major macrovascular events and major microvascular events, but only the reduction in microvascular events was statistically significant.
“Intensive control significantly reduced the total number of major macrovascular events (death from cardiovascular causes, non-fatal myocardial infarction, nonfatal stroke) and major microvascular events (new or worsening nephropathy or retinopathy), but only the reduction in microvascular events was statistically significant.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [435] Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationA meta-analysis of intensive glucose control including UKPDS, PROactive, ACCORD, ADVANCE, and VADT showed a significant reduction in non-fatal myocardial infarction and CHD events, but no effect on stroke or total mortality.
“A meta-analysis of intensive glucose control including data from UKPDS, Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive), ACCORD, ADVANCE, and VADT 447 showed a significant reduction in non-fatal myocardial infarction and CHD events, but no effect on stroke or total mortality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [447] Ray, 2009, Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials, Lancet source
Not checked in the free run.
May combine two claims.
Findingnone givenIntensive management of hyperglycaemia in diabetes reduces the risk of microvascular complications and, to a lesser extent, cardiovascular disease.
“Intensive management of hyperglycaemia in diabetes reduces the risk of microvascular complications and, to a lesser extent, that of cardiovascular disease.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAggressive control of hypertension and lowering cholesterol levels with statins reduce the risk of cardiovascular events.
“Aggressive control of hypertension and lowering cholesterol levels with statins reduce the risk of cardiovascular events”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationA more recent meta-analysis excluding PROactive found a significant reduction in CHD and CVD events, but no reduction in cardiovascular mortality or total mortality.
“A more recent meta-analysis examined trials of intensive vs. conventional glycaemic control, but did not include PROactive, and again identified the UKPDS, ACCORD, ADVANCE, and VADT trials.449 Similar results were found with a significant reduction in CHD and CVD events, but no reduction in cardiovascular mortality or total mortality.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [449] Turnbull, 2009, Intensive glucose control and macrovascular outcomes in type 2 diabetes, Diabetologia source
Not checked in the free run.
May combine two claims.
FindingcitationIn the Heart Protection Study, the treatment effect was independent of baseline cholesterol, although absolute risk and treatment effect increased with rising cholesterol concentration.
“The reactive treatment effect was independent of baseline cholesterol, although the absolute risk and treatment effect increased with rising cholesterol concentration.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [436] Collins, 2003, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial, Lancet source
Not checked in the free run.
May combine two claims.
FindingcitationThe ACCORD BP study found no improvement in the primary endpoint, slight reductions in the secondary endpoint of strokes, and an increase in side effects with a lower target systolic blood pressure below 120 mmHg.
“There was no improvement in the primary endpoint, with slight reductions in the secondary endpoint of strokes, and an increase in side effects with a lower target.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [451] Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationThe Steno-2 intensive multifactorial intervention significantly reduced the incidence of microvascular complications after 4 years and produced a significant 53% risk reduction in macrovascular complications after 8 years.
“The benefit of the intensive multifactorial intervention was demonstrated by a significant reduction in the incidence of microvascular complications after 4 years, and a significant 53% risk reduction in macrovascular complications after 8 years.455”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [455] Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationAspirin significantly reduced the risk of myocardial infarction in men, but not in women.
“Aspirin significantly reduced the risk of myocardial infarction in men, but not in women.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [443] De Berardis, 2009, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials, BMJ source
Not checked in the free run.
May combine two claims.
FindingcitationApoB can be substituted for LDL cholesterol but does not add further to risk assessment.
“apoB can be substituted for LDL cholesterol, 475 but it does not add further to the risk assessment.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [475] Thompson, 2006, Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies, J Intern Med source
Not checked in the free run.
May combine two claims.
Findingnone givenHypertriglyceridaemia and low HDL cholesterol are independent CVD risk factors.
“Hypertriglyceridaemia and low HDL cholesterol are independent CVD risk factors.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationApoB is a similar risk marker to LDL cholesterol and a better index of the adequacy of LDL-lowering therapy.
“it appears that apoB is a similar risk marker to LDL cholesterol and a better index of the adequacy of LDL-lowering therapy.476”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [476] McQueen, 2008, Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study, Lancet source
Not checked in the free run.
May combine two claims.
FindingcitationIn the HOT study, 75 mg of aspirin further reduced the risk of major cardiovascular events in well-controlled hypertensive patients with diabetes, but non-fatal major bleeds were significantly more common among patients receiving aspirin.
“In the HOT study, 75 mg of aspirin further reduced the risk of major cardiovascular events in well-controlled hypertensive patients with diabetes, but non-fatal major bleeds were significantly more common among patients receiving aspirin.440”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [440] Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCVD remains a major cause of premature death in Europe, although mortality from it has fallen considerably in many European countries in recent decades.
“It remains the major cause of premature death in Europe, even though CVD mortality has fallen considerably over recent decades in many European countries.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] European Heart Network, 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGlobal disability-adjusted life years lost to CVD are expected to rise from 85 million in 1990 to 150 million in 2020, remaining the leading somatic cause of productivity loss.
“within the coming decades the disability-adjusted life years (DALYs) estimate is expected to rise from a loss of 85 million DALYs in 1990 to a loss of 150 million DALYs globally in 2020, thereby remaining the leading somatic cause of loss of productivity. 1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] SIGN (Scottish Intercollegiate Guidelines Network), 2007, Risk Estimation and the Prevention of Cardiovascular Disease. A National Clinical Guideline
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe level of evidence and strength of recommendation for particular treatment options were weighed and graded according to ESC recommendations.
“The level of evidence and the strength of recommendation of particular treatment options were weighed and graded according to the ESC recommendations (Tables 1 and 2).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenStatements disclosing conflicts of interest from the writing panel are available on the ESC website, and changes during the writing period were notified.
“Statements from the writing panel disclosing conflicts of interest are available on the ESC website.Changes in conflicts of interest that arose during the writing period were notified.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGRADE may be used in conjunction with appraisals of resource use and cost-effectiveness.
“and may also be used in conjunction with appraisals of resource use and cost-effectiveness.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Guyatt, 2008, What is ‘quality of evidence’ and why is it important to clinicians?, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenPreparation and publication of the fifth JTF report was financially supported by the ESC without any involvement of the pharmaceutical industry.
“The preparation and publication of the fifth JTF report was supported financially by the ESC without any involvement of the pharmaceutical industry.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenThe concept of primary and secondary prevention was replaced by recognition that atherosclerosis is a continuous process.
“The concept of primary and secondary prevention was replaced by the recognition that atherosclerosis was a continuous process.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenExperts from nine organizations performed a comprehensive review and critical evaluation of diagnostic and therapeutic procedures, including assessment of the risk-benefit ratio.
“In short, experts from the nine organizations performed a comprehensive review and a critical evaluation of diagnostic and therapeutic procedures, including assessment of the risk-benefit ratio.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationGRADE uses a transparent and rigorous process to assess quality of evidence in terms of whether further research would change confidence in estimates of intervention effects or diagnostic accuracy.
“The JTF introduced GRADE as it uses a transparent and rigorous process to assess the quality of evidence in terms of whether further research would or would not change confidence in the estimate of intervention effects or diagnostic accuracy.10”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Guyatt, 2008, What is ‘quality of evidence’ and why is it important to clinicians?, BMJ source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningBecause resources are valued differently across Europe, it is not feasible in these guidelines to make judgements about the appropriateness of resource use for the interventions and diagnostic strategies considered.
“However, as resources are valued differently across Europe, it is not feasible in these guidelines to make judgements about the appropriateness of resource use for the interventions and diagnostic strategies considered here.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenOnce finalized, the document was submitted for extensive independent external review.
“Once the document had been finalized by the fifth JTF experts it was submitted for extensive independent external review.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGRADE distinguishes quality of evidence from strength of recommendation, and strong evidence does not automatically lead to a strong recommendation.
“GRADE also distinguishes quality of evidence and strength of recommendation.9 Strong evidence does not automatically lead to a strong recommendation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGRADE uses only two categories of recommendation: strong or weak (discretionary, conditional).
“Rather than have a range of classes of recommendation (e.g.Class I-Class III), GRADE only uses two categories-strong or weak (i.e.discretionary, conditional).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence strength of recommendations, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAtherosclerotic CVD, especially CHD, remains the leading cause of premature death worldwide.
“Atherosclerotic CVD, especially CHD, remains the leading cause of premature death worldwide.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Schunemann, 2008, Grading quality of evidence and strength of recommendations for diagnostic tests and strategies, BMJ source
Not checked in the free run.
May combine two claims.
PremisecitationCVD mortality is changing, with declining age-standardized rates in most European countries, but rates remain high in Eastern Europe.
“CVD mortality is changing, with declining age-standardized rates in most European countries, which remain high in Eastern Europe.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Levi, 2009, Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe document was published after revision and acceptance by the ESC Committee for Practice Guidelines and the co-operating organizations in the fifth JTF.
“Following this revision and after acceptance by the ESC Committee for Practice Guidelines and the co-operating organizations in the fifth JTF, the document was published.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningGRADE is helpful for assessing evidence in CVD prevention because RCTs of health behaviours are difficult to conduct and may be misleading.
“This is very helpful in assessing evidence for CVD prevention where RCTs of health behaviours are difficult to conduct and may be misleading.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe IMPACT model has been applied in different countries, and results are rather consistent and similar to other studies.
“This model has been applied in different countries; the results from these studies are rather consistent and similar to what has been observed in other studies of the same subject, as summarized in Figure 1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Ford, 2007, deaths from coronary disease, 1980–2000, N Engl J Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenStroke is another substantial cause of death and disability.
“The second major CVD-stroke-is another substantial cause of death and disability.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe majority of CHD patients develop the disease at an advanced age, leading to compression of morbidity in the very old and prolonged life expectancy in good health.
“The majority of these patients develop the disease at an advanced age, leading to a compression of morbidity in the very old of the community and to a prolonged life expectancy in good health.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSince Geoffrey Rose, two approaches to CVD prevention are considered: the population strategy and the high-risk strategy.
“Since the instruction by Geoffrey Rose decades ago, two approaches towards prevention of CVD are considered: the population strategy and the high-risk strategy.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Rose, 1985, Sick individuals and sick populations, Int J Epidemiol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe only reasonable explanation for these changes is that both environmental changes, especially related to lifestyle, and improved management are important.
“The only reasonable explanation is that both environmental changes, especially related to lifestyle, and improved management are important.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIt was concluded that both primary prevention and treatment of cardiovascular events influence mortality.
“Thus it was concluded that both primary prevention and treatment of cardiovascular events influence mortality.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn the high-risk approach, individuals targeted are more likely to benefit, but population impact is limited because people at such high risk are few.
“Although individuals targeted in this strategy are more likely to benefit from the preventive interventions, the impact on the population level is limited, because people at such high risk are few.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPrevention works: more than 50% of reductions in CHD mortality relate to changes in risk factors, and 40% to improved treatments.
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Ford, 2007, deaths from coronary disease, 1980–2000, N Engl J Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe MONICA project indicated a heterogeneous trend in CHD incidence in Europe in the 1980s to 1990s.
“Results from the Multinational MONItoring of trends and determinants in CArdiovascular disease (MONICA) project indicated a heterogeneous trend in CHD incidence in the 1980s to 1990s in Europe.16”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
Not checked in the free run.
May combine two claims.
InterpretationreasoningA healthy lifestyle in the young is crucial, although ethical and other reasons prohibit strong randomized trial evidence for benefits of school health education or smoking cessation programmes.
“Thus a healthy lifestyle in the young is crucial, although ethical and other reasons prohibit the provision of strong levels of evidence based on randomized trials for the benefits in terms of reduced incidence of CVD from, for example, school programmes on health education or smoking cessation actions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCHD is now the leading cause of death worldwide, is on the rise, and has become a pandemic that respects no borders.
“'Coronary heart disease (CHD) is now the leading cause of death worldwide; it is on the rise and has become a true pandemic that respects no borders'.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Schunemann, 2008, Grading quality of evidence and strength of recommendations for diagnostic tests and strategies, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAt present there is no standardized source of Europe-wide CVD morbidity data.
“At present there is no standardized source of Europe-wide CVD morbidity data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenPrevention in the young, the very old, or those with moderate or mild risk is still limited but can result in substantial benefit.
“CVD prevention in the young, the very old, or those with just a moderate or mild risk is still limited, but can result in substantial benefit.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent reports suggest that mortality and morbidity from CHD is levelling, especially in younger adults.
“This pattern may have changed, and results from recent reports do suggest that mortality and morbidity from CHD is levelling, especially in younger adults.17,18”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17] Ford, Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates, J Am Coll Cardiol 2007 source
Not checked in the free run.
- cites [18] Vander Stichele, 2008, Is the decline in coronary attack rates leveling off in Flanders?, Eur J Cardiovasc Prev Rehabil
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe population strategy may bring large benefits to the population although it may offer little to the individual.
“The advantage is that it may bring large benefits to the population although it may offer little to the individual.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningDespite gaps in understanding, there is ample evidence to justify intensive public health and individual preventive efforts.
“Despite gaps in our understanding, there is ample evidence to justify intensive public health and individual preventive efforts.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationChildren are at very low absolute risk of CVD, but those at relatively high risk compared with peers remain at increased risk later in life because of tracking of risk factors.
“Although children are at very low absolute risk of developing CVD, those at a relatively high risk compared with their peers remain at increased risk of experiencing a cardiovascular event later in life because of 'tracking' of risk factors”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Vos, 2003, Adolescent blood pressure and blood pressure tracking into young adulthood are related to subclinical atherosclerosis: the Atherosclerosis Risk in Young Adults (ARYA) study, Am J Hypertens source
Not checked in the free run.
May combine two claims.
PremisecitationThe population strategy was long considered more cost-effective than the high-risk approach, but since the introduction of highly effective lipid-lowering drugs, improved smoking cessation programmes, and lower costs of antihypertensive drugs, the effectiveness of the high-risk approach has increased.
“For a long time the population strategy has been considered to be more costeffective than the high-risk approach but since the introduction of highly effective lipid lowering drugs, improvement in smoking cessation programmes and lower costs of antihypertensive drugs, the effectiveness of the high risk approach has increased.20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Manuel, 2006, Revisiting Rose: strategies for reducing coronary heart disease, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Europe, CVD remains a major cause of premature deaths and loss of DALYs.
“In Europe, the burden remains high: CVD remains a major cause of premature deaths and loss of DALYs-a composite of premature death and living with the disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] European Heart Network, 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe distinction between primary and secondary prevention in CVD is arbitrary because atherosclerosis develops gradually.
“Prevention is typically categorized as primary or secondary prevention, although in CVD the distinction between the two is arbitrary in view of the underlying, gradually developing atherosclerotic process.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisenone givenOur understanding of the reasons for changes in behaviour of populations and individuals remains incomplete.
“Our understanding of the reasons for changes in the behaviour of both populations and individuals remains incomplete.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningAlthough clinicians often ask for threshold values to trigger intervention, this is problematic because risk is a continuum and there is no exact point above which a drug is automatically indicated, nor below which lifestyle advice may not usefully be offered.
“Although clinicians often ask for threshold values at which to trigger an intervention, this is problematic since risk is a continuum and there is no exact point above which, for example, a drug is automatically indicated, nor below which lifestyle advice may not usefully be offered.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningThe choice of CVD mortality rather than total (fatal + nonfatal) events in SCORE was deliberate although not universally popular.
“The choice of CVD mortality rather than total (fatal + nonfatal) events was deliberate although not universally popular.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenAll risk estimation systems are relatively crude and require attention to qualifying statements.
“All risk estimation systems are relatively crude and require attention to qualifying statements.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenPersons with established CVD are already at very high risk of further events and need prompt intervention on all risk factors.
“As noted in the 'priorities' section, persons with established CVD are already at very high risk of further events and need prompt intervention on all risk factors”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenPatients who have had a clinical event such as an acute coronary syndrome or stroke automatically qualify for intensive risk factor evaluation and management.
“Patients who have had a clinical event such as an acute coronary syndrome (ACS) or stroke automatically qualify for intensive risk factor evaluation and management.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe implication that total risk assessment is associated with improved clinical outcomes compared with other strategies has not been adequately tested.
“Having said that, the implication that total risk assessment, while logical, is associated with improved clinical outcomes when compared with other strategies has not been adequately tested.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe potential for prevention based on healthy lifestyles, appropriate management of classical risk factors, and selective use of cardioprotective drugs is obvious.
“The potential for prevention based on healthy lifestyles, appropriate management of classical risk factors, and selective use of cardioprotective drugs is obvious.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationnone givenIn younger persons, a low absolute risk may conceal a very high relative risk, and use of the relative risk chart or calculation of risk age may help advise them of the need for intensive lifestyle efforts.
“In younger persons, a low absolute risk may conceal a very high relative risk, and use of the relative risk chart or calculation of their 'risk age' may help in advising them of the need for intensive lifestyle efforts.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany committees from other countries have almost the same views as NICE.
“and many committees from other countries have almost the same views.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Kotseva, 2009, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningA risk estimation system such as SCORE can assist in making logical management decisions and may help avoid both under- and overtreatment.
“A risk estimation system such as SCORE can assist in making logical management decisions, and may help to avoid both under-and overtreatment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 2003 guidelines used the SCORE chart for risk estimation, which was based on data from 12 European cohort studies; it included 205,178 subjects examined at baseline between 1970 and 1988 with 2.7 million years of follow-up and 7934 cardiovascular deaths.
“The 2003 guidelines 44 used the SCORE chart for risk estimation, 45 which was based on data from 12 European cohort studies; it included 205 178 subjects examined at baseline between 1970 and 1988 with 2.7 million years of follow-up and 7934 cardiovascular deaths.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenThe SCORE system estimates the 10-year risk of a first fatal atherosclerotic event, whether heart attack, stroke, aneurysm of the aorta, or other.
“The SCORE system estimates the 10-year risk of a first fatal atherosclerotic event, whether heart attack, stroke, aneurysm of the aorta, or other.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe multiplier to convert fatal to total CVD is unstable and often less than clinicians expect because follow-up ends at the first event and subsequent events are not counted.
“The multiplier to convert fatal to total CVD is similarly unstable and is often less than clinicians expect, since follow-up is terminated in all current systems with the first event, and subsequent fatal or non-fatal events are not counted.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenRisk charts such as SCORE are intended to facilitate risk estimation in apparently healthy persons.
“Risk charts such as SCORE are intended to facilitate risk estimation in apparently healthy persons.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenWhile women appear to be at lower CVD risk than men, this is misleading because risk is deferred by 10 years rather than avoided.
“While women appear to be at lower CVD risk than men, this is misleading as risk is deferred by 10 years rather than avoided.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenWhile the ideal scenario would be for all adults to have their risk of CVD assessed, this may not be practicable for many societies.
“While the ideal scenario would be for all adults to have their risk of CVD assessed, this may not be practicable for many societies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisereasoning'Total risk' is not comprehensive because the effects of other risk factors are not considered except as qualifying statements.
“The term has become widely used; however, 'total risk' is not comprehensive because the effects of other risk factors are not considered except as qualifying statements.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenAny risk estimation system will overpredict in countries in which mortality has fallen and underpredict in those in which it has risen.
“Any risk estimation system will overpredict in countries in which mortality has fallen and underpredict in those in which it has risen.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenWomen and old and young subjects have been underrepresented in the classic drug trials that have informed guidelines to date.
“In general, women and old and young subjects have been underrepresented in the classic drug trials that have informed guidelines to date.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenMost people will visit their family doctor at least once over a 2-year period, giving an opportunity for risk assessment.
“Most people will visit their family doctor at least once over a 2-year period giving an opportunity for risk assessment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe total risk approach allows flexibility: if perfection cannot be achieved with one risk factor, risk can still be reduced by trying harder with others.
“The total risk approach allows flexibility: if perfection cannot be achieved with one risk factor, risk can still be reduced by trying harder with others.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe 20% total CVD or CHD risk used to denote high risk in many guidelines is likely variable, unstable over time, and hard to validate.
“Thus, the '20% total CVD (or CHD)' risk used to denote high risk in many guidelines is likely to be variable, unstable over time, and hard to validate.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAdditional factors affecting risk can be accommodated in electronic risk estimation systems such as HeartScore.
“Additional factors affecting risk can be accommodated in electronic risk estimation systems such as HeartScore (www.heartscore.org).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenIndividuals at the highest levels of risk gain most from risk factor management.
“As such, they acknowledge that individuals at the highest levels of risk gain most from risk factor management.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenCertain individuals are at high CVD risk without needing risk scoring and require immediate intervention for all risk factors.
“Certain individuals are at high CVD risk without needing risk scoring and require immediate intervention for all risk factors.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenDeath is a hard and reproducible endpoint, whereas non-fatal events are variable and depend on definitions, diagnostic criteria, and diagnostic tests that may vary over time.
“Death is a hard and reproducible endpoint; a non-fatal event is variable and depends upon definitions, diagnostic criteria, and diagnostic tests, all of which may vary over time.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMost other risk estimation systems estimate CHD risk only.
“Most other systems estimate CHD risk only.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenStriking changes in both diagnostic tests and therapies have occurred since the SCORE cohorts were assembled.
“Striking changes in both diagnostic tests and therapies have occurred since the SCORE cohorts were assembled.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenAll elderly people will eventually be at high risk of death and may be overexposed to drug treatments.
“and the fact that all elderly people will eventually be at high risk of death and may be overexposed to drug treatments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIt is uncertain whether CVD is merely deferred by preventive efforts or can be avoided completely.
“It is uncertain whether CVD is merely deferred by preventive efforts or if it of can be avoided completely.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningFor these reasons, CVD mortality charts were produced and have been re-calibrated for a number of European countries.
“For these reasons, the CVD mortality charts were produced, and have been re-calibrated for a number of European countries.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenIn SCORE, accounting for family history is probably very crude and most certainly an underestimate.
“In SCORE, accounting for family history is probably very crude and is most certainly an underestimate.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIncreasing age and male sex increase CVD risk and are fixed characteristics used to stratify risk assessments.
“Increasing age and male sex increase CVD risk and are 'fixed' characteristics used to stratify risk assessments.45”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenEven the high-risk charts may underestimate risk in very-high-risk countries.
“Even the high-risk charts may underestimate risk in these countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenThe higher the risk, the greater the benefit from preventive efforts.
“The higher the risk the greater the benefit from preventive efforts, which guides the following priorities:”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenFamily history is a variable combination of genetics and shared environment.
“Family history is a variable combination of genetics and shared environment.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationRisk age can be used in any population regardless of baseline risk and secular changes in mortality, avoiding re-calibration.
“Risk age can be used in any population regardless of baseline risk and of secular changes in mortality, and therefore avoids the need for re-calibration.68”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Cuende, 2010, How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation, Eur Heart J source
Not checked in the free run.
May combine two claims.
Interpretationnone givenRisk will be overestimated in countries with falling CVD mortality and underestimated in countries with increasing mortality.
“Risk will be overestimated in countries with a falling CVD mortality, and underestimated in countries in which mortality is increasing.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMany lifestyle measures are less amenable to RCT assessment than drug treatments, so they tend to receive a higher grade.
“While this is appropriate, many lifestyle measures are less amenable to such assessment than are drug treatments, which will therefore tend to receive a higher grade.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningNational re-calibrations likely better represent current risk levels.
“Such charts are likely to better represent current risk levels.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenRisk may be higher than indicated in charts in sedentary subjects and those with central obesity; the increased risk associated with overweight is greater in younger subjects.
“Sedentary subjects and those with central obesity; these characteristics determine many of the other aspects of risk listed below.The increased risk associated with overweight is greater in younger subjects than in older subjects.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn very-high-risk countries, the male:female ratio is smaller than in low-risk countries, suggesting a major problem for women.
“low-risk countries, suggesting a major problem for women.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThe risk of CVD in women, as in men, can be reduced by not smoking, being active, avoiding overweight, and having blood pressure and blood cholesterol checked and treated if elevated.
“The risk of CVD in women, as in men, can be reduced by not smoking, by being active, avoiding overweight, and by having a blood pressure and blood cholesterol check (and intervention, if elevated).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenRisk rises with increasing blood sugar concentration before overt diabetes occurs.
“Risk rises with increasing blood sugar concentration before overt diabetes occurs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenCurrent systems of grading evidence give most weight to RCTs.
“Current systems of grading evidence give most weight to RCTs.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenRisk may be higher than indicated in charts in individuals with low HDL, increased triglycerides, fibrinogen, apoB, Lp(a), especially with familial hypercholesterolaemia, and perhaps increased hsCRP.
“Individuals with low HDL cholesterol, increased triglycerides, fibrinogen, apolipoprotein B (apoB), and lipoprotein(a) [Lp(a)] levels, especially in combination with familial hypercholesterolaemia, and perhaps increased high-sensitivity CRP (hsCRP).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenThe young, women, older people, and ethnic minorities continue to be under-represented in clinical trials.
“The young, women, older people, and ethnic minorities continue to be under-represented in clinical trials.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenCVD is by far the biggest cause of death in women.
“CVD is by far the biggest cause of death in women.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningSimilar considerations apply in women who are at lower absolute risk at younger ages and may have high levels of specific risk factors.
“Similar considerations apply in women who are at lower absolute risk at younger ages and may have high levels of specific risk factors.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationInvestment in additional measurements such as CT coronary calcium may be helpful but adds cost and time, and its benefit remains unproven.
“Investment in additional measurements such as imaging with computed tomography to obtain coronary calcium scores may be helpful, 79 but adds considerably to the cost and time involved in risk factor scoring, and its benefit remains unproven.80”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationnone givenCVD mortality does not accelerate in women following menopause, indicating women postpone risk rather than avoid it.
“CVD mortality does not accelerate in women following the menopause, indicating that women are postponing their risk rather than avoiding it altogether.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAsymptomatic women and older people benefit from risk scoring to determine management.
“Asymptomatic women and older people benefit from risk scoring to determine management.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMechanisms linking psychosocial factors to increased CVD risk include unhealthy lifestyle, increased healthcare utilization, and low adherence to behaviour-change recommendations or cardiac medications.
“Mechanisms that link psychosocial factors to increased CVD risk include unhealthy lifestyle (more frequent smoking, unhealthy food choice, and less physical exercise), increased healthcare utilization, and low adherence to behaviour-change recommendations or cardiac medications.88,90,116 -119”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [88] Stringhini, 2010, Association of socioeconomic position with health behaviors and mortality, JAMA source
Not checked in the free run.
- cites [90] Albert, 2006, Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events, Circulation source
Not checked in the free run.
- cites [116] Wamala, 1999, Potential explanations for the educational gradient in coronary heart disease: a population-based case–control study of Swedish women, Am J Public Health source
Not checked in the free run.
- cites [117] Chandola, 2008, Work stress and coronary heart disease: what are the mechanisms?, Eur Heart J source
Not checked in the free run.
- cites [118] Rozanski, 2005, The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology, J Am Coll Cardiol source
Not checked in the free run.
- cites [119] Whooley, 2008, Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease, JAMA source
Not checked in the free run.
May combine two claims.
InterpretationcitationMRI is a promising research tool, but its routine use remains limited and it is not yet appropriate for identifying patients at high risk for CVD.
“At present, MRI is a promising research tool, but its routine use remains limited and it is not yet appropriate for identifying patients at high risk for CVD.146”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] Greenland, 2000, Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationLpPLA2 is an independent risk factor for plaque rupture and atherothrombotic events, with high consistency and precision.
“LpPLA2 has recently emerged as a marker with high consistency and precision as an independent risk factor for plaque rupture and atherothrombotic events.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129] Garza, 2007, Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review, Mayo Clin Proc source
Not checked in the free run.
May combine two claims.
PremisecitationThe Agatston score is an independent risk marker regarding the extent of CHD and prognostic impact.
“The Agatston score is an independent risk marker regarding the extent of CHD 157 and prognostic impact.158”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [157] Hecht, 2001, Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women, J Am Coll Cardiol source
Not checked in the free run.
- cites [158] Hadamitzky, 2009, Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease, JACC Cardiovasc Imaging source
Not checked in the free run.
May combine two claims.
Premisenone givenThe effect of LpPLA2 on risk at the general population level is modest, and study limitations or bias are present.
“The magnitude of effect on risk remains modest at the level of the general population; study limitations or bias are present.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSignificant stenosis without coronary calcium is more likely in unstable angina or NSTEMI than in stable chest pain, and occurs more frequently in younger patients.
“It is more likely in the setting of unstable angina or non-ST elevation myocardial infarction (NSTEMI) than in stable chest pain, and occurs more frequently in younger patients.155”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [155] Marwan, 2009, Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography, Heart source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenNo more than mandatory education and/or a yes for one or more items indicates a higher risk than that assessed with SCORE tools or priority categories.
“No more than mandatory education and/or a 'yes' for one or more items indicates a higher risk than that assessed with the SCORE tools or priority categories.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenThis variation in disease is probably due to genetic susceptibility, combinations of different risk factors, and interactions between genetic and environmental factors.
“This variation in disease is probably due to genetic susceptibility, combinations of different risk factors, and interactions between genetic and environmental factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAtherosclerosis is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate, and activate lesions in the arterial tree.
“Atherosclerosis is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate, and activate lesions in the arterial tree.170”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [170] Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisereasoningCVD risk is increased at an early stage of rheumatoid arthritis, and this risk excess beyond traditional risk parameters is possibly related to systemic inflammation and a prothrombotic state.
“CVD risk is increased at an early stage of the disease, and this risk excess beyond traditional risk parameters is possibly related to systemic inflammation and a prothrombotic state.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPatients in whom psoriasis was classified as severe had a higher risk of myocardial infarction than patients with mild psoriasis, consistent with the hypothesis that greater immune activity in psoriasis is related to a higher risk of myocardial infarction and cardiovascular death.
“Patients in whom the psoriasis was classified as severe had a higher risk of myocardial infarction than patients with mild psoriasis, consistent with the hypothesis that greater immune activity in psoriasis is related to a higher risk of myocardial infarction and cardiovascular death.185,186”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [185] Gelfand, 2006, Risk of myocardial infarction in patients with psoriasis, JAMA source
Not checked in the free run.
- cites [186] Mehta, 2010, Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database, Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationPeriodontitis is associated with endothelial dysfunction, atherosclerosis, and an increased risk of myocardial infarction and stroke.
“Periodontitis is associated with endothelial dysfunction, atherosclerosis, and an increased risk of myocardial infarction and stroke.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenPlaques are related to both coronary obstructive disease and the risk of cerebrovascular events.
“Plaques are related to both coronary obstructive disease and the risk of cerebrovascular events.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLipid lowering appears useful in a wide range of patients with advanced CKD but with no known history of myocardial infarction or coronary revascularization: a reduction of LDL cholesterol by 0.85 mmol/L with daily 20 mg simvastatin plus 10 mg ezetimibe reduced the incidence of major events.
“Lipid lowering appears useful in a wide range of patients with advanced CKD but with no known history of myocardial infarction or coronary revascularization: a reduction of low-density lipoprotein (LDL) cholesterol by 0.85 mmol/L (33 mg/dL) with daily 20 mg simvastatin plus 10 mg ezetimibe reduced the incidence of major events”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [174] Baigent, 2011, The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationInflammatory mediators and promoters of calcification are increased and inhibitors of calcification are reduced in CKD, which favours vascular calcification and vascular injury.
“Inflammatory mediators and promoters of calcification are increased and inhibitors of calcification are reduced in CKD, which favours vascular calcification and vascular injury.136”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] Schiffrin, 2007, Chronic kidney disease: effects on the cardiovascular system, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe place of ophthalmoscopy in vascular disease risk assessment remains uncertain.
“However, its place in vascular disease risk assessment remains uncertain.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningSystemic lupus erythematosus is associated with endothelial dysfunction and an increased risk of CHD that is not fully explained by classic CHD risk factors.
“Systemic lupus erythematosus is associated with endothelial dysfunction and an increased risk of CHD that is not fully explained by classic CHD risk factors.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationED afflicts to some degree 52% of male adults between the ages of 40 and 70 years.
“Erectile dysfunction (ED), defined as the consistent inability to reach and maintain an erection satisfactory for sexual activity, afflicts to some degree 52% of male adults between the ages of 40 and 70 years.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCoronary microvascular dysfunction is an early marker of accelerated coronary atherosclerosis and may contribute to the increased cardiovascular morbidity and mortality in patients with systemic lupus erythematosus.
“Coronary microvascular dysfunction is an early marker of accelerated coronary atherosclerosis and may contribute to the increased cardiovascular morbidity and mortality in these patients.189”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [189] Recio-Mayoral, 2009, Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease, Eur Heart J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOSA affects an estimated 9% of adult women and 24% of adult men.
“It affects an estimated 9% of adult women and 24% of adult men.175”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Young, 1993, The occurrence of sleep-disordered breathing among middle-aged adults, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIMT is a measurement not only of early atherosclerosis but also of smooth muscle hypertrophy/hyperplasia, which may be related to genetic factors, hypertension, and age-related sclerosis.
“The IMT is a measurement not only of early atherosclerosis but also of smooth muscle hypertrophy/hyperplasia, which may be related even to genetic factors, hypertension, and age-related sclerosis.132”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Sramek, 2000, Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries, Invest Radiol source
Not checked in the free run.
May combine two claims.
PremisereasoningThe risk of myocardial infarction associated with psoriasis is greatest in young patients with severe psoriasis, is attenuated with age, and remains increased even after controlling for traditional cardiovascular risk factors.
“The risk of myocardial infarction associated with psoriasis is greatest in young patients with severe psoriasis, is attenuated with age, and remains increased even after controlling for traditional cardiovascular risk factors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationED is a marker for CVD and a predictor of future events in middle-aged and older men but not beyond that offered by the Framingham risk score.
“ED is a marker for CVD and a predictor of future events in middle-aged and older men but not beyond that offered by the Framingham risk score.182 -184”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [182] Feldman, 2000, Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study, Prev Med source
Not checked in the free run.
- cites [183] Jackson, 2006, Erectile dysfunction: a marker of silent coronary artery disease, Eur Heart J source
Not checked in the free run.
- cites [184] Araujo, 2010, Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
Premisenone givenPatients with rheumatoid arthritis have a higher mortality rate after myocardial infarction, which may only partially explain their reduced life expectancy (5-10 years shorter than patients without the condition).
“They also have a higher mortality rate after myocardial infarction, which may only partially explain their reduced life expectancy (5-10 years shorter than patients without the condition).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAn ABI value indicating significant PAD adds additional value to medical history, because 50-89% of patients with an ABI <0.9 do not have typical claudication.
“An ABI value indicating significant PAD adds additional value to medical history, because 50 -89% of patients with an ABI ,0.9 do not have typical claudication.134”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] McDermott, 2002, The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study, Ann Intern Med source
Not checked in the free run.
May combine two claims.
Premisenone givenThere is a graded increase in cardiovascular risk with rising IMT, and a value >0.9 mm is considered abnormal.
“Although there is a graded increase in cardiovascular risk with rising IMT, a value .0.9 mm is considered abnormal.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationcitationPeriodontitis can be considered a risk indicator for a generally decreased cardiovascular health status and its treatment is indicated as well as management of the underlying cardiovascular risk factors.
“Periodontitis can be considered a risk indicator for a generally decreased cardiovascular health status and its treatment is indicated as well as management of the underlying cardiovascular risk factors.190”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] Tonetti, 2007, Treatment of periodontitis and endothelial function, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationThe risk increases to four- to 10-fold in stage 4 and to 10- to 50-fold in stage 5 renal failure.
“The risk increases to four-to 10-fold in stage 4 (GFR 15 -29 mL/min/1.73m 2 ) and to 10-to 50-fold in stage 5 renal failure (end-stage) (GFR ,15 mL/min/ 1.73 m 2 or dialysis).136”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Schiffrin, 2007, Chronic kidney disease: effects on the cardiovascular system, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationThe relative risk for events is slightly lower after statistical correction for traditional risk factors, but the risk remains elevated at higher IMT.
“Although the relative risk for events is slightly lower after statistical correction for the presence of traditional risk factors, the risk remains elevated at higher IMT.130”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] O'Leary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group, N Engl J Med source
Not checked in the free run.
May combine two claims.
Premisenone givenThe extent of carotid IMT is an independent predictor of cerebral and coronary events, but seems to be more predictive in women than in men.
“The extent of carotid IMT is an independent predictor of cerebral and coronary events, but seems to be more predictive in women than in men.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe extent of retinal artery atherosclerosis correlates with the extent of coronary artery atherosclerosis and with serum levels of cholesterol, triglycerides, and apoB.
“It has been shown that the extent of retinal artery atherosclerosis correlates with the extent of coronary artery atherosclerosis and with serum levels of cholesterol, triglycerides, and apoB.164”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [164] Tedeschi-Reiner, 2004, Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins, Croat Med J
Not checked in the free run.
May combine two claims.
PremisecitationDuration also plays a role, and all types of smoked tobacco, including low-tar, filter cigarettes, cigars, and pipes, are harmful.
“Duration also plays a role, and, while cigarette smoking is the most common, all types of smoked tobacco, including low-tar ('mild' or 'light') cigarettes, filter cigarettes, cigars, and pipes, are harmful.211”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [211] Center for Disease Control and Prevention, 2010, How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking-attributable Disease
Not checked in the free run.
May combine two claims.
PremisecitationAdministration of statins improves endothelial dysfunction, slows the development of cardiac allograft vasculopathy, and benefits survival.
“Administration of statins improves endothelial dysfunction, slows the development of cardiac allograft vasculopathy, and benefits survival.194”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [194] Hunt, 2008, The changing face of heart transplantation, J Am Coll Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIndividuals of low socio-economic status, of older age, or female gender may need tailored programmes in order to meet their specific needs regarding information and emotional support.
“Individuals of low socio-economic status, of older age, or female gender may need tailored programmes in order to meet their specific needs regarding information and emotional support.202,206”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [202] Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
- cites [206] Burell, 2002, Women's hearts need special treatment, Int J Behav Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenSmoking is an established cause of a plethora of diseases and is responsible for 50% of all avoidable deaths in smokers, half of these due to CVD.
“Smoking is an established cause of a plethora of diseases and is responsible for 50% of all avoidable deaths in smokers, half of these due to CVD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough the rate of smoking is declining in Europe, it is still very common among individuals who have received little education; and widening education-related inequalities in smoking-cessation rates have been observed in many European countries in recent years.
“Although the rate of smoking is declining in Europe, it is still very common among individuals who have received little education; and widening education-related inequalities in smoking-cessation rates have been observed in many European countries in recent years.214,216,217”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [214] Edwards, 2004, The problem of tobacco smoking, BMJ source
Not checked in the free run.
- cites [216] Huisman, 2005, Inequalities in the prevalence of smoking in the European Union: comparing education and income, Prev Med source
Not checked in the free run.
- cites [217] Giskes, 2005, Trends in smoking behaviour between 1985 and 2000 in nine European countries by education, J Epidemiol Community Health source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningIncreased awareness of these factors facilitates empathy and counselling, thus facilitating behavioural change.
“Increased awareness of these factors facilitates empathy and counselling (simple and explicit advice), thus facilitating behavioural change.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenA friendly and positive interaction is a powerful tool to enhance an individual's ability to cope with illness and adhere to recommended lifestyle changes and medication use.
“A friendly and positive interaction is a powerful tool to enhance an individual's ability to cope with illness and adhere to recommended lifestyle changes and medication use.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationReactive oxygen species present in inhaled smoke cause oxidation of plasma LDL; oxidized LDL triggers the inflammatory process in the intima through stimulation of monocyte adhesion to the vessel wall, resulting in increased atherosclerosis.
“Reactive oxygen speciesfree radicals-present in inhaled smoke cause oxidation of plasma LDL; oxidized LDL triggers the inflammatory process in the intimae of the arteries through stimulation of monocyte adhesion to the vessel wall, resulting in increased atherosclerosis.232,239 -242”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [232] Yamaguchi, 2001, Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits, Atherosclerosis source
Not checked in the free run.
- cites [239] Weber, 1996, Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers, Circulation source
Not checked in the free run.
- cites [240] Weber, 1995, Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b, Biochem Biophys Res Commun source
Not checked in the free run.
May combine two claims.
Premisenone givenSmoking enhances both the development of atherosclerosis and the occurrence of superimposed thrombotic phenomena.
“it is clear that smoking enhances both the development of atherosclerosis and the occurrence of superimposed thrombotic phenomena.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThese factors impede the ability to adopt a healthy lifestyle, as does complex or confusing advice from medical caregivers.
“In addition, these factors impede the ability to adopt a healthy lifestyle, as does complex or confusing advice from medical caregivers.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the EUROASPIRE III survey, 30% of participants were smokers up to the time of their coronary event and this had dropped by one-half after a median of 1.5 years; evidence-based treatment for smoking cessation was underused.
“In the EUROASPIRE III survey 30% of the participants were smokers up to the time of their coronary event and this had dropped by one-half after a median of 1.5 years.The survey also found that evidence-based treatment for smoking cessation was underused.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Kotseva, 2009, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenSocial support provided by caregivers may be of importance in helping individuals maintain healthy habits and follow medical advice.
“Social support provided by caregivers may be of importance in helping individuals maintain healthy habits and follow medical advice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenThese patterns are framed during childhood and adolescence by an interaction of environmental and genetic factors, and are maintained or even promoted by the individual's social environment as an adult.
“These patterns are framed during childhood and adolescence by an interaction of environmental and genetic factors, and are maintained or even promoted by the individual's social environment as an adult.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningMarked differences in health behaviour between individuals but also between social groups can be observed.
“Consequently, marked differences in health behaviour between individuals but also between social groups can be observed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenLifestyle is usually based on long-standing behavioural patterns.
“'Lifestyle' is usually based on long-standing behavioural patterns.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMoving forward in small, consecutive steps is one of the key points in changing long-term behaviour.
“Moving forward in small, consecutive steps is one of the key points in changing long-term behaviour.202”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGoal setting combined with self-monitoring of the chosen behaviour are the main tools needed to achieve a positive outcome.
“goal setting combined with selfmonitoring of the chosen behaviour are the main tools needed to achieve a positive outcome.202”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenPrevious negative, unsuccessful attempts to change behaviour often result in a lower self-efficacy for future change and often lead to another failure.
“Previous negative, unsuccessful attempts to change behaviour often result in a lower self-efficacy for future change and often lead to another failure.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenIndividualized counselling is the basis for evoking and gaining the patient's motivation and commitment.
“Individualized counselling is the basis for evoking and gaining the patient's motivation and commitment.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe risk associated with smoking is primarily related to the amount of tobacco smoked daily and shows a clear dose-response relationship with no lower limit for deleterious effects.
“The risk associated with smoking is primarily related to the amount of tobacco smoked daily and shows a clear dose-response relationship with no lower limit for deleterious effects.220”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [220] Prescott, 2002, Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study, J Epidemiol Community Health source
Not checked in the free run.
May combine two claims.
PremisecitationThese interventions enhance coping with illness, and improve adherence with prescribed medication, efforts to change behaviour, and cardiac outcome.
“They enhance coping with illness, and improve adherence with prescribed medication, efforts to change behaviour, and cardiac outcome.195,197,198”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [195] Dusseldorp, 1999, A meta-analysis of psychoeduational programs for coronary heart disease patients, Health Psychol source
Not checked in the free run.
- cites [197] Clark, 2005, Meta-analysis: secondary prevention programs for patients with coronary artery disease, Ann Intern Med source
Not checked in the free run.
- cites [198] Auer, 2008, Efficacy of in-hospital multidimensional interventions of secondary prevention after acute coronary syndrome: a systematic review and meta-analysis, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationMechanisms point towards the effect of smoking on endothelial function, oxidative processes, platelet function, fibrinolysis, inflammation, and modification of lipids and vasomotor function.
“Mechanisms have been elucidated through observational cohort studies, experimental observations, and laboratory studies in humans and animals, 225,227 -229 and point towards the effect of smoking on endothelial function, 230,231 oxidative processes, 232 platelet function, 233 fibrinolysis, inflammation, 234 -238 and modification of lipids and vasomotor function.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [225] Raupach, 2006, Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm, Eur Heart J source
Not checked in the free run.
- cites [227] Ambrose, 2004, The pathophysiology of cigarette smoking and cardiovascular disease: an update, J Am Coll Cardiol source
Not checked in the free run.
- cites [228] Armani, 2009, Molecular and biochemical changes of the cardiovascular system due to smoking exposure, Curr Pharm Des source
Not checked in the free run.
May combine two claims.
PremisecitationWhile the relative risk of myocardial infarction in smokers >60 years of age is doubled, the relative risk in smokers <50 years is five-fold higher than in non-smokers.
“However, while the relative risk of myocardial infarction in smokers .60 years of age is doubled, the relative risk in smokers ,50 years is five-fold higher than in non-smokers.214,215”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationStopping smoking after a myocardial infarction is potentially the most effective of all preventive measures: a systematic review and meta-analysis of 20 cohort studies showed a mortality benefit of 0.64 (95% CI 0.58-0.71) compared with continued smokers.
“Stopping smoking after a myocardial infarction is potentially the most effective of all preventive measures: a systematic review and meta-analysis of 20 cohort studies of smoking cessation after myocardial infarction showed a mortality benefit of 0.64 [95% confidence interval (CI) 0.58-0.71]compared with continued smokers.249”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [249] Critchley, 2004, Smoking cessation for the secondary prevention of coronary heart disease, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
PremisecitationAll available forms of nicotine replacement therapy are effective for abstinence; systematic review OR 1.58 (95% CI 1.50-1.66) versus control.
“All available forms of NRT are effective: in a systematic review, the OR for abstinence with NRT vs. control was 1.58 (95% CI 1.50-1.66).213”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [213] Stead, 2008, Nicotine replacement therapy for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
May combine two claims.
PremisecitationIndividual and group behavioural support both help smokers to stop.
“Both individual and group behavioural interventions are effective in helping smokers quit.225,266 -268”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [225] Raupach, 2006, Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm, Eur Heart J source
Not checked in the free run.
- cites [266] Stead, 2005, Group behaviour therapy programmes for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- cites [267] Lancaster, 2005, Individual behavioural counselling for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- cites [268] Rice, 2004, Nursing interventions for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
May combine two claims.
Premisenone givenPublic health measures such as smoking bans, tobacco taxation, and media campaigns are efficient aids in preventing smoking uptake and supporting smoking cessation.
“Public health measures such as smoking bans, tobacco taxation, and media campaigns are efficient aids in preventing smoking uptake and supporting smoking cessation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe risk is rapidly reduced after cessation, with significant morbidity reductions reported within the first 6 months.
“The risk is rapidly reduced after cessation, with significant morbidity reductions reported within the first 6 months.250”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [250] Chow, 2010, Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationCytisine seems to increase quitting chances, but the evidence is not conclusive.
“Cytisine, a low cost partial nicotine receptor agonist available in some European countries, also seems to increase the chances of quitting, but the evidence at present is not conclusive.264”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [264] West, 2011, Placebo-controlled trial of cytisine for smoking cessation, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationLow doses of EPA and DHA are associated with lower risk of fatal CHD but not non-fatal CHD.
“In various studies, low doses of eicosapentaenoic acid and docosahexaenoic acid are associated with a lower risk of fatal CHD but not of non-fatal CHD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [271] He, 2004, Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationMethodological issues may explain the null finding for saturated fat and CVD.
“although there may be several methodological issues explaining this null finding.280”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [280] Stamler, 2010, Diet–heart: a problematic revisit, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationEPA and DHA do not affect serum cholesterol but reduce CHD mortality and, to a lesser extent, stroke mortality.
“They do not have an impact on serum cholesterol levels, but have been shown to reduce CHD mortality and to a lesser extent stroke mortality.271,282”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [271] He, 2004, Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies, Circulation source
Not checked in the free run.
- cites [282] He, 2004, Fish consumption and incidence of stroke: a meta-analysis of cohort studies, Stroke source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe European Medicines Agency stated that varenicline's small excess cardiovascular risk is outweighed by its smoking-cessation benefit.
“the European Medicines Agency has announced that the slightly increased risk of cardiovascular events associated with varenicline does not outweigh the benefits of the drug in helping people to stop smoking.263”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [263] Hawkes, 2011, Varenicline raises risk of heart problems, analysis indicates, BMJ
Not checked in the free run.
May combine two claims.
PremisecitationThe mortality benefit was consistent over gender, duration of follow-up, study site, and time period.
“The mortality benefit was consistent over gender, duration of follow-up, study site, and time period.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [249] Critchley, 2004, Smoking cessation for the secondary prevention of coronary heart disease, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
PremisecitationNortriptyline and clonidine aid smoking cessation but are second-line choices because of side effects.
“The antidepressant nortriptyline and the antihypertensive drug clonidine aid smoking cessation, 258,265 but, owing to side effects, are second-line choices.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [258] Hughes, 2007, Antidepressants for smoking cessation, Cochrane Database Syst Rev source
Not checked in the free run.
- cites [265] Gourlay, 2004, Clonidine for smoking cessation, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
InterpretationreasoningPlaque formation is not thought to be fully reversible and thus smokers would never be expected to reach the risk level of never-smokers concerning CVD.
“Plaque formation is not thought to be fully reversible and thus smokers would never be expected to reach the risk level of never-smokers concerning CVD.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationThe American Institute of Medicine recommends an intake of 3.4 g/MJ, equivalent to 30-45 g/day for adults.
“The American Institute of Medicine recommends an intake of 3.4 g/MJ, equivalent to an intake of 30 -45 g/day for adults.296”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [296] Food and Nutrition Board, 2002
Not checked in the free run.
May combine two claims.
PremisecitationThe Seven Countries Study showed a large difference in cardiovascular mortality rates between northern and southern Europe; even at similar cholesterol levels and after adjusting for BP and smoking, the difference in cardiovascular risk remained.
“The Seven Countries Study showed a large difference in cardiovascular mortality rates between northern and southern Europe.Even at similar cholesterol levels, and after adjusting for BP and smoking, the difference in cardiovascular risk remained (Figure 8).304”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [304] Verschuren, 1995, Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationThe risk of CVD (including CHD and stroke) or CHD alone is significantly reduced in more physically active or fit persons, with relative risk reduction nearly twice as great for cardiorespiratory fitness than for physical activity increase at all percentiles >25th.
“The risk of CVD (including CHD and stroke) or CHD alone is significantly reduced in more physically active or fit persons, with a relative risk reduction nearly twice as great for cardiorespiratory fitness than for physical activity increase at all percentiles .25th.308,328,329”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [308] Schnohr, 2007, Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [328] Williams, 2001, Physical fitness and activity as separate heart disease risk factors: a meta-analysis, Med Sci Sports Exerc source
Not checked in the free run.
- cites [329] Tipton, 2006
Not checked in the free run.
May combine two claims.
PremisecitationA simulation study estimated that reducing salt intake by 3 g/day in the USA would reduce CHD incidence by 5.9-9.6%, stroke incidence by 5.0-7.8%, and death from any cause by 2.6-4.1%.
“A recent simulation study estimated that for the USA, a reduction in salt intake of 3 g/day would result in a reduction of 5.9 -9.6% in the incidence of CHD (low and high estimate based on different assumptions), a reduction of 5.0 -7.8% in the incidence of stroke, and a reduction of 2.6-4.1% in death from any cause.286”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [286] Bibbins-Domingo, 2010, Projected effect of dietary salt reductions on future cardiovascular disease, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationA modest increase in fish consumption of 1-2 servings a week would reduce CHD mortality by 36% and all-cause mortality by 17%.
“A modest increase in fish consumption of 1 -2 servings a week would reduce CHD mortality by 36% and all-cause mortality by 17%.298”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [298] Mozaffarian, 2006, Fish intake, contaminants, and human health: evaluating the risks and the benefits, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationHigh fibre intake reduces post-prandial glucose responses after carbohydrate-rich meals and lowers total and LDL cholesterol levels.
“Although the mechanism is not elucidated completely, it is known that a high fibre intake reduces post-prandial glucose responses after carbohydrate-rich meals, and lowers total and LDL cholesterol levels.295”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [295] Weickert, 2008, Metabolic effects of dietary fiber consumption and prevention of diabetes, J Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationA Cochrane meta-analysis of eight RCTs found homocysteine-lowering interventions did not reduce risk of fatal/non-fatal MI (RR 1.03, 95% CI 0.94-1.13), stroke (RR 0.89, 95% CI 0.73-1.08), or death by any cause (RR 1.00, 95% CI 0.92-1.09).
“The Cochrane Collaboration concluded in a recent meta-analysis of eight RCTs that homocysteine-lowering interventions did not reduce the risk of fatal/non-fatal myocardial infarction (RR 1.03, 95% CI 0.94-1.13),stroke (RR 0.89, 95% CI 0.73 -1.08), or death by any cause (RR 1.00, 95% CI 0.92-1.09).290”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [290] Marti-Carvajal, 2009, Homocysteine lowering interventions for preventing cardiovascular events, Cochrane Database Syst Rev source
Not checked in the free run.
May combine two claims.
PremisecitationHe et al. reported pooled RR of stroke 0.89 (95% CI 0.83-0.97) for eating 3-5 servings of fruits and vegetables daily compared with <3 servings, and 0.74 (95% CI 0.69-0.79) for >5 servings.
“He et al. updated this estimate by adding two additional cohorts, and reported a pooled RR of stroke of 0.89 (95% CI 0.83 -0.97) for those eating 3-5 servings of fruits and vegetables daily compared with those eating ,3 servings, and a pooled RR of 0.74 (95% CI 0.69-0.79)for those eating .5 servings.274”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [274] He, 2006, Fruit and vegetable consumption and stroke: meta-analysis of cohort studies, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationGreater adherence to the Mediterranean diet, by a 2-point higher score, is associated with a 10% reduction in cardiovascular incidence or mortality (pooled RR 0.90, 95% CI 0.87-0.93) and an 8% reduction in all-cause mortality (pooled RR 0.92, 95% CI 0.90-0.94).
“The meta-analysis showed that greater adherence to the Mediterranean diet, by a 2-point higher score, was associated with a 10% reduction in cardiovascular incidence or mortality (pooled RR 0.90, 95% CI 0.87-0.93)and also with an 8% reduction in all-cause mortality (pooled RR 0.92, 95% CI 0.90-0.94).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [276] Sofi, 2010, Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationRegular consumption of sugar-sweetened beverages (two servings per day compared with one serving per month) is associated with a 35% higher risk of CHD in women, even after accounting for other unhealthy lifestyle and dietary factors; artificially sweetened beverages were not associated with CHD.
“Similarly, regular consumption of sugar-sweetened beverages (i.e. two servings per day compared with one serving per month) was associated with a 35% higher risk of CHD in women, even after other unhealthy lifestyle and dietary factors were accounted for, whereas artificially sweetened beverages were not associated with CHD.301”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [301] Fung, 2009, Sweetened beverage consumption and risk of coronary heart disease in women, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationThe volume of moderate-intensity physical activity or aerobic exercise training that reduces all-cause and cardiovascular mortality ranges from 2.5 to 5 h/week; longer total weekly duration is associated with greater benefits.
“The volume of moderate-intensity physical activity or aerobic exercise training able to provide a reduction in all-cause and cardiovascular mortality ranges from 2.5 to 5 h/week; 306 -308,311,312 the longer the total duration of physical activity/aerobic exercise training performed over the week the greater the observed benefits.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [306] Nocon, 2008, Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [307] Lollgen, 2009, Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories, Int J Sports Med source
Not checked in the free run.
- cites [308] Schnohr, 2007, Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- cites [311] US Department of Health and Human Services, 2008, Physical Activity Guidelines Advisory Committee Report
Not checked in the free run.
- cites [312] Richardson, 2004, Physical activity and mortality across cardiovascular disease risk groups, Med Sci Sports Exerc source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with prior acute myocardial infarction, CABG, PTCA, or stable angina, aerobic exercise training has no effect on non-fatal myocardial infarction, and data are insufficient on revascularization rates.
“Insufficient data were available as to the effects of aerobic exercise training on revascularization rates; moreover, aerobic exercise training did not show any effect on the occurrence of non-fatal myocardial infarction.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [333] Heran, 2011, Exercise-based cardiac rehabilitation for coronary heart disease, Cochrane Database Syst Rev source
Not checked in the free run.
May combine two claims.
PremisecitationIn hostile CHD patients, group-based hostility-control intervention may decrease hostility, depression, resting heart rate, and cardiovascular reactivity to mental stress, and increase social support and life satisfaction.
“In hostile CHD patients, a group-based hostility-control intervention may lead not only to decreases in behaviourally assessed hostility levels, but also to decreased levels of depression, resting heart rate, and cardiovascular reactivity to mental stress, as well as to increased social support and satisfaction with life.359,360”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [359] Gidron, 1999, The short-term effects of a hostility-reduction intervention on male coronary heart disease patients, Health Psychol source
Not checked in the free run.
- cites [360] Bishop, 2005, Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting, Am Heart J source
Not checked in the free run.
May combine two claims.
PremisereasoningThe total weekly volume of physical activity/aerobic exercise training can be obtained by summing multiple daily bouts each lasting ≥10 min, and should be distributed over most days of the week.
“Moreover, the available evidence suggests that the total weekly volume of physical activity/aerobic exercise training can be obtained by summing multiple daily bouts of exercise, each lasting ≥10 min, and that physical activity/aerobic exercise training should be distributed over most days of the week.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMajor cardiovascular events during supervised aerobic exercise training in cardiac rehabilitation are rare: 1 in 50,000 to 1 in 120,000 patient-hours, with fatality 1 in 340,000 to 1 in 750,000 patient-hours.
“The occurrence of major cardiovascular events during supervised aerobic exercise training in cardiac rehabilitation programmes is rare: from 1 in 50 000 to 1 in 120 000 patient-hours of exercise, with fatality incidence ranging between 1 in 340 000 and 1 in 750 000 patienthours of exercise.340,341”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [340] Franklin, 1998, Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up, Chest source
Not checked in the free run.
- cites [341] Scheinowitz, 2005, Safety of cardiac rehabilitation in a medically supervised, community-based program, Cardiology source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with chronic heart failure due to left ventricular systolic dysfunction, moderate to vigorous aerobic exercise training improves survival and significantly extends time to readmission.
“Overall, moderate to vigorous intensity aerobic exercise training resulted in improved survival in patients with chronic heart failure due to left ventricular systolic dysfunction, and time to readmission to hospital was also significantly extended.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [310] Piepoli, 2004, Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH), BMJ source
Not checked in the free run.
May combine two claims.
PremisecitationA secondary analysis of an RCT found beneficial cardiovascular effects only in white men and in patients who responded to antidepressant treatment.
“A secondary analysis of another RCT found beneficial cardiovascular effects in white men only, 344 and in patients who responded to antidepressant treatment.346”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [344] Schneiderman, 2004, Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial, Psychosom Med source
Not checked in the free run.
- cites [346] Carney, 2004, Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study, Psychosom Med source
Not checked in the free run.
May combine two claims.
PremisecitationPrognosis improvement from aerobic exercise training in chronic heart failure is greater in patients with ischaemic aetiology, lower left ventricular ejection fraction and peak VO2, and higher NYHA class.
“Prognosis improvement was higher in patients with ischaemic aetiology, lower left ventricular ejection fraction and peak VO 2 , and higher New York Heart Association class.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [310] Piepoli, 2004, Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH), BMJ source
Not checked in the free run.
May combine two claims.
PremisecitationCoronary patients with clinically significant depression can be safely and effectively treated with psychotherapy or SSRIs, but evidence for a beneficial effect on cardiac endpoints is inconclusive.
“Coronary patients with clinically significant depression can be safely and effectively treated with psychotherapy 84,85,351 -353 or selective serotonin re-uptake inhibitors, 354 -356 although evidence for a beneficial effect on cardiac endpoints is inconclusive.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [84] Rollman, 2009, Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial, JAMA source
Not checked in the free run.
- cites [85] Davidson, 2010, Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial, Arch Intern Med source
Not checked in the free run.
- cites [351] Berkman, 2003, Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial, JAMA source
Not checked in the free run.
- cites [352] Lesperance, 2007, Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial, JAMA source
Not checked in the free run.
- cites [353] Freedland, 2009, Treatment of depression after coronary artery bypass surgery: a randomized controlled trial, Arch Gen Psychiatry source
Not checked in the free run.
- cites [354] Glassman, 2002, Sertraline treatment of major depression in patients with acute MI or unstable angina, JAMA source
Not checked in the free run.
- cites [355] van Melle, 2007, Effects of antidepressant treatment following myocardial infarction, Br J Psychiatry source
Not checked in the free run.
- cites [356] Dowlati, 2010, Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis, Can J Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationRisk stratification algorithms identify patients at increased risk for exercise-related cardiovascular events and who may require more intensive cardiac monitoring; safety of medically supervised exercise programmes following such indications is well established.
“Available risk stratification algorithms help to identify patients who are at increased risk for exercise-related cardiovascular events and who may require more intensive cardiac monitoring, 338,339 and the safety of medically supervised exercise programmes that follow such indications for exercise-related risk stratification is well established.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [338] American Association of Cardiovascular & Pulmonary Rehabilitation, 2004
Not checked in the free run.
- cites [339] American College of Sports Medicine, 2009
Not checked in the free run.
May combine two claims.
PremisecitationMost studies showed no significant beneficial effect of treating depression on cardiac endpoints, but a recent RCT revealed fewer depressive symptoms and fewer major adverse cardiac events.
“Whereas most studies could show no significant beneficial effect, 84,351 -356 a recent RCT revealed fewer depressive symptoms as well as fewer major adverse cardiac events.85”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [84] Rollman, 2009, Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial, JAMA source
Not checked in the free run.
- cites [351] Berkman, 2003, Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial, JAMA source
Not checked in the free run.
- cites [352] Lesperance, 2007, Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial, JAMA source
Not checked in the free run.
- cites [353] Freedland, 2009, Treatment of depression after coronary artery bypass surgery: a randomized controlled trial, Arch Gen Psychiatry source
Not checked in the free run.
- cites [354] Glassman, 2002, Sertraline treatment of major depression in patients with acute MI or unstable angina, JAMA source
Not checked in the free run.
- cites [355] van Melle, 2007, Effects of antidepressant treatment following myocardial infarction, Br J Psychiatry source
Not checked in the free run.
- cites [356] Dowlati, 2010, Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis, Can J Psychiatry source
Not checked in the free run.
- cites [85] Davidson, 2010, Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial, Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn low-risk patients, aerobic exercise training is at least as effective as PCI in improving clinical status and myocardial perfusion and is associated with fewer cardiovascular events.
“aerobic exercise training in low-risk patients has been shown to be at least as effective in improving clinical status and myocardial perfusion, and associated with fewer cardiovascular events as compared with an invasive strategy such as a PCI.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [336] Hambrecht, 2004, Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationStress-management programmes improve subjective well-being, risk factor levels, and CVD outcomes.
“Stress-management programmes have repeatedly been shown to improve not only subjective well-being but also risk factor levels and CVD outcomes.199,200,358”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [199] Linden, 2007, Psychological treatment of cardiac patients: a meta-analysis, Eur Heart J source
Not checked in the free run.
- cites [200] Rees, 2004, Psychological interventions for coronary heart disease, Cochrane Database Syst Rev
Not checked in the free run.
- cites [358] Gulliksson, 2011, Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM), Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationOne RCT of a nurse-led home-based intervention in post-CABG patients showed beneficial effects on anxiety, but sample size and follow-up were too limited to demonstrate impact on cardiac events.
“One RCT involving a nurse-led, home-based intervention in post-CABG patients revealed beneficial effects on anxiety, but the sample was too small and the follow-up period too short to demonstrate an impact on cardiac events.357”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [357] Lie, 2007, Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial, J Psychosom Res source
Not checked in the free run.
May combine two claims.
PremisecitationReduction of work stress in managers and supervisors may have beneficial health effects on them and improve perceived social support in subordinates.
“Hence, reduction of work stress in managers and supervisors may have beneficial health effects on the target individuals and may also improve perceived social support in their subordinates.362”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [362] Theorell, 2001, Employee effects of an educational program for managers at an insurance company, Psychosom Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn Europe, general obesity and abdominal adiposity are both associated with increased risk of death.
“In Europe, a recent study of nearly 360 000 participants from nine European countries showed that general obesity and abdominal adiposity are both associated with increased risk of death.372”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [372] Pischon, 2008, General and abdominal adiposity and risk of death in Europe, N Engl J Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationObesity is becoming a worldwide epidemic in both children and adults.
“Obesity is becoming a worldwide epidemic in both children and adults.370”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [370] Poirier, 2006, Obesity, cardiovascular disease: pathophysiology, evaluation, effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationMultimodal behavioural interventions can reduce mood symptoms and enhance health-related quality of life, although evidence for a definite beneficial effect on cardiac endpoints is inconclusive.
“This approach can reduce mood symptoms and enhance health-related quality of life, although evidence for a definite beneficial effect on cardiac endpoints is inconclusive.”
Quote in the paperSubstantial claim0 of 9 sources checked- cites [85] Davidson, 2010, Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial, Arch Intern Med source
Not checked in the free run.
- cites [86] Katon, 2010, Collaborative care for patients with depression and chronic illnesses, N Engl J Med source
Not checked in the free run.
- cites [199] Linden, 2007, Psychological treatment of cardiac patients: a meta-analysis, Eur Heart J source
Not checked in the free run.
- cites [200] Rees, 2004, Psychological interventions for coronary heart disease, Cochrane Database Syst Rev
Not checked in the free run.
- cites [343] Whalley, 2011, Psychological interventions for coronary heart disease, Cochrane Database Syst Rev source
Not checked in the free run.
- cites [344] Schneiderman, 2004, Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial, Psychosom Med source
Not checked in the free run.
- cites [345] Taylor, 2005, Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction, Arch Gen Psychiatry source
Not checked in the free run.
- cites [346] Carney, 2004, Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study, Psychosom Med source
Not checked in the free run.
- cites [347] Sauer, 2003, Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction, Circulation source
Not checked in the free run.
May combine two claims.
InterpretationreasoningEvidence is accumulating that psychological interventions counteract psychosocial stress, promote healthy behaviours, and contribute to CVD prevention.
“Evidence is accumulating to suggest that psychological interventions counteract psychosocial stress, promote healthy behaviours, and contribute to the prevention of CVD.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningVisceral adipose tissue process impacts CVD risk factors and risk; mechanical effects of overweight impact non-cardiovascular morbidity and mortality.
“This process impacts on CVD risk factors and hence on risk, and the mechanical effects of overweight impact on non-cardiovascular causes of morbidity and mortality.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDue to poorer accuracy and reliability of waist and hip measurements, they cannot be established as alternatives to BMI in routine practice; BMI was not a stronger predictor than other measures, while central obesity measures had somewhat stronger associations with all-cause mortality and type 2 diabetes.
“On the basis of evidence regarding the poorer accuracy and reliability of measuring waist circumference and hip circumference, 381 -383 it is not possible to establish these measures of visceral adiposity as alternatives to BMI in routine practice; it is also notable that BMI was not a stronger predictor of any outcomes than were the other measures, whereas measures of central obesity had somewhat”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [381] Sebo, 2008, Reliability of doctors' anthropometric measurements to detect obesity, Prev Med source
Not checked in the free run.
- cites [382] Nadas, 2008, Intraobserver and interobserver variability of measuring waist circumference, Med Sci Monit
Not checked in the free run.
- cites [383] Nordhamn, 2000, Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables, Int J Obes Relat Metab Disord source
Not checked in the free run.
May combine two claims.
PremisecitationA meta-analysis of 32 studies found no overall difference between BMI, waist circumference, and waist:hip ratio in association with incident diabetes, and no important sex differences.
“A recent meta-analysis of 32 studies found no overall difference between BMI, waist circumference, and waist:hip ratio in their association with incident diabetes, 378 and showed no important differences between the sexes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [378] Vazquez, 2007, Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis, Epidemiol Rev source
Not checked in the free run.
May combine two claims.
PremisecitationAt population level, obesity is associated with increased CVD incidence and mortality; among those with established coronary artery disease, evidence is contradictory.
“If, at the population level, obesity is associated with an increased risk of CVD incidence and mortality, among those with established coronary artery disease, the evidence is contradictory.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [366] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Not checked in the free run.
- cites [367] Oreopoulos, 2008, Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis, Obesity (Silver Spring) source
Not checked in the free run.
- cites [368] Hastie, 2010, Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention, Eur Heart J source
Not checked in the free run.
- cites [369] Lavie, 2009, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningWaist circumference thresholds are based on Caucasians; different cut-off points are required in different races and ethnicities.
“These thresholds have been calculated based on Caucasians and it is apparent that different cut-off points for anthropometric measurements are required in different races and ethnicities.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationIn EPIC, BMI, waist circumference, and waist:hip ratio were all independently associated with all-cause mortality; authors recommended waist circumference or waist:hip ratio in addition to BMI; no direct comparisons of magnitudes were made.
“In the multicentre European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study, BMI, waist circumference, and waist:hip ratio were all independently associated with allcause mortality; the authors recommended the use of waist circumference or waist:hip ratio in addition to BMI for assessing risk of death; however, no direct comparisons of the magnitudes of associations between”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [372] Pischon, 2008, General and abdominal adiposity and risk of death in Europe, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationECG LVH can document LVH regression, possibly associated with reduced incidence of new-onset AF.
“ECG LVH can be used as a tool documenting LVH regression, possibly associated with a reduced incidence of new-onset AF. 419”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [419] Okin, 2004, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationCarotid-femoral pulse wave velocity provides a comprehensive non-invasive assessment of arterial stiffness and has independent predictive value for all-cause and cardiovascular morbidity, coronary events, and strokes in patients with uncomplicated essential hypertension and in the general population.
“Measurement of carotid -femoral pulse wave velocity provides a comprehensive non-invasive assessment of arterial stiffness 423 and has an independent predictive value for all-cause and cardiovascular morbidity, coronary events, and strokes in patients with uncomplicated essential hypertension as well as in the general population.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [423] Willum-Hansen, 2006, Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population, Circulation source
Not checked in the free run.
May combine two claims.
Interpretationnone givenLong-acting drugs minimize blood pressure variability, which may offer protection against progression of organ damage and risk of cardiovascular events.
“Long-acting drugs also minimize BP variability, which may offer protection against progression of organ damage and risk of cardiovascular events.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningCarotid alterations are common in untreated hypertensive individuals without target organ damage on routine examination; thus, carotid ultrasound may often detect vascular damage and make risk stratification more precise.
“These alterations are common in untreated hypertensive individuals without target organ damage on routine examination; thus, carotid ultrasound may often detect vascular damage and make risk stratification more precise.”
Quote in the paperSubstantial claim- Rests on an assumption: Ultrasound scans limited to common carotid arteries are likely to detect vascular hypertrophy only, whereas assessment of atherosclerosis also requires scanning bifurcations and/or internal carotids where plaques are more frequent.
May combine two claims.
PremisecitationA low ABI indicates advanced atherosclerosis, whereas carotid IMT measurements detect earlier changes.
“A low ABI indicates advanced atherosclerosis, 422 whereas carotid IMT measurements are able to detect earlier changes.421”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationObservational evidence shows BP levels correlate negatively with cognitive function and hypertension is associated with increased incidence of dementia.
“Observational evidence is also available that BP levels correlate negatively with cognitive function and that hypertension is associated with an increased incidence of dementia.411”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [411] Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenIt remains unclear whether drug-induced diabetes carries the same negative prognosis as naturally occurring diabetes.
“Furthermore, it is still unclear whether drug-induced diabetes carries the same negative prognosis as naturally occurring diabetes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn hypertensive patients with and without diabetes, microalbuminuria even below current threshold predicts cardiovascular events, and a continuous relationship exists between cardiovascular and non-cardiovascular mortality and urinary protein/creatinine ratios ≥3.9 mg/g in men and ≥7.5 mg/g in women.
“In hypertensive patients with and without diabetes, microalbuminuria, even below the currently used threshold values, predicts cardiovascular events, 424 and a continuous relationship between cardiovascular as well as non-cardiovascular mortality and urinary protein/creatinine ratios ≥3.9 mg/g in men and ≥7.5 mg/ g in women has been reported in several studies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [424] Sarnak, 2003, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationSubclinical organ damage predicts cardiovascular death independently of SCORE, and the combination may improve risk prediction especially in subjects at low or moderate risk (SCORE 1-4%).
“In conclusion, there is evidence that subclinical organ damage predicts cardiovascular death independently of SCORE, and the combination may improve risk prediction, especially in subjects at low or moderate risk (SCORE 1-4%).400”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [400] Sehestedt, 2010, Risk prediction is improved by adding markers of subclinical organ damage to SCORE, Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationSome studies show wide pulse pressure is a better predictor of adverse cardiovascular outcomes than SBP or DBP individually, and identifies patients with systolic hypertension at particularly high risk.
“A wide pulse pressure (SBP minus DBP) has been shown in some studies to be a better predictor of adverse cardiovascular outcomes than either SBP or DBP individually, 413 and to identify patients with systolic hypertension who are at particularly high risk.414”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [413] Franklin, 2001, Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study, Circulation source
Not checked in the free run.
- cites [414] Benetos, 2000, A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationElevated BP is a major risk factor for CHD, heart failure, cerebrovascular disease, PAD, renal failure, and atrial fibrillation.
“Elevated BP is a major risk factor for CHD, heart failure, cerebrovascular disease, PAD, renal failure, and atrial fibrillation.”
- Also stated in: § 4.7.1 Introduction · plain
“In a number of epidemiological studies, elevated BP has been identified as a risk factor for CHD, heart failure, cerebrovascular disease, PAD renal failure, and, more recently, atrial fibrillation (AF).409,410”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [409] MacMahon, 1990, Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, Lancet source
Not checked in the free run.
- cites [410] Wattigney, 2003, Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention, Circulation source
Not checked in the free run.
- Also stated in: § 4.7.1 Introduction · plain
May combine two claims.
PremisecitationCardiac abnormalities detected by echocardiography more precisely quantify left ventricular mass and geometric LVH patterns, and have additional predictive power.
“Cardiac abnormalities detected by echocardiography more precisely quantify left ventricular mass and geometric LVH patterns, and have an additional predictive power.420”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [420] Taylor, 2007, Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study), Am J Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenIt cannot be ruled out that being underweight is associated with increased cardiovascular morbidity and mortality.
“It cannot be ruled out that being underweight is associated with increased cardiovascular morbidity and mortality.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe reason for the poorer outcome in the intensive group in ACCORD is not clear but may be associated with hypoglycaemia.
“The reason for the poorer outcome in the intensive group is not clear, but may be associated with hypoglycaemia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningFixed-dose combinations simplify treatment and may improve patient compliance.
“Fixed-dose combinations simplify treatment and may thus improve patient compliance.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenCardiovascular disease is the leading cause of morbidity and mortality in people with diabetes mellitus.
“Cardiovascular disease is the leading cause of morbidity and mortality in people with diabetes mellitus.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHypertriglyceridaemia is a significant independent risk factor for cardiovascular disease, though its association is weaker than that of hypercholesterolaemia.
“Hypertriglyceridaemia is a significant independent CVD risk factor, but it seems that the association is not as strong as for hypercholesterolaemia.55”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Sarwar, 2007, Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationFamilial hypercholesterolaemia is a dominantly inherited condition affecting 1 in 500 people of European descent (heterozygous), most commonly caused by a mutation of the LDL receptor, and characterized by very high LDL cholesterol levels (usually 5-10 mmol/L).
“Familial hypercholesterolaemia is a dominantly inherited condition affecting 1 in 500 people of European descent (heterozygous) most commonly caused by a mutation of the LDL receptor, and is characterized by very high levels of LDL cholesterol (usually 5-10 mmol/L or 200-400 mg/dL).42”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationNon-fasting triglycerides may predict coronary heart disease risk even better than fasting triglycerides, because individuals are in the postprandial state most of the time.
“There is evidence that non-fasting triglycerides may predict CHD risk even better, as individuals are in the postprandial state most of the time.477”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [477] Nordestgaard, 2007, Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with transient ischaemic attack or ischaemic stroke, dipyridamole plus aspirin versus clopidogrel alone had similar rates of recurrent stroke, including haemorrhagic stroke (916 vs 898; HR 1.01, 95% CI 0.92-1.11), with a higher frequency of major haemorrhagic events with dipyridamole plus aspirin (4.1% vs 3.6%); stroke, myocardial infarction, and vascular death occurred in 13.1% in
“In patients with transient ischaemic attack or ischaemic stroke, a direct comparison of dipyridamole plus aspirin vs. clopidogrel alone 508 showed that the two regimens had similar rates of recurrent stroke, including haemorrhagic stroke (916 vs. 898; HR 1.01, 95% CI 0.92-1.11).There was a higher frequency of major haemorrhagic events with dipyridamole plus aspirin (4.1% vs. 3.6%).Stroke,”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [508] Sacco, 2008, Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationWith ticagrelor given for 12 months, the composite endpoint of death from vascular causes, myocardial infarction, or stroke occurred in 9.8% versus 11.7% with clopidogrel (HR 0.84, 95% CI 0.77-0.92; P<0.001), with no significant difference in major bleeding.
“With ticagrelor given for 12 months the composite endpoint of death from vascular causes, myocardial infarction, or stroke occurred in 9.8% as compared with 11.7% of those receiving clopidogrel (HR 0.84, 95% CI 0.77-0.92;P , 0.001).No significant difference in rate of major bleeding was found.501 -503”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [501] Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med source
Not checked in the free run.
- cites [502] Gurbel, 2009, Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study, Circulation source
Not checked in the free run.
- cites [503] Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationStatins, by decreasing LDL cholesterol, reduce cardiovascular morbidity and mortality and the need for coronary artery interventions.
“Statins, by decreasing LDL cholesterol, reduce cardiovascular morbidity and mortality as well as the need for coronary artery interventions.166,436”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [166] Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet source
Not checked in the free run.
- cites [436] Collins, 2003, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationHigh cholesterol levels are a risk factor for ischaemic but not haemorrhagic stroke.
“In contrast to earlier observations, recent studies have now shown that high cholesterol levels are a risk factor for ischaemic but not haemorrhagic stroke.489”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [489] Hebert, 1997, Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with prior non-cardioembolic ischaemic stroke, oral vitamin K antagonists are not superior to aspirin but are associated with a higher bleeding risk.
“In such patients oral vitamin K antagonists are not superior to aspirin but are associated with a higher bleeding risk.512,513”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [512] Mohr, 2001, A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke, N Engl J Med source
Not checked in the free run.
- cites [513] Liu, 2000, Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
PremisecitationSolely reducing dosage demands resulted in strong effects (effect size 0.89-1.20), but other interventions such as repetitive monitoring and feedback (effect size 0.27-1.2), multisession information (effect size 0.35-1.13), and combined behavioural interventions (effect size 0.43-1.20) have shown effects ranging from low to strong.
“Solely reducing dosage demands resulted in strong effects (effect size 0.89-1.20),but other interventions such as repetitive monitoring and feedback (effect size 0.27 -1.2), multisession information (effect size 0.35 -1.13), and combined behavioural interventions (effect size 0.43-1.20)have shown effects ranging from low to strong.520”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [520] Kripalani, 2007, Interventions to enhance medication adherence in chronic medical conditions: a systematic review, Arch Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe World Health Organization has categorized potential reasons for medication non-adherence into five broad groupings: health system-related, condition, patient, therapy, and socio-economic factors.
“As outlined in Table 18, the WHO has categorized potential reasons for medication non-adherence into five broad groupings that include health system-related, condition, patient, therapy, and socio-economic factors.518”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [518] Ho, 2009, Medication adherence: its importance in cardiovascular outcomes, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationA recent systematic review has shown that several types of interventions are effective in improving adherence in chronic medical conditions; however, effect sizes on adherence varied and so did medical outcome.
“A recent systematic review has shown that several types of interventions are effective in improving adherence in chronic medical conditions; however, effect sizes on adherence varied and so did medical outcome.520”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [520] Kripalani, 2007, Interventions to enhance medication adherence in chronic medical conditions: a systematic review, Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationWith prasugrel, the primary efficacy endpoint occurred in 9.9% versus 12.1% with clopidogrel (HR 0.81, 95% CI 0.73-0.90; P<0.001), and the risk of major bleeding was increased.
“With prasugrel, the primary efficacy endpoint occurred in 9.9% of patients as compared with 12.1% receiving clopidogrel (HR 0.81, 95% CI 0.73-0.90;P , 0.001).The risk of major bleeding was increased with prasugrel.501”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [501] Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn a meta-analysis of 16 trials comprising 17,000 individuals, allocation to aspirin was associated with serious vascular events in 6.7% per year versus 8.2% of controls; total stroke 2.08% versus 2.59% (P=0.002); coronary events 4.3% versus 5.3% (P=0.0001); aspirin was associated with a 10% reduction in total mortality (RR 0.90, 95% CI 0.82-0.99) and a significant excess of major bleeds, but the
“In a meta-analysis of 16 trials comprising 17 000 individuals, the Antithrombotic Trialists' Collaboration, 2009 507 found that allocation to aspirin was associated with serious vascular events in 6.7% of patients per year vs. 8.2% of controls.The risk of total stroke was 2.08% per year vs. 2.59% (P ¼ 0.002) and coronary events 4.3% per year vs. 5.3% (P ¼ 0.0001).Aspirin was associated with a 10%”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [507] Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationAs adherence with placebo also improves survival, adherence to medication may reflect generally better health behaviour.
“In addition, as adherence with placebo also improves survival, 524 physicians should be aware that adherence to medication may reflect generally better health behaviour.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [524] Simpson, 2006, A meta-analysis of the association between adherence to drug therapy and mortality, BMJ source
Not checked in the free run.
May combine two claims.
PremisecitationStatin therapy has a beneficial effect on cardiovascular disease outcomes in chronic kidney disease stages 2 and 3 and slows the rate of kidney function loss.
“Statin therapy has a beneficial effect on CVD outcomes in CKD stages 2 and 3 and slows the rate of kidney function loss.493”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [493] Fellstrom, 2009, Rosuvastatin and cardiovascular events in patients undergoing hemodialysis, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationOther CVD risk factors such as smoking, high blood pressure, and obesity are undermanaged and show little improvement over time.
“There is also the issue of undermanagement and little improvement over time in other CVD risk factors such as smoking, high BP, and obesity.540”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [540] Wood, 2007, Clinical reality of coronary prevention in Europe: a comparison of EUROPASPIRE I, II, and III surveys. Paper presented at, The 29th Annual Congress of the European Society of Cardiology
Not checked in the free run.
May combine two claims.
PremisecitationA link exists between accuracy in recordings and both quality of care and adherence to guidelines.
“A link exists between accuracy in recordings and both quality of care and adherence to guidelines.437”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [437] Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPhysicians are concerned about overestimating risk in national populations, which may lead to overuse of medical therapy.
“Physicians are also concerned about overestimating risk in national populations, which may lead to overuse of medical therapy.545,547”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [545] van Steenkiste, 2004, Barriers to implementing cardiovascular risk tables in routine general practice, Scand J Prim Health Care source
Not checked in the free run.
- cites [547] Marshall, 2006, Estimating the value of information in strategies for identifying patients at high risk of cardiovascular disease, Inform Prim Care
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe affected individuals would include men and elderly people, who have a higher tendency to require lipid-lowering medications.
“Affected individuals would include men and elderly individuals who would have a higher tendency to require lipid-lowering medications.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationBarriers to implementing risk-adjusted prevention are multiple: risk scoring is considered time consuming, oversimplifies a complex situation, and may lead to overmedication.
“Barriers to implementation of risk-adjusted prevention are multiple: risk scoring is considered to be time consuming, simplifying a complex situation, and may result in overmedication.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOther studies have demonstrated the effectiveness of nurse-led prevention clinics in primary care compared with usual care, with greater success in secondary as opposed to primary prevention.
“Other studies have demonstrated the effectiveness of nurse-led prevention clinics in primary care compared with usual care, with greater success in secondary as opposed to primary prevention.532 -534”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [532] Voogdt-Pruis, 2010, Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial, Br J Gen Pract source
Not checked in the free run.
- cites [533] Campbell, 1998, Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care, Heart source
Not checked in the free run.
- cites [534] Koelewijn-van Loon, 2010, Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care, Prev Med source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough self-testing showed no difference in hard endpoints, it gives greater independence and results in better quality of life.
“Although there was no difference in hard endpoints, self-testing gives greater independence and results in a better quality of life.553”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [553] Matchar, 2010, Effect of home testing of international normalized ratio on clinical events, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIntuitive assessment based on personal experience appears to underestimate real CVD risk; physicians estimated CVD risk as less severe than the recommendations in WHO-International Society of Hypertension guidelines.
“Although preferred by many physicians, intuitive assessment based on personal experience appears to underestimate the real risk of CVD: physicians (110 general practitioners and 29 internists) estimated CVD risk as being less severe than detailed in recommendations provided in the WHO-International Society of Hypertension guidelines.542,543”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [542] Persson, 2004, Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy, J Hypertens source
Not checked in the free run.
- cites [543] 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee, 1999, J Hypertens
Not checked in the free run.
May combine two claims.
PremisecitationNurse case management models tested in several randomized trials of secondary prevention have shown significant improvements in risk factors, exercise tolerance, glucose control, and appropriate medication use, along with decreases in cardiac events and mortality, regression of coronary atherosclerosis, and improved patient perception of health compared with usual care.
“Nurse case management models tested in several randomized trials of secondary prevention have shown significant improvements in risk factors, exercise tolerance, glucose control, and appropriate medication use, along with decreases in cardiac events and mortality, regression of coronary atherosclerosis, and improved patient perception of health compared with usual care.530,531”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [530] Berra, 2006, Cardiovascular disease prevention and disease management: a critical role for nursing, J Cardiopulm Rehabil source
Not checked in the free run.
- cites [531] Berra, 2011, Global cardiovascular disease prevention: a call to action for nursing: the global burden of cardiovascular disease, J Cardiovasc Nurs source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation57% of physicians believed that numerical information from prediction rules is frequently unhelpful for clinical decision-making.
“More than half of the physicians (57%) believed that the numerical information resulting from prediction rules is frequently unhelpful for clinical decision-making.544”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [544] Eichler, 2007, Barriers to apply cardiovascular prediction rules in primary care: a postal survey, BMC Fam Pract source
Not checked in the free run.
May combine two claims.
PremisecitationIn a survey of general practitioners and internists in two Swiss regions, 74% rarely or never used CVD prediction rules, citing fears of oversimplification (58%) or overuse of medical therapy (54%).
“A survey among general practitioners and internists working in clinical practice in two Swiss regions revealed that 74% rarely or never used CVD prediction rules, 544 due to fears of oversimplification of risk assessment (58%) or overuse of medical therapy (54%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [544] Eichler, 2007, Barriers to apply cardiovascular prediction rules in primary care: a postal survey, BMC Fam Pract source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMost current CVD prevention risk calculators use short-term risk over 5 or 10 years, which makes them more likely to classify older people as high risk and younger people as low risk.
“Most of the current CVD prevention risk calculators focus on shortterm (5 or 10 year) risk, and therefore inevitably are more likely to classify the elderly as at high risk and the young as at low risk.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe EUROACTION trial showed that a nurse-co-ordinated multidisciplinary prevention programme in hospitals and primary care practices led to healthier lifestyle changes in diet and physical activity, improvements in lifestyle, and more effective control of risk factors such as blood pressure in both patients and their partners in the intervention arm compared with usual care.
“A nurse-co-ordinated multidisciplinary prevention programme in both hospitals and primary care practices was evaluated in the EUROACTION trial studying patients with CHD and those at high risk of CVD in eight countries.35 The approach was family centred and led to healthier lifestyle changes in terms of diet and physical activity, improvements in lifestyle (diet and physical activity), and more”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Wood, 2008, Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationIncentives have been shown to be effective in the UK, where the Quality and Outcomes Framework links primary care income with achievement of specific evidence-based targets.
“Incentives have been shown to be effective in the UK, where the Quality and Outcomes Framework (QOF) scheme links primary care income with achievement of specific evidencebased targets in healthcare delivery.549”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [549] Hedback, 1987, 5-year results of a comprehensive rehabilitation programme after myocardial infarction, Eur Heart J source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningA thorough cardiologist examination will often profoundly change the risk score in many patients perceived to be at low risk.
“This will in many patients with perceived low risk often change the risk score profoundly.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationNurse case management and nurse-coordinated multidisciplinary prevention programmes are more effective than usual care at reducing cardiovascular risk and can be adapted to various healthcare settings.
“The evidence shows that nurse case management and nurse-co-ordinated multidisciplinary prevention programmes are more effective than usual care in reducing cardiovascular risk, and can be adapted to a variety of healthcare settings.”
- Also stated in: § 5.1.2 Sustained contact is necessary for lifestyle change · plain
“Nurse-led clinics or nurse-co-ordinated multidisciplinary prevention programmes are more effective than usual care in reducing cardiovascular risk, in a variety of healthcare settings.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [531] Berra, 2011, Global cardiovascular disease prevention: a call to action for nursing: the global burden of cardiovascular disease, J Cardiovasc Nurs source
Not checked in the free run.
- Also stated in: § 5.1.2 Sustained contact is necessary for lifestyle change · plain
May combine two claims.
PremisecitationIn an ESC survey across six European countries, 85% of cardiologists and physicians knew that CVD risk assessment should combine all CVD risk factors, but 62% used subjective methods instead of risk calculators.
“An ESC survey conducted in six European countries indicates why physicians rely on their own expertise for the prevention and treatment of CHD: although most cardiologists and physicians (85%) knew they should base CVD risk assessment on the combination of all CVD risk factors, 62% of physicians used subjective methods to gauge risk rather than using risk calculators.541”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [541] Graham, 2006, Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
May combine two claims.
PremisecitationThe most common barriers to guideline implementation were government or local health policy (40%), patient compliance (36%), and lack of time (23%).
“The most common barriers to guideline implementation were government or local health policy (40%), patient compliance (36%), and lack of time (23%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [541] Graham, 2006, Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
May combine two claims.
InterpretationcitationWhether rehabilitation is ambulatory or residential is probably of lesser importance; duration, educational level, and patient motivation are also important for long-term outcome.
“Whether the rehabilitation course is applied in an ambulatory setting or as a residential course is probably of lesser importance; the duration of the programme, the educational level, and the motivation of the patient are also important for long-term outcome.205”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [205] Piepoli, 2010, Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
May combine two claims.
PremisecitationMultivariable analysis adjusting for 14 clinical variables confirmed that compliance with all performance measures was statistically significantly higher for PCI patients than for CABG patients and was lowest for non-intervention patients.
“Multivariable analysis adjusting for 14 clinical variables confirmed that compliance with all performance measures was statistically significantly higher for PCI patients than for CABG patients and was lowest for non-intervention patients.556”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [556] Hiratzka, 2007, Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationDefect-free compliance was highest for PCI patients (71.5%), followed by CABG patients (65.1%), then no-intervention patients (62.1%).
“Defect-free (100%) compliance was highest for PCI patients (71.5%), followed by CABG patients (65.1%), then no-intervention patients (62.1%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [556] Hiratzka, 2007, Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationOnly 30% of eligible patients in Europe participate in a rehabilitation programme after a cardiac event, with considerable variation between countries.
“The participation rate in a rehabilitation programme after a cardiac event is far lower than desirable: only 30% of eligible patients in Europe participate in such a programme, with considerable variation reported between countries.5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet source
Not checked in the free run.
May combine two claims.
InterpretationcitationCardiac rehabilitation is considered cost-effective after an acute coronary event; it improves prognosis by reducing recurrent hospitalizations and healthcare expenditure while prolonging life.
“Cardiac rehabilitation is considered a cost-effective intervention following an acute coronary event; it improves prognosis by reducing recurrent hospitalizations and healthcare expenditure while prolonging life.562”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [562] Jolliffe, 2001, Exercise-based rehabilitation for coronary heart disease, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
PremisecitationIn the same RCT, the intensive intervention reduced clinical endpoints: cardiovascular mortality, non-fatal myocardial infarction, and stroke by 33% (P=0.02); cardiac death plus non-fatal myocardial infarction by 36% (P=0.02); total stroke by 32%; and total mortality by 21% (not significant).
“Clinical endpoints were also reduced by the intensive intervention: cardiovascular mortality, non-fatal myocardial infarction, and stroke by 33% (P ¼ 0.02), and cardiac death plus non-fatal myocardial infarction by 36% (P ¼ 0.02), total stroke by 32%, and total mortality by 21% (P ¼ not significant).565”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [565] Giannuzzi, 2008, Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network, Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationA low-intensity quality-improvement programme in a randomized national study of 458 hospitals after bypass surgery significantly increased optimal secondary prevention, with better adherence in all patient subgroups, particularly women and the elderly, and almost eliminated previous treatment gaps.
“A significant increase was observed in the rate of optimal secondary prevention, with better adherence to guidelines in all patient subgroups, particularly women and the elderly; previously existing treatment gaps were almost eliminated, and improvements were seen in the use of lipid-lowering therapy, ACE inhibitor treatment, and tobaccocessation counselling.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [560] Williams, 2011, Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationA 3-year multicentre RCT found that a long-term, reinforced, multifactorial educational and behavioural intervention coordinated by a cardiologist after standard cardiac rehabilitation improved risk factors and increased medication adherence over time, with significant improvement in lifestyle habits.
“The intervention proved effective in improving risk factors and increasing medication adherence over time, with significant improvement in lifestyle habits (i.e.exercise, diet, psychosocial stress, and body weight).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [565] Giannuzzi, 2008, Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network, Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn randomized studies with a structured treatment regimen and frequent follow-up after ACS, the compliance rate is high and the event rate is low.
“In randomized studies with a structured treatment regimen and frequent follow-up following an ACS, the compliance rate is high and the event rate low.561”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [561] Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSelf-help groups increase independence and improve quality of life.
“Self-help groups increase independence and improve quality of life.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Risk is a continuum and there is no threshold at which a drug is automatically indicated.
“thresholds to trigger certain interventions are problematic since risk is a continuum and there is no threshold at which, for example, a drug is automatically indicated.”
The paper relies on this without support.
Treatment of periodontitis improves endothelial dysfunction, one of the earliest signs of atherosclerosis.
“Treatment of periodontitis improves endothelial dysfunction, one of the earliest signs of atherosclerosis.”
The paper relies on this without support.
Detecting asymptomatic but diseased patients is crucial for an adequate prevention programme.
“Detection of asymptomatic but diseased patients is crucial for an adequate prevention programme.”
The paper relies on this without support.
Management of all risk factors in diseases with increased cardiovascular risk is advisable even without randomized studies.
“Management of all risk factors appears advisable even in the absence of randomized studies.”
The paper relies on this without support.
Motivation is the most important predictor of successful smoking cessation and can be increased by professional assistance.
“The most important predictor of successful quitting is motivation, which can be increased by professional assistance.”
The paper relies on this without support.
The momentum for smoking cessation is particularly strong at the time of diagnosing CVD and in connection with invasive treatment such as CABG, percutaneous transluminal coronary angioplasty, or vascular surgery.
“The momentum for smoking cessation is particularly strong at the time of diagnosing CVD and in connection with an invasive treatment such as CABG, percutaneous transluminal coronary angioplasty, or vascular surgery.”
The paper relies on this without support.
Smoking cessation leads to average weight gain of about 5 kg.
“Smokers should be advised about expected weight gain of on average 5 kg and that the health benefits of tobacco cessation far outweigh the risks from weight gain.”
The paper relies on this without support.
Long-term safety and efficacy data for all pharmacological smoking-cessation therapies are lacking.
“All pharmacological smoking-cessation therapies should be used short term since long-term safety and efficacy data are lacking.”
The paper relies on this without support.
Support from partner and family is very important, and getting other family members who smoke to quit together with the patient is of great help.
“Support from the partner and family is very important.Getting other family members who smoke to quit together with the patient is of great help.”
The paper relies on this without support.
Dietary habits influence cardiovascular risk through effects on risk factors such as serum cholesterol, BP, body weight, and diabetes, or independently of these risk factors.
“Dietary habits are known to influence cardiovascular risk, either through an effect on risk factors such as serum cholesterol, BP, body weight, and diabetes, or through an effect independent of these risk factors.”
The paper relies on this without support.
A healthy diet reduces the risk of other chronic diseases such as cancer.
“A healthy diet also reduces the risk of other chronic diseases such as cancer.”
The paper relies on this without support.
In CVD prevention, the fatty acid composition of the diet is more important than total fat content.
“In prevention, the fatty acid composition of the diet is more important than the total fat content.”
The paper relies on this without support.
Polyunsaturated fatty acids lower LDL cholesterol and, to a lesser extent, HDL cholesterol when they replace saturated fatty acids.
“Polyunsaturated fatty acids lower LDL cholesterol levels, and to a lesser extent HDL cholesterol levels, when they replace saturated fatty acids.”
The paper relies on this without support.
Trans fatty acids increase total cholesterol and decrease HDL cholesterol.
“The subclass of unsaturated fatty acids with a so-called 'trans configuration', the trans fatty acids, have been shown to increase total cholesterol and decrease HDL cholesterol levels.”
The paper relies on this without support.
The impact of dietary cholesterol on serum cholesterol is weak compared with that of fatty acid composition.
“The impact of dietary cholesterol on serum cholesterol levels is weak compared with that of the fatty acid composition of the diet.”
The paper relies on this without support.
The effect of sodium intake on BP is well established.
“The effect of sodium intake on BP is well established.”
The paper relies on this without support.
Higher potassium intake reduces BP.
“A higher potassium intake has been shown to reduce BP.”
The paper relies on this without support.
Case-control and prospective observational studies observed inverse associations between vitamin A and E levels and CVD risk.
“Many case -control and prospective observational studies have observed inverse associations between levels of vitamin A and E and risk of CVDs.”
The paper relies on this without support.
Consumption of dietary fibre reduces the risk of CVD.
“Consumption of dietary fibre reduces the risk of CVD.”
The paper relies on this without support.
Observational studies show a protective effect of fruit and vegetable consumption on CVD prevention.
“Observational studies have shown a protective effect of consumption of fruits and vegetables on CVD prevention.”
The paper relies on this without support.
Results from epidemiological studies show a protective effect of moderate alcohol consumption on CVD occurrence.
“Results from epidemiological studies show a protective effect of moderate alcohol consumption on the occurrence of CVD.”
The paper relies on this without support.
The relationship between alcohol consumption and CVD is J-shaped, not explained by special characteristics of abstainers.
“The relationship is J-shaped, which is not explained by special characteristics of abstainers.”
The authors state this as an assumption.
An intake of 30–45 g/day of fibre is assumed to be the optimal preventive level.
“This intake is assumed to be the optimal preventive level.”
The paper relies on this without support.
After multivariable adjustment, raised blood cholesterol and reduced HDL cholesterol remain independently associated with risk, while the association between weight and risk tends to lose significance.
“Raised blood cholesterol and reduced HDL cholesterol levels remain independently associated with risk after adjustment for other major risk factors, whereas the association between weight and risk tends to lose significance.”
The paper relies on this without support.
Increasing BMI is highly associated with risk of CVD.
“Increasing BMI is highly associated with risk of CVD.”
The paper relies on this without support.
Diet, exercise, and behaviour modifications are mainstay therapies for overweight and obesity but are often unsuccessful for long-term treatment.
“Although diet, exercise, and behaviour modifications are the mainstay therapies for overweight and obesity (Table 12), they are often unsuccessful for long-term treatment.”
The paper relies on this without support.
Major issues in bariatric surgery are lack of consensus on available procedures and need for technique refinement to decrease associated risks.
“The major issues in the field of bariatric surgery are the lack of consensus in terms of the diverse procedures available and of the refinement of techniques that will evolve to decrease the associated risks.”
The paper relies on this without support.
Individuals with elevated BP more commonly have other CVD risk factors (diabetes, insulin resistance, dyslipidaemia) and target organ damage.
“Individuals with an elevated BP more commonly have other risk factors for CVD (diabetes, insulin resistance, dyslipidaemia) and target organ damage.”
The paper relies on this without support.
Ambulatory and home BP monitoring allow diagnosis of white coat or isolated clinic hypertension and masked hypertension.
“They also allow two specific clinical conditions to be diagnosed, namely 'white coat' or isolated clinic hypertension characterized by higher office BP with normal ambulatory BP values, and 'masked' hypertension characterized by normal office BP with high ambulatory BP values.417”
The paper relies on this without support.
BP thresholds for definition of hypertension by 24-h ambulatory and home BP monitoring differ from office or clinic measurements.
“BP thresholds for the definition of hypertension by 24-h ambulatory and home BP monitoring differ from those measured at office or clinic (Table 14).”
The paper relies on this without support.
Diagnosis of hypertension and assessment of treatment are still largely based on office or clinic blood pressure.
“Diagnosis of hypertension and assessment of treatment are still largely based on office or clinic blood pressure.”
The paper relies on this without support.
Established cardiovascular or renal disease dramatically increases risk of subsequent cardiovascular events regardless of BP level.
“Established cardiovascular or renal disease (Table 15) dramatically increases the risk of subsequent cardiovascular events regardless of BP level.”
The paper relies on this without support.
Association of hypertension and other cardiovascular risk factors, especially diabetes, also dramatically increases risk.
“This is also the case for the association of hypertension and other cardiovascular risk factors, not least diabetes.”
The paper relies on this without support.
Echocardiography is more sensitive than electrocardiography in diagnosing LVH and predicting cardiovascular risk, and may help in more precise risk stratification and directing therapy.
“Echocardiography is more sensitive than electrocardiography in diagnosing LVH and in predicting cardiovascular risk, and may help in more precise stratification of the overall risk and in directing therapy.”
The paper relies on this without support.
Ultrasound scans limited to common carotid arteries are likely to detect vascular hypertrophy only, whereas assessment of atherosclerosis also requires scanning bifurcations and/or internal carotids where plaques are more frequent.
“Ultrasound scans limited to the common carotid arteries (an infrequent site of atherosclerosis) are likely to detect vascular hypertrophy only, whereas assessment of atherosclerosis also requires scanning of bifurcations and/or internal carotids where plaques are more frequent.”
The paper relies on this without support.
Evidence of arterial damage may also be suggested by an ABI <0.9.
“Evidence of arterial damage may also be suggested by an ABI ,0.9.”
The paper relies on this without support.
A threshold >12 m/s has been suggested as a conservative estimate of significant alterations of aortic function in middle-aged hypertensive patients.
“Although the relationship between aortic stiffness and events is continuous, a threshold .12m/s has been suggested as a conservative estimate of significant alterations of aortic function in middle-aged hypertensive patients.”
The paper relies on this without support.
Diagnosis of hypertension-induced renal damage is based on reduced renal function and/or elevated urinary albumin excretion.
“The diagnosis of hypertension-induced renal damage is based on the finding of a reduced renal function and/or the detection of elevated urinary albumin excretion.”
The paper relies on this without support.
Renal insufficiency is classified according to eGFR calculated using MDRD, Cockcroft-Gault, or CKD-EPI.
“Renal insufficiency is classified according to the eGFR calculated using the MDRD, Cockroft-Gault formula, or CKD-EPI.”
The paper relies on this without support.
The three formulae help detect mildly impaired renal function, particularly if serum creatinine is within normal range and body weight low and/or age advanced.
“The three formulae help to detect mildly impaired renal function, particularly if serum creatinine values are still within the normal range and the body weight low and/or the age advanced.”
The paper relies on this without support.
Microalbuminuria can be measured from spot urine samples by indexing urinary albumin to creatinine; 24-h or night-time urine samples are discouraged due to inaccuracy.
“Microalbuminuria can be measured from spot urine samples (24-h or night-time urine samples are discouraged due to the inaccuracy of urinary sample collection) by indexing the urinary albumin concentration to the urinary creatinine concentration.”
The paper relies on this without support.
A delay in achieving blood pressure control in high-risk hypertensive patients is associated with a worse outcome.
“A delay in achieving BP control in high-risk hypertensive patients is associated with a worse outcome.”
The paper relies on this without support.
In high-risk hypertensive patients, even intense cardiovascular drug therapy cannot lower total cardiovascular risk below the high-risk threshold.
“This is because, in high-risk hypertensive patients, even intense cardiovascular drug therapy-although beneficialcannot lower total cardiovascular risk below the high-risk threshold.”
The paper relies on this without support.
Tobacco smoking has a particularly adverse effect on cardiovascular risk.
“As tobacco smoking has a particularly adverse effect on cardiovascular risk”
The paper relies on this without support.
Long-term compliance with lifestyle changes may be poor.
“As long-term compliance with lifestyle changes may be poor”
The paper relies on this without support.
In type 2 diabetes, LDL cholesterol often remains within the normal range or is just moderately elevated, while a major CVD risk factor is diabetic dyslipidaemia characterized by hypertriglyceridaemia and low HDL cholesterol.
“However, it has to be stressed that in patients with type 2 diabetes, LDL cholesterol often remains within the normal range or is just moderately elevated, while one of the major CVD risk factors in these patients is diabetic dyslipidaemia characterized by hypertriglyceridaemia and low HDL cholesterol.”
The paper relies on this without support.
There are no randomized trials providing sufficient evidence to derive target levels for triglycerides.
“There are, however, no randomized trials to provide sufficient evidence to derive target levels for triglycerides.”
The paper relies on this without support.
There is insufficient scientific evidence for any HDL cholesterol value to be considered a goal of therapy.
“However, there is still not sufficient scientific evidence for any HDL cholesterol value to be considered as a goal of therapy”
The paper relies on this without support.
The cardiovascular risk associated with hypertriglyceridaemia is stronger for moderate than for very severe hypertriglyceridaemia (>10 mmol/L or 900 mg/dL).
“The risk is associated more strongly with moderate than with very severe hypertriglyceridaemia (.10 mmol/L or 900 mg/dL)”
The paper relies on this without support.
Very severe hypertriglyceridaemia (>10 mmol/L or 900 mg/dL) is a risk factor for pancreatitis.
“which is on the other hand a risk factor for pancreatitis.”
The paper relies on this without support.
Fasting triglycerides above 1.7 mmol/L (150 mg/dL) are a marker of increased cardiovascular risk.
“At present, fasting triglycerides .1.7 mmol/L ( 150 mg/dL) continue to be considered as a marker of increased risk”
The paper relies on this without support.
Measuring non-fasting triglycerides lacks standardization.
“However, due to the lack of standardization, measuring non-fasting triglycerides is not recommended.”
The paper relies on this without support.
The combination of moderately elevated triglycerides and low HDL cholesterol is very common in high-risk patients with type 2 diabetes, abdominal obesity, insulin resistance, and physical inactivity.
“The combination of moderately elevated triglycerides and low concentrations of HDL cholesterol is very common in high-risk patients with type 2 diabetes, abdominal obesity, insulin resistance, and who are physically inactive.”
The paper relies on this without support.
This combination is part of a pattern of deranged plasma lipoproteins characterized by increased triglycerides, small dense LDL particles, and low HDL cholesterol.
“It is part of a pattern of deranged plasma lipoproteins characterized by a triad of increased triglycerides, the presence of small, dense, and very atherogenic LDL particles, and low concentrations of HDL cholesterol.”
The paper relies on this without support.
HDL cholesterol below 1.0 mmol/L in men and below 1.2 mmol/L in women may be regarded as a marker of increased risk.
“although HDL cholesterol ,1.0 mmol/L ( 40 mg/dL) in men and ,1.2 mmol/L ( 45 mg/dL) in women may be regarded as a marker of increased risk.”
The paper relies on this without support.
Measurement of apolipoproteins is not available to all physicians in Europe, is more costly than currently used lipid variables, and does not add more information.
“As the measurement of apolipoproteins is not available to all physicians in Europe, is more costly than currently used lipid variables, and does not add more information”
The paper relies on this without support.
Secondary dyslipidaemias can be caused by alcohol abuse, diabetes, Cushing's syndrome, liver and kidney diseases, and several drugs.
“Secondary dyslipidaemias can also be caused by alcohol abuse, diabetes, Cushing's syndrome, diseases of the liver and kidneys, and several drugs (e.g.corticosteroids, isotretinoin and etretinate, cyclosporin).”
The paper relies on this without support.
Treatment of underlying disease often improves hyperlipidaemia and may make other antilipaemic therapy unnecessary.
“as often the treatment of underlying disease improves hyperlipidaemia and no other antilipaemic therapy is necessary.”
The paper relies on this without support.
Dyslipidaemia is common in organ transplant patients due to underlying disease, lifestyle, and treatments including immunosuppressive therapy.
“Dyslipidaemia is common in patients who have undergone organ transplantation due to a combination of factors relating to the underlying disease, lifestyle, and treatments, including immunosuppressive therapy.”
The paper relies on this without support.
5-10% of patients receiving statins develop myopathy, but rhabdomyolysis is extremely rare.
“5-10% of patients receiving statins develop myopathy, but rhabdomyolysis is extremely rare.”
The paper relies on this without support.
The safety profile of statins is acceptable, and earlier observations that lipid-lowering treatment may increase non-cardiovascular mortality or mental disorders have not been confirmed.
“In general, the safety profile of statins is acceptable, and earlier observations that lipid-lowering treatment may contribute an increase in non-cardiovascular mortality (e.g.cancers, suicides, depression) or mental disorders have not been confirmed.”
The paper relies on this without support.
Bile acid sequestrants decrease total and LDL cholesterol but tend to increase triglyceride concentrations.
“Bile acid sequestrants also decrease total and LDL cholesterol but tend to increase triglyceride concentrations.”
The paper relies on this without support.
Combinations of a statin and a bile acid sequestrant or a statin and ezetimibe can achieve greater LDL cholesterol reduction than either drug alone.
“Combinations of a statin and a bile acid sequestrant or a combination of a statin and ezetimibe can be used for greater reduction of LDL cholesterol than can be achieved with either drug alone.”
The paper relies on this without support.
Combinations of niacin and a statin increase HDL cholesterol and decrease triglycerides better than either drug alone, but flushing is the main adverse effect of niacin, which may affect compliance.
“Combinations of niacin and a statin increase HDL cholesterol and decrease triglycerides better than either of these drugs alone, but flushing is the main adverse effect of niacin, which may affect compliance.”
The paper relies on this without support.
Adding laropiprant to niacin might help reduce the incidence of flushing.
“Adding laropiprant to niacin might help in reducing the incidence of this adverse effect.”
The paper relies on this without support.
Fibrates, particularly fenofibrate, may be useful for decreasing high triglycerides and increasing low HDL cholesterol, and can further lower LDL cholesterol when combined with a statin.
“Fibrates, particularly fenofibrate, may be useful, not only for decreasing high triglyceride concentrations and increasing low HDL cholesterol, but can further lower LDL cholesterol when applied together with a statin.”
The paper relies on this without support.
Stroke is the most serious complication of atrial fibrillation.
“Stroke is the most serious complication of AF.”
The paper relies on this without support.
Atrial fibrillation is often unrecognized and untreated in patients admitted with acute ischaemic stroke.
“AF is often unrecognized and untreated in patients admitted with acute ischaemic stroke.”
The paper relies on this without support.
Cost-related medication non-adherence is a relevant problem in many healthcare systems, especially in the elderly and people of low socio-economic status.
“Cost-related medication non-adherence is a relevant problem in many healthcare systems, especially in the elderly and people of low socio-economic status.”
The paper relies on this without support.
Cardiovascular disease is the single most important cause of death for both men and women and can often be prevented.
“Cardiovascular disease is the single most important cause of death for both men and women and can often be prevented!”
The paper relies on this without support.
After a cardiovascular event, secondary preventive efforts within a structured rehabilitation programme have been shown to be particularly important and cost-effective.
“After a cardiovascular event, secondary preventive efforts within a structured rehabilitation programme have been shown to be particularly important and cost-effective.”
The paper relies on this without support.
Smoking bans in public places, by law, lead to a decrease in incidence of myocardial infarction.
“Smoking bans in public places, by law, lead to a decrease in incidence of myocardial infarction.”
The paper relies on this without support.
Microalbuminuria is a risk factor for cardiovascular disease, rising progressively from normal GFR to end-stage renal disease.
“Microalbuminuria is a risk factor for CVD, which rises progressively from a normal GFR to end-stage renal disease.”
The paper relies on this without support.
Effective prevention programmes are undeniably needed.
“However, the need for effective prevention programmes is undeniable, and the evidence shows that nurses can successfully lead or co-ordinate such schemes in a variety of settings.”
The paper relies on this without support.
General practitioners are critical to the implementation and success of CVD prevention programmes in Europe.
“General practitioners are critical to the implementation and success of CVD prevention programmes in Europe.”
The paper relies on this without support.
In most countries, general practitioners deliver more than 90% of consultations and provide most public health medicine.
“In most countries, they deliver .90% of consultations and provide most public health medicine (preventive care, disease screening, chronic disease monitoring, and follow-up).”
The paper relies on this without support.
Primary prevention of CVD performs worse at least partly because it is more difficult to predict who is at greater risk and may benefit from treatment.
“The performance of primary prevention of CVD is even worse, at least partly because of additional difficulties in predicting those at greater risk who may benefit from treatment interventions.”
The paper relies on this without support.
Most cases of CVD are preventable through lifestyle changes and appropriate use of medications already in existence.
“It was concluded that most cases of CVD are preventable through lifestyle changes and appropriate use of medications already in existence.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
According to practice guidelines in place at the time of patient enrollment in IMPROVE-IT, treatment of hypercholesterolemia was based on lowering LDL cholesterol to target levels, which were set on the basis of a patient's risk of cardiovascular events.
“According to practice guidelines in place at the time of patient enrollment in IMPROVE-IT, treatment of hypercholesterolemia was based on lowering LDL cholesterol to target levels, 20,21 which were set on the basis of a patient's risk of cardiovascular events.”
From Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes (2015) · cites this paper as [21]
Aspirin has been shown to be effective in reducing cardiovascular morbidity and mortality in high-risk individuals with previous MI or stroke (secondary prevention).
“Aspirin has been shown to be effective in reducing cardiovascular morbidity and mortality in high-risk individuals with previous MI or stroke (secondary prevention) and is strongly recommended.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [174]
For people with documented ASCVD, use of aspirin for secondary prevention has far greater benefit than risk.
“For people with documented ASCVD, use of aspirin for secondary prevention has far greater benefit than risk; for this indication, aspirin is still recommended (174).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [174]
The 2012 and 2016 European Guidelines on CVD prevention recommend SCORE because it rests on large representative European cohort data and is relatively easy to recalibrate for individual countries.
“The European Guidelines on CVD prevention in clinical practice (both the 2012 [9] and 2016 [10] versions) recommend the use of the SCORE system because it is based on large, representative European cohort data sets and because it is relatively straightforward to recalibrate for individual countries.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [9]
In primary prevention among people without prior cardiovascular events, aspirin's net benefit is controversial.
“In primary prevention, however, among patients with no previous cardiovascular events, its net bene fi t is more controversial (129,140).”
From 10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i> (2023) · cites this paper as [140]
In high-risk patients with prior MI or stroke, aspirin reduces cardiovascular morbidity and mortality.
“Aspirin has been shown to be effective in reducing cardiovascular morbidity and mortality in high-risk patients with previous MI or stroke (secondary prevention) and is strongly recommended.”
From 10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i> (2023) · cites this paper as [140]
The 2012 European Guidelines on cardiovascular disease prevention recommend SCORE because it is based on large, representative European cohort datasets.
“The European Guidelines on CVD prevention in clinical practice (version 2012) 6 recommend use of the SCORE system because it is based on large, representative European cohort datasets.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [6]
The JPAD studies conducted in Japan did not show any protective effects of aspirin on cardiovascular events in patients with DM.
“However, the JPAD studies conducted in Japan did not show any protective effects of aspirin on cardiovascular events in patients with DM825, 826).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [826]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting blood-pressure threshold for starting treatment in diabetes
MajorOne section says to initiate antihypertensive treatment in diabetes at ≥140/90 mmHg; the diabetes section says ≥140/80 mmHg. These thresholds give different treatment decisions for a patient whose systolic pressure is at least 140 and diastolic pressure is between 80 and 89 mmHg.
“In patients with diabetes, antihypertensive treatment should always be initiated when the BP is ≥140/90 mmHg.”
“In diabetic patients, antihypertensive treatment should be initiated when the BP is ≥140/80 mmHg.”
Cites
3 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257 · see citing works
RetractedShaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427 · see citing works
RetractedSmoking cessation for the secondary prevention of coronary heart disease
Critchley, J., & Capewell, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003041.pub2 · Cited by 342 · see citing works
RetractedFriedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364 · see citing works
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026 · see citing works
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805 · see citing works
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · see citing works
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · see citing works
(2014) · Medical Entomology and Zoology · Cited by 9,400 · see citing works
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319 · see citing works
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · see citing works
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E., Green, L. A., Hand, M. M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,345 · see citing works
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261 · see citing works
Self-citationLee, I.-M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61031-9 · Cited by 8,215 · see citing works
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117 · see citing works
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943 · see citing works
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
Self-citation(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848 · see citing works
Self-citationPrasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790 · see citing works
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503 · see citing works
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470 · see citing works
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317 · see citing works
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993 · see citing works
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981 · see citing works
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works
Self-citationHansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728 · see citing works
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638 · see citing works
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290 · see citing works
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138 · see citing works
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · see citing works
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074 · see citing works
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945 · see citing works
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685 · see citing works
D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,474 · see citing works
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · see citing works
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,198 · see citing works
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.061 · Cited by 4,165 · see citing works
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · see citing works
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · see citing works
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974 · see citing works
Subcommittee, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,895 · see citing works
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works
Self-citationSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768 · see citing works
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757 · see citing works
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755 · see citing works
Sick individuals and sick populations
Rose, G. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.427 · Cited by 3,736 · see citing works
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598 · see citing works
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568 · see citing works
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works
Self-citationTelmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502 · see citing works
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,489 · see citing works
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · see citing works
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322 · see citing works
Self-citationType 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · see citing works
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250 · see citing works
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208 · see citing works
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165 · see citing works
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092 · see citing works
Authors Task Force Members, Hamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,069 · see citing works
Self-citationKodama, S. (2009) · JAMA · doi:10.1001/jama.2009.681 · Cited by 3,035 · see citing works
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911 · see citing works
Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67185-1 · Cited by 2,909 · see citing works
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903 · see citing works
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · see citing works
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,819 · see citing works
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775 · see citing works
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761 · see citing works
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757 · see citing works
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works
Dennis, M. S. (1996) · The Lancet · Cited by 2,724 · see citing works
Sick individuals and sick populations
ROSE, G. (1985) · International Journal of Epidemiology · doi:10.1093/ije/14.1.32 · Cited by 2,701 · see citing works
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658 · see citing works
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · see citing works
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,514 · see citing works
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502 · see citing works
Self-citationUse of mass media campaigns to change health behaviour
Wakefield, M. A., Loken, B., & Hornik, R. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60809-4 · Cited by 2,485 · see citing works
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479 · see citing works
Self-citationStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works
Self-citationStein, J. H., Korcarz, C. E., Hurst, R. T., Lonn, E., Kendall, C. B., Mohler, E. R., Najjar, S. S., Rembold, C. M., & Post, W. S. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.11.011 · Cited by 2,424 · see citing works
The pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394 · see citing works
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326 · see citing works
Body-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317 · see citing works
Authors Task Force Members, de Werf, F. V., Bax, J. J., Betriu, A., Blomström‐Lundqvist, C., Crea, F., Falk, V., Filippatos, G. S., Fox, K. A. A., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,294 · see citing works
Self-citationDiener, H.-C., Bogousslavsky, J., Brass, L. M., Cimminiello, C., Csiba, L., Kaste, M., Leys, D., Matias-Guiu, J., & Rupprecht, H.-J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16721-4 · Cited by 2,275 · see citing works
Self-citationTaylor, R. S., Brown, A., Ebrahim, S., Jolliffe, J., Noorani, H., Rees, K., Skidmore, B., Stone, J. A., Thompson, D. R., & Oldridge, N. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.009 · Cited by 2,239 · see citing works
Self-citationFletcher, G. F., Ades, P. A., Kligfield, P., Arena, R., Balady, G. J., Bittner, V. A., Coke, L. A., Fleg, J. L., Forman, D. E., Gerber, T. C., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829b5b44 · Cited by 2,235 · see citing works
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
Mitchell, G. F., Hwang, S.-J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., Vita, J. A., Levy, D., & Benjamin, E. J. (2010) · Circulation · doi:10.1161/circulationaha.109.886655 · Cited by 2,225 · see citing works
Porta, M. (2026) · doi:10.1093/acref/9780197663639.001.0001 · Cited by 2,175 · see citing works
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173 · see citing works
Self-citationCardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · see citing works
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155 · see citing works
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143 · see citing works
Guide to Clinical Preventive Services
Allen, T. W. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,132 · see citing works
International Journal of Obesity
(2019) · International Journal of Obesity · doi:10.1038/41366.1476-5497 · Cited by 2,092 · see citing works
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081 · see citing works
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., & Velazquez, E. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806182 · Cited by 2,065 · see citing works
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058 · see citing works
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047 · see citing works
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036 · see citing works
Self-citationThe diabetes risk score: a practical tool to predict type 2 diabetes risk.
Lindström, J., & Tuomilehto, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 2,022 · see citing works
Chambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990 · see citing works
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966 · see citing works
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,958 · see citing works
Self-citationPhysician advice for smoking cessation
Stead, L. F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub4 · Cited by 1,955 · see citing works
Fletcher, G. F., Balady, G. J., Amsterdam, E. A., Chaitman, B., Eckel, R., Fleg, J., Froelicher, V. F., Leon, A. S., Piña, I. L., Rodney, R., et al. (2001) · Circulation · doi:10.1161/hc3901.095960 · Cited by 1,923 · see citing works
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · see citing works
Fowkes, F. G. R., Murray, G. D., Butcher, I., Heald, C. L., Lee, R. J., Chambless, L. E., Folsom, A. R., Hirsch, A. T., Dramaix, M., DeBacker, G., et al. (2008) · JAMA · doi:10.1001/jama.300.2.197 · Cited by 1,870 · see citing works
Self-citationMotivational interviewing: a systematic review and meta-analysis.
Rubak, S., Sandbæk, A., Lauritzen, T., & Christensen, B. (2005) · Europe PMC (PubMed Central) · Cited by 1,855 · see citing works
Exercise-based cardiac rehabilitation for coronary heart disease
Heran, B. S., Chen, J. M., Ebrahim, S., Moxham, T., Oldridge, N., Rees, K., Thompson, D. R., & Taylor, R. S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001800.pub2 · Cited by 1,844 · see citing works
Self-citationMancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f0580f · Cited by 1,837 · see citing works
Self-citationGibbons, R., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P., Douglas, J. S., Ferguson, T., Fihn, S. D., Fraker, T., Gardin, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047041.66447.29 · Cited by 1,830 · see citing works
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807 · see citing works
Self-citation(2010) · PsycEXTRA Dataset · doi:10.1037/e590462011-001 · Cited by 1,799 · see citing works
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782 · see citing works
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · see citing works
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · see citing works
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715 · see citing works
Collaborative care for patients with depression and chronic illnesses
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003955 · Cited by 1,697 · see citing works
Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., DEEDWANIA, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., Gardin, J. M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02848-6 · Cited by 1,688 · see citing works
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665 · see citing works
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655 · see citing works
Self-citationRomero-Corral, A., Montori, V. M., Somers, V. K., Korinek, J., Thomas, R. J., Allison, T. G., Mookadam, F., & Lopez-Jimenez, F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69251-9 · Cited by 1,652 · see citing works
Cardiovascular fitness, cortical plasticity, and aging
Colcombe, S. J., Kramer, A. F., Erickson, K. I., Scalf, P., McAuley, E., Cohen, N. J., Webb, A., Jerome, G. J., Marquez, D. X., & Elavsky, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400266101 · Cited by 1,648 · see citing works
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647 · see citing works
Self-citationMancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643 · see citing works
Self-citationSugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641 · see citing works
Ronksley, P. E., Brien, S. E., Turner, B. J., Mukamal, K. J., & Ghali, W. A. (2011) · BMJ · doi:10.1136/bmj.d671 · Cited by 1,610 · see citing works
Sofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605 · see citing works
A strategy to reduce cardiovascular disease by more than 80%
Wald, N., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568 · see citing works
Gottlieb, D. J., Yenokyan, G., Newman, A. B., O'Connor, G. T., Punjabi, N. M., Quan, S. F., Redline, S., Resnick, H. E., Tong, E. K., Diener-West, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901801 · Cited by 1,551 · see citing works
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541 · see citing works
Celermajer, D. S., Sørensen, K. E., Georgakopoulos, D., Bull, C., Thomas, O., Robinson, J. T. C., & Deanfield, J. E. (1993) · Circulation · doi:10.1161/01.cir.88.5.2149 · Cited by 1,532 · see citing works
Willum Hansen, T., Staessen, J. A., Torp-Pedersen, C., Rasmussen, S., Thijs, L., Ibsen, H., & Jeppesen, J. (2006) · Circulation · doi:10.1161/circulationaha.105.579342 · Cited by 1,515 · see citing works
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509 · see citing works
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Endorsed by: the European Stroke Organisation (ESO), Authors/Task Force Members, Tendera, M., Aboyans, V., Bartelink, M.-L., Baumgartner, I., Clément, D., Collet, J.-P., Cremonesi, A., De Carlo, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr211 · Cited by 1,506 · see citing works
Self-citationMedication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488 · see citing works
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials
Mensink, R. P., & Katan, M. B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.911 · Cited by 1,477 · see citing works
European cardiovascular disease statistics
Allender, S. E., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R., & Gray, A. M. (2008) · Deakin Research Online (Deakin University) · Cited by 1,459 · see citing works
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459 · see citing works
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189375 · Cited by 1,450 · see citing works
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · see citing works
Mortality in relation to smoking : 40 years' observations on male British doctors
Doll, H. (1994) · Medical Entomology and Zoology · Cited by 1,417 · see citing works
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414 · see citing works
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · see citing works
Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391 · see citing works
Franklin, S. S., Larson, M. G., Khan, S. A., Wong, N. D., Leip, E. P., Kannel, W. B., & Levy, D. (2001) · Circulation · doi:10.1161/01.cir.103.9.1245 · Cited by 1,390 · see citing works
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · see citing works
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
Smeeth, L. L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., & Vallance, P. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041747 · Cited by 1,375 · see citing works
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358 · see citing works
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353 · see citing works
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · see citing works
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352 · see citing works
de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A. A., White, H. D., Rouleau, J.-L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., et al. (2004) · JAMA · doi:10.1001/jama.292.11.1307 · Cited by 1,333 · see citing works
Treatment of periodontitis and endothelial function
Tonetti, M. S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A. D., Vallance, P., & Deanfield, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063186 · Cited by 1,326 · see citing works
Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325 · see citing works
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 1,321 · see citing works
Sleep Apnea and Cardiovascular Disease
Somers, V. K., White, D. P., Amin, R. S., Abraham, W. T., Costa, F., Culebras, A., Daniels, S. R., Floras, J. S., Hunt, C. E., Olson, L. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189420 · Cited by 1,301 · see citing works
Lue, T. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422407 · Cited by 1,261 · see citing works
Siri-Tarino, P. W., Sun, Q., Hu, F. B., & Krauss, R. M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27725 · Cited by 1,253 · see citing works
Projected effect of dietary salt reductions on future cardiovascular disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907355 · Cited by 1,253 · see citing works
Wood, D., Backer, G. D., Færgeman, O., Graham, I. D., Mancia, G., & Pyörälà, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,251 · see citing works
Self-citationA review of European research on consumer response to nutrition information on food labels
Grunert, K. G., & Wills, J. M. (2007) · Journal of Public Health · doi:10.1007/s10389-007-0101-9 · Cited by 1,250 · see citing works
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243 · see citing works
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice
Rozanski, A., Blumenthal, J. A., Davidson, K. W., Saab, P. G., & Kubzansky, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.005 · Cited by 1,238 · see citing works
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works
Self-citationThe Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216 · see citing works
Dauchet, L., Amouyel, P., Hercberg, S., & Dallongeville, J. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.10.2588 · Cited by 1,204 · see citing works
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
Farrell, B., Godwin, J., Richards, S. M., & Warlow, C. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.12.1044 · Cited by 1,201 · see citing works
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · see citing works
Flagged first, then by citations
Research works printed but not linked: 24
- SIGN (Scottish Intercollegiate Guidelines Network), 2007, Risk Estimation and the Prevention of Cardiovascular Disease. A National Clinical Guideline
- World Health Organization, 2002, Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases
- World Health Organization, Regional Office for Europe, 1973, The Prevention and Control of Major Cardiovascular Diseases. Report of a Conference
- Tunstall-Pedoe H (World Health Organization), 2003, MONICA Monograph and Multimedia Sourcebook
- Vander Stichele, 2008, Is the decline in coronary attack rates leveling off in Flanders?, Eur J Cardiovasc Prev Rehabil, 15 suppl 1, S1
- National Institute for Health and Clinical Excellence, 2010, Prevention of Cardiovascular Disease: Costing Report
- Cooney, 2009, How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators, Eur J Cardiovasc Prev Rehabil, 16, 304, 10.1097/hjr.0b013e3283213140 · DOI · Paper page
- Cooney, 2009, HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk, Atherosclerosis, 206, 611, 10.1016/j.atherosclerosis.2009.02.041 · DOI · Paper page
- World Health Organization, Global Health Observatory Data Repository
- Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med, 1, 108
- Thun, 1997, Age and the exposure–response relationships between cigarette smoking and premature death in Cancer Prevention Study II, 383
- Center for Disease Control and Prevention, 2010, How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking-attributable Disease
- WHO Study Group on Tobacco Product Regulation TobReg, 2005, Waterpipe Tobacco Smoking: Health Effects, Research Needs and Recommended Actions by Regulators
- International Agency for Research on Cancer, 2007, Tobacco Control: Reversal of Risk After Quitting Smoking. IARC Handbooks of Cancer Prevention
- National Institute for Health and Clinical Excellence, 2008, NICE Public Health Guidance 10. Smoking Cessation Services in Primary Care, Pharmacies, Local Authorities and Workplaces, Particularly for Manual Working Groups, Pregnant Women and Hard to Reach Communities
- European Heart, 2011, Diet, Physical Activity and Cardiovascular Disease Prevention in Europe
- Abuannadi, 2011, Give me sunshine: vitamin D cardiovascular health, Prim Care Cardiovasc J, 4, 59
- US Department of Health and Human Services, 2008, Physical Activity Guidelines Advisory Committee Report
- US Department of Health and Human Services, 2008, 2008 Physical Activity Guidelines for Americans
- World Health Organization, 1998, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, World Health Organization Technical Report Series
- Lohman, 1998, Anthoropometric Standardization Reference Manual
- Antithrombotic Trialists' Collaboration, 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 · DOI · Paper page
- Liu, 2000, Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack, Cochrane Database Syst Rev, 2
- Wood, 2007, Clinical reality of coronary prevention in Europe: a comparison of EUROPASPIRE I, II, and III surveys. Paper presented at, The 29th Annual Congress of the European Society of Cardiology
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
Self-citationJames, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · see citing works
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,638 · see citing works
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429 · see citing works
Self-citation2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works
Self-citationHindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works
Self-citationIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728 · see citing works
Self-citation2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167 · see citing works
Self-citation2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166 · see citing works
Self-citationAuthors Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Mario, C. D., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,837 · see citing works
Self-citation2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485 · see citing works
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866 · see citing works
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655 · see citing works
Self-citation2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945 · see citing works
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works
Self-citationArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536 · see citing works
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572 · see citing works
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510 · see citing works
Self-citationEzetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487 · see citing works
2014 ESC/EACTS Guidelines on myocardial revascularization
Authors Task Force Members, Windecker, S., Kolh, P., Alfonso, F., Collet, J., Cremer, J., Falk, V., Filippatos, G., Hamm, C. W., Head, S. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,340 · see citing works
Self-citation2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P. H., Windecker, S., Alfonso, F., Collet, J., Cremer, J., Falk, V., Filippatos, G. S., Hamm, C. W., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,211 · see citing works
Self-citationPriori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893 · see citing works
Self-citationESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
Self-citationGoff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437741.48606.98 · Cited by 3,697 · see citing works
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works
Self-citationHeidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works
Self-citationZelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845 · see citing works
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · see citing works
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761 · see citing works
Self-citationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644 · see citing works
Self-citationWanhainen, A., Verzini, F., HERZEELE, I. V., Allaire, É., Bown, M. J., Cohnert, T. U., Dick, F., van Herwaarden, J. A., Karkos, C. D., Koelemay, M. J. W., et al. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.09.020 · Cited by 2,326 · see citing works
Self-citation2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215089 · Cited by 2,011 · see citing works
Guidelines on the management of valvular heart disease (version 2012)
Authors Task Force Members, Vahanian, A. S., Alfieri, O., Andreotti, F., Antunes, M. J., Barón‐Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., Bonis, M. D., et al. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs455 · Cited by 2,000 · see citing works
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958 · see citing works
Self-citationAuthors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,958 · see citing works
Self-citation2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896 · see citing works
Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease
Anderson, L., Oldridge, N., Thompson, D. R., Zwisler, A.-D., Rees, K., Martin, N., & Taylor, R. S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.044 · Cited by 1,910 · see citing works
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880 · see citing works
Exercise-based cardiac rehabilitation for coronary heart disease
Heran, B. S., Chen, J. M., Ebrahim, S., Moxham, T., Oldridge, N., Rees, K., Thompson, D. R., & Taylor, R. S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001800.pub2 · Cited by 1,844 · see citing works
Self-citationCritical review: vegetables and fruit in the prevention of chronic diseases
Boeing, H., Bechthold, A., Bub, A., Ellinger, S., Haller, D., Kroke, A., Leschik‐Bonnet, E., Müller, M. J., Oberritter, H., Schulze, M. B., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0380-y · Cited by 1,776 · see citing works
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
Authors Task Force Members, Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. D., Ford, I., González‐Juanatey, J. R., Görenek, B., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,650 · see citing works
Self-citationAuthors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,667 · see citing works
Self-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works
Self-citationESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,578 · see citing works
Reed, G. W., Rossi, J., & Cannon, C. P. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,569 · see citing works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547 · see citing works
Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., McGuire, D. K., Rosengren, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800256 · Cited by 1,475 · see citing works
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Mónica Acevedo, B., Appelman, Y., Merz, C. N. B., Chieffo, A., Figtree, G. A., Guerrero, M. E., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,536 · see citing works
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482 · see citing works
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,409 · see citing works
Self-citationDepression and cardiovascular disease: a clinical review
Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht462 · Cited by 1,362 · see citing works
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380 · see citing works
Cardiovascular disease in Europe: epidemiological update
Nichols, M. S., Townsend, N. P., Scarborough, P., & Rayner, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht356 · Cited by 1,349 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works
Self-citationEffects of stress on the development and progression of cardiovascular disease
Kivimäki, M., & Steptoe, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.189 · Cited by 1,197 · see citing works
Kaptoge, S. K., Pennells, L. A. M., Bacquer, D. D., Cooney, M. T., Kavousi, M., Stevens, G. A., Riley, L. M., Savin, S., Khan, T., Altay, S., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30318-3 · Cited by 1,206 · see citing works
Self-citationC-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150 · see citing works
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,183 · see citing works
The Assessment of Endothelial Function
Flammer, A. J., Anderson, T. J., Celermajer, D. S., Creager, M. A., Deanfield, J. E., Ganz, P., Hamburg, N. M., Lüscher, T. F., Shechter, M., Taddei, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.093245 · Cited by 1,157 · see citing works
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,219 · see citing works
Self-citationChowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1788 · Cited by 1,139 · see citing works
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116 · see citing works
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
McNeil, J. J., Wolfe, R., Woods, R. L., Tonkin, A. M., Donnan, G. A., Nelson, M. R., Reid, C. M., Lockery, J. E., Kirpach, B., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805819 · Cited by 1,139 · see citing works
Nolan, J. P., Sandroni, C., Böttiger, B. W., Cariou, A., Cronberg, T., Friberg, H., Genbrugge, C., Haywood, K. L., Lilja, G., Moulaert, V. R. M., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06368-4 · Cited by 1,082 · see citing works
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,305 · see citing works
Update on acute coronary syndromes: the pathologists' view
Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V., & Virmani, R. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs411 · Cited by 1,047 · see citing works
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Tao, L., Xu, J., Wang, T., Hua, F., & Li, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01511-x · Cited by 1,059 · see citing works
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051 · see citing works
Pathophysiology of Atherosclerosis
Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito‐Vicente, A., & Martı́n, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,078 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2019
Timmis, A., Townsend, N. P., Gale, C. P., Torbica, A., Lettino, M., Petersen, S. E., Mossialos, E. A., Maggioni, A. P., Kazakiewicz, D., May, H. T., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz859 · Cited by 1,035 · see citing works
Self-citationThijssen, D. H. J., Bruno, R. M., van Mil, A. C. C. M., Holder, S. M., Faita, F., Greyling, A., Zock, P. L., Taddei, S., Deanfield, J. E., Lüscher, T. F., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz350 · Cited by 1,007 · see citing works
Kotseva, K., Wood, D., Bacquer, D. D., Backer, G. D., Rydén, L., Jennings, C. S., Gyberg, V., Amouyel, P., Bruthans, J., Conde, A. C., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315569401 · Cited by 1,004 · see citing works
Self-citationAdvancing social connection as a public health priority in the United States.
Holt-Lunstad, J., Robles, T. F., & Sbarra, D. A. (2017) · American Psychologist · doi:10.1037/amp0000103 · Cited by 978 · see citing works
The Mediterranean Diet, its Components, and Cardiovascular Disease
Widmer, R. J., Flammer, A. J., Lerman, L. O., & Lerman, A. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.014 · Cited by 963 · see citing works
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Timon, I. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 982 · see citing works
Coronary Calcium Score and Cardiovascular Risk
Greenland, P., Blaha, M. J., Budoff, M. J., Erbel, R., & Watson, K. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.027 · Cited by 967 · see citing works
Ambrosetti, M., Abreu, A., Corrà, U., Davos, C. H., Hansen, D., Frederix, I., Iliou, M. C., Pedretti, R. F. E., Schmid, J.-P., Vigorito, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1177/2047487320913379 · Cited by 965 · see citing works
State of the art review: depression, stress, anxiety, and cardiovascular disease
Cohen, B. E., Edmondson, D., & Kronish, I. M. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv047 · Cited by 955 · see citing works
Srour, B., Fezeu, L. K., Kesse-Guyot, E., Allès, B., Méjean, C., Andrianasolo, R. M., Chazelas, E., Deschasaux, M., Hercberg, S., Galan, P., et al. (2019) · BMJ · doi:10.1136/bmj.l1451 · Cited by 955 · see citing works
Nolan, J. P., Soar, J., Cariou, A., Cronberg, T., Moulaert, V. R. M., Deakin, C. D., Böttiger, B. W., Friberg, H., Sunde, K., & Sandroni, C. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4051-3 · Cited by 946 · see citing works
Kotseva, K., Backer, G. D., Bacquer, D. D., Rydén, L., Hoes, A. W., Grobbee, D. E., Maggioni, A. P., Marques-Vidal, P. M., Jennings, C. S., Abreu, A., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318825350 · Cited by 940 · see citing works
Self-citationOlsen, M., Angell, S., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J., Damasceno, A. A., Delles, C., Gimenez-Roqueplo, A., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 825 · see citing works
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works
Matsushita, K., Coresh, J., Sang, Y., Chalmers, J. P., Fox, C. S., Güallar, E., Jafar, T. H., Jassal, S. K., Landman, G. W. D., Muntner, P., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00040-6 · Cited by 913 · see citing works
Scherr, J., Wolfarth, B., Christle, J. W., Pressler, A., Wagenpfeil, S., & Halle, M. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2421-x · Cited by 875 · see citing works
10. Cardiovascular Disease and Risk Management: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s010 · Cited by 869 · see citing works
Lelieveld, J., Klingmüller, K., Pozzer, A., Pöschl, U., Fnais, M. S., Daiber, A., & Münzel, T. F. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz135 · Cited by 908 · see citing works
Stress and Cardiovascular Disease: An Update on Current Knowledge
Steptoe, A., & Kivimäki, M. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114452 · Cited by 879 · see citing works
Mancia, G., Laurent, S., Agabiti‐Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cífková, R., Clement, D. L., Coca, A., Dominiczak, A. F., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 893 · see citing works
Self-citationGaziano, J. M., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P. B., Howard, G., Pearson, T. A., Rothwell, P. M., Ruilope, L. M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31924-x · Cited by 883 · see citing works
Self-citationSong, P., Fang, Z. A., Wang, H., Cai, Y. S., Rahimi, K., Zhu, Y., Fowkes, F. G. R., Fowkes, F. J. I., & Rudan, I. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30117-0 · Cited by 880 · see citing works
Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G. F., Sypniewska, G., Wiklund, O., Borén, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw152 · Cited by 847 · see citing works
Self-citationDE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870 · see citing works
Cavalcante, J. L., Lima, J. A. C., Redheuil, A. B., & Al-Mallah, M. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.017 · Cited by 845 · see citing works
Hochhaus, A., Saglio, G. N., Hughes, T. P., Larson, R. A., Kim, D.-W., Issaragrisil, S., le Coutre, P. D., Étienne, G., Dorlhiac‐Llacer, P. E., Clark, R. E., et al. (2016) · Leukemia · doi:10.1038/leu.2016.5 · Cited by 836 · see citing works
Fanouriakis, A., Kostopoulou, M., Cheema, K., Anders, H., Aringer, M., Bajema, I. M., Boletis, J., Frangou, E. A., Houssiau, F., Hollis, J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-216924 · Cited by 846 · see citing works
- Authors
- Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvänne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. L., Zannad, F., guidelines:, O. E. W. C. T. P. O. T., Cooney, M. T., ESC Committee for Practice Guidelines (CPG):, Bax, J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B. A., Reiner, Ž., Sechtem, U., Sirnes, P. A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Reviewers:, D., Funck-Brentano, C., Sirnes, P. A., Aboyans, V., Ezquerra, E. A., Baigent, C., Brotons, C., Burell, G., Ceriello, A., De Sutter, J., Deckers, J., Del Prato, S., Diener, H.-C., Fitzsimons, D., Fras, Z., Hambrecht, R., Jankowski, P., Keil, U., Kirby, M., Larsen, M. L., Mancia, G., Manolis, A. J., McMurray, J., Pająk, A., Parkhomenko, A., Rallidis, L., Rigo, F., Rocha, E., Ruilope, L. M., van der Velde, E., Vanuzzo, D., Viigimaa, M., Volpe, M., Wiklund, O., & Wolpert, C.
- Affiliations
- Linnaeus University (SE)
- 1 Societies: 1European Society of Cardiology (ESC)
- European Society of Cardiology (FR)
- European Society of Hypertension (IT)
- 5 European Society of Hypertension (ESH)
- European Association for the Study of Diabetes (DE)
- 6 European Association for the Study of Diabetes (EASD)
- European Heart Network (BE)
- Corresponding author
- Authors/Task Force Members:
- ORCID
- Graham, Ian
- Albus, Christian
- Benlian, Pascale
- Ebrahim, Shah
- Hobbs, Richard
- Karadeniz, Sehnaz
- Mezzani, Alessandro
- Prescott, Eva
- Scherer, Martin
- Wood, David
- Zannad, Faiez
- Cooney, Marie Therese
- Bax, Jeroen
- Ceconi, Claudio
- Hasdai, David
- Kirchhof, Paulus
- Knuuti, Juhani
- Kolh, Philippe
- McDonagh, Theresa
- Popescu, Bogdan A.
- Torbicki, Adam
- Vahanian, Alec
- Windecker, Stephan
- Aboyans, Victor
- Baigent, Colin
- Brotons, Carlos
- Ceriello, Antonio
- Fitzsimons, Donna
- Fras, Zlatko
- Hambrecht, Rainer
- Jankowski, Piotr
- Kirby, Mike
- Mancia, Giuseppe
- Manolis, Athanasios J.
- McMurray, John
- Parkhomenko, Alexander
- Rigo, Fausto
- Rocha, Evangelista
- Ruilope, Luis Miguel
- Vanuzzo, Diego
- Viigimaa, Margus
- Volpe, Massimo
- Wiklund, Olov
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-03
- Volume
- 33
- Issue
- 13
- Pages
- 1635-1701
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W3021842026
- Cited by
- 8,490
- References
- 868
- Citations by year
- 2026: 29 · 2025: 94 · 2024: 237 · 2023: 331 · 2022: 409 · 2021: 740 · 2020: 895 · 2019: 837 · 2018: 799 · 2017: 802 · 2016: 694 · 2015: 684 · 2014: 693 · 2013: 561 · 2012: 329
- FWCI
- 700.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Wellcome Trust (084674)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- cardiovascular disease prevention, cardiovascular risk management, primary prevention, secondary prevention, cardiovascular risk assessment
- MeSH terms
- Smoking Prevention, Adult, Aged, Antihypertensive Agents, Blood Pressure, Cardiology, Cardiovascular Agents, Cardiovascular Diseases, Chronic Disease, Delivery of Health Care, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diagnostic Imaging, Diet, Drug Combinations, Female, Health Promotion, Hospitalization, Humans, Hypercholesterolemia, Hypertension, Life Style, Lipids, Male, Middle Aged, Obesity, Physician's Role, Primary Health Care, Prognosis, Self Care, Smoking, Socioeconomic Factors, Stress, Psychological, Biomarkers, Exercise, Smoking Cessation, Risk Assessment, Patient Selection, Evidence-Based Medicine, Nurse's Role, Risk Reduction Behavior, Early Diagnosis, Medication Adherence, Electronic Health Records, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-04.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-04.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review